20140101 8:00AM UTC,"Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda",http://www.reuters.com/article/2014/01/01/bc-ac-idUSnPnjsB9hn+88+PRN20140101,
20140108 9:30AM UTC,CUA and Pfizer Canada Award Clinical Fellowships in Incontinence,http://www.reuters.com/article/2014/01/08/idUSnMKWtPnF3a+1d4+MKW20140108,
20140108 8:00AM UTC,"Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix",http://www.reuters.com/article/2014/01/08/bc-aaa-research-reports-idUSnPn7JSwhn+98+PRN20140108,
20140109 8:47AM UTC,Avillion Group Partners with Pfizer to Co-develop BOSULIFÂ® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia,http://www.reuters.com/article/2014/01/09/avillion-group-pfizer-idUSnPnPHj5ljh+160+PRN20140109,
20140109 8:03AM UTC,Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease,http://www.reuters.com/article/2014/01/09/ma-akili-labs-pfizer-idUSnPnNEj27hr+160+PRN20140109,
20140113 8:00AM UTC,"Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis",http://www.reuters.com/article/2014/01/13/idUSnGNX96Hs1J+1c9+GNW20140113,
20140114 8:00AM UTC,"Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene",http://www.reuters.com/article/2014/01/14/bc-a-idUSnPn84wwhn+80+PRN20140114,
20140114 6:23AM UTC,"Exclusive: Valeant, Actavis, Mylan eye Pfizer's generics unit",http://www.reuters.com/article/2014/01/14/us-pfizer-valeant-idUSBREA0D0CZ20140114,
20140117 10:15AM UTC,Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health,http://www.reuters.com/article/2014/01/17/pfizer-idUSnBw175501a+100+BSW20140117,
20140123 8:00AM UTC,Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study,http://www.reuters.com/article/2014/01/23/pfizer-idUSnBw235110a+100+BSW20140123,
20140127 10:45AM UTC,Pfizer lung cancer drug fails in two large studies,http://www.reuters.com/article/2014/01/27/us-pfizer-lungcancerdrug-idUSBREA0Q0NL20140127,
20140127 10:39AM UTC,UPDATE 2-Pfizer lung cancer drug fails in two large studies,http://www.reuters.com/article/2014/01/27/pfizer-lungcancerdrug-idUSL3N0L13ND20140127,
20140127 7:20AM UTC,Pfizer says lung cancer drug fails two late-stage studies,http://www.reuters.com/article/2014/01/27/pfizer-lungcancerdrug-idUSL3N0L13KG20140127,
20140127 7:00AM UTC,Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer,http://www.reuters.com/article/2014/01/27/pfizer-idUSnBw275477a+100+BSW20140127,
20140127 5:01AM UTC,"Pfizer, VF Corp. and GT Nexus to Explore Benefits of a Shared Global Trade Information Network",http://www.reuters.com/article/2014/01/27/idUSnMKWmcxbQa+1c2+MKW20140127,
20140128 5:52PM UTC,US STOCKS-Wall St recovers with Pfizer; futures up on Turkey's rate hike,http://www.reuters.com/article/2014/01/28/markets-usa-stocks-idUSL2N0L21Y220140128,
20140128 4:50PM UTC,US STOCKS-Wall St rebounds with Pfizer and the Fed; Apple sinks,http://www.reuters.com/article/2014/01/28/markets-usa-stocks-idUSL2N0L21ST20140128,
20140128 2:08PM UTC,"Pfizer beats profit estimates, investors eye experimental drugs",http://www.reuters.com/article/2014/01/28/us-pfizer-results-idUSBREA0R0SP20140128,
20140128 2:07PM UTC,"UPDATE 4-Pfizer beats profit estimates, investors eye experimental drugs",http://www.reuters.com/article/2014/01/28/pfizer-results-idUSL2N0L20G920140128,
20140128 7:17AM UTC,Pfizer beats fourth quarter forecasts on sales,http://www.reuters.com/article/2014/01/28/pfizer-results-idUSL2N0L11ZO20140128,
20140128 7:00AM UTC,Pfizer Reports Fourth-Quarter and Full-Year 2013 Results; Provides 2014 Financial Guidance,http://www.reuters.com/article/2014/01/28/pfizer-idUSnBw285798a+100+BSW20140128,
20140203 11:28AM UTC,Pfizer breast cancer drug succeeds in mid-stage trial,http://www.reuters.com/article/2014/02/03/us-pfizer-study-cancer-idUSBREA120OD20140203,
20140203 11:25AM UTC,UPDATE 2-Pfizer breast cancer drug succeeds in mid-stage trial,http://www.reuters.com/article/2014/02/03/pfizer-study-cancer-idUSL3N0L82AU20140203,
20140203 7:18AM UTC,Pfizer breast cancer drug succeeds in mid-stage trial,http://www.reuters.com/article/2014/02/03/pfizer-study-cancer-idUSL3N0L829K20140203,
20140203 7:00AM UTC,Pfizer Announces Positive Top-Line Results From PALOMA-1 Evaluating Palbociclib Plus Letrozole in Women with Advanced Breast Cancer,http://www.reuters.com/article/2014/02/03/pfizer-idUSnBw035581a+100+BSW20140203,
20140204 1:08PM UTC,"MARKET PULSE-Microsoft, AOL, Zynga, Furiex, Enzo Biochem, Pfizer",http://www.reuters.com/article/2014/02/04/markets-usa-stocks-pulse-idUSL3N0L93JT20140204,
20140204 10:00AM UTC,LiveWorld and Pfizer to Present a Series of Panels on Social Media Within Regulated Industries at Social Media Week,http://www.reuters.com/article/2014/02/04/ca-liveworld-idUSnBw045705a+100+BSW20140204,
20140204 7:45AM UTC,Jacobs and Pfizer Provide Sterile Drug Product Manufacturing Technology to Emerging Markets,http://www.reuters.com/article/2014/02/04/ca-jacobs-engineering-idUSnBw045457a+100+BSW20140204,
20140206 1:01PM UTC,Pfizer beats back generic competition for Lyrica,http://www.reuters.com/article/2014/02/06/pfizer-teva-lyrica-idUSL2N0LB18A20140206,
20140210 9:30AM UTC,"The Zacks Analyst Blog Highlights:Walt Disney, Chevron, Wal-Mart Stores, Pfizer and Microsoft",http://www.reuters.com/article/2014/02/10/zacks-equity-research-idUSnPnCGqTvkT+169+PRN20140210,
20140211 2:03PM UTC,Pfizer Statement on Todayâ€™s Joint Meeting of FDA Advisory Committees,http://www.reuters.com/article/2014/02/11/pfizer-idUSnBw116555a+100+BSW20140211,
20140213 3:27AM UTC,Pfizer faces legal action from Australian competition regulator,http://www.reuters.com/article/2014/02/13/us-pfizer-australia-idUSBREA1C0C520140213,
20140213 3:26AM UTC,Pfizer faces legal action from Australian competition regulator,http://www.reuters.com/article/2014/02/13/pfizer-australia-idUSL3N0LI33S20140213,
20140214 9:30AM UTC,Mytrus And Pfizer Win Best Practice Award For Strategic Innovation In Clinical Trials At Summit for Clinical Ops Executives (SCOPE),http://www.reuters.com/article/2014/02/14/ma-inventiv-mytrus-idUSnPnNYsd3kT+161+PRN20140214,
20140218 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,http://www.reuters.com/article/2014/02/18/pfizer-idUSnBw185079a+100+BSW20140218,
20140224 4:10PM UTC,UPDATE 4-Pfizer's Prevnar prevents pneumonia in elderly - study,http://www.reuters.com/article/2014/02/24/pfizer-vaccine-idUSL1N0LT0TR20140224,
20140224 11:45AM UTC,Pfizer's Prevnar prevents pneumonia in elderly - study,http://www.reuters.com/article/2014/02/24/us-pfizer-vaccine-idUSBREA1N10120140224,
20140224 11:45AM UTC,Pfizer Announces FDA Approval to Include Radiographic Data on Reduction of Progression of Structural Joint Damage for Adults with Moderately to Severely Active Rheumatoid Arthritis in Labeling for XELJANZÂ® (tofacitinib citr,http://www.reuters.com/article/2014/02/24/pfizer-idUSnBw246438a+100+BSW20140224,
20140224 8:28AM UTC,Pfizer study shows Prevenar prevents pneumonia in people 65 and older,http://www.reuters.com/article/2014/02/24/pfizer-vaccine-idUSL1N0LT0SE20140224,
20140224 7:00AM UTC,Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*,http://www.reuters.com/article/2014/02/24/pfizer-idUSnBw245899a+100+BSW20140224,
20140305 1:13PM UTC,"Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array",http://www.reuters.com/article/2014/03/05/bc-analysts-review-idUSnPnpHMTtf+9c+PRN20140305,
20140306 6:08PM UTC,Pfizer recalls antidepressant after report of wrong drug in bottle,http://www.reuters.com/article/2014/03/06/pfizer-recall-idUSL1N0M32M120140306,
20140306 5:15PM UTC,Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizerâ€™s Effexor XRÂ® 150 Mg Extended-Release Capsules and One Lot of Greenstoneâ€™s Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence,http://www.reuters.com/article/2014/03/06/pfizer-idUSnBw066389a+100+BSW20140306,
20140306 12:16PM UTC,"Morning Briefing - 52-Weeks High Breakers: Wells Fargo, Corning, Delta Air Lines and Pfizer",http://www.reuters.com/article/2014/03/06/bc-ie-idUSnPnpMy2rn+90+PRN20140306,
20140307 11:06AM UTC,"Research and Markets: Global Orphan Drugs Market 2014-2018: Novartis, F. Hoffmann-La Roche, Celgene, Pfizer & Sanofi Dominate the Market",http://www.reuters.com/article/2014/03/07/research-and-markets-idUSnBw075568a+100+BSW20140307,
20140310 11:36AM UTC,"Research and Markets: Global Hemophilia Market Report 2014-2018 with Baxter, Bayer, Novo Nordisk & Pfizer Dominating",http://www.reuters.com/article/2014/03/10/research-and-markets-idUSnBw105915a+100+BSW20140310,
20140312 4:35PM UTC,Pfizer says U.S. court invalidates Celebrex patent; generics loom,http://www.reuters.com/article/2014/03/12/us-pfizer-celebrex-idUSBREA2B1TJ20140312,
20140312 4:32PM UTC,UPDATE 2-Pfizer says U.S. court invalidates Celebrex patent; generics loom,http://www.reuters.com/article/2014/03/12/pfizer-celebrex-idUSL3N0M94AE20140312,
20140312 2:45PM UTC,Pfizer says court invalidates Celebrex patent reissue,http://www.reuters.com/article/2014/03/12/pfizer-celebrex-idUSL3N0M94A720140312,
20140312 2:28PM UTC,Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent,http://www.reuters.com/article/2014/03/12/pfizer-idUSnBw126277a+100+BSW20140312,
20140312 11:23AM UTC,Pfizer's Prevnar almost halves elderly pneumonias in study,http://www.reuters.com/article/2014/03/12/pfizer-prevnar-idUSL2N0M915L20140312,
20140312 10:00AM UTC,Pfizer Announces Webcast Of April 6 Conference Call With Securities Analysts To Review Palbociclib Phase 2 Final Results Following Presentation At AACR Annual Meeting 2014,http://www.reuters.com/article/2014/03/12/pfizer-idUSnBw125700a+100+BSW20140312,
20140312 6:37AM UTC,Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*,http://www.reuters.com/article/2014/03/12/pfizer-idUSnBw125592a+100+BSW20140312,
20140205 7:00AM UTC,Ichor Enters into an Agreement with Pfizer to Develop Electroporation Devices for Use in Therapeutic Cancer Vaccine Regimens,http://www.reuters.com/article/2014/02/05/ca-ichor-medical-systems-idUSnBw055085a+100+BSW20140205,
20140205 6:45AM UTC,Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies,http://www.reuters.com/article/2014/02/05/pfizer-idUSnBw055504a+100+BSW20140205,
20140205 6:40AM UTC,"Merck Enters Strategic Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475",http://www.reuters.com/article/2014/02/05/nj-merck-idUSnBw055453a+100+BSW20140205,
20140331 4:05PM UTC,"Research and Markets: Global Alzheimer's Drugs Market 2012-2016 with H. Lundbeck A/S, Novartis AG and Pfizer Inc. Dominating",http://www.reuters.com/article/2014/03/31/research-and-markets-idUSnBw316505a+100+BSW20140331,
20140331 9:30AM UTC,"The Zacks Analyst Blog Highlights: Pfizer, Amgen,Sanofi, Alkermes and JPMorgan Chase",http://www.reuters.com/article/2014/03/31/zacks-analyst-blog-idUSnPnbQvzLk+92+PRN20140331,
20140418 1:20PM UTC,Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting of Shareholders,http://www.reuters.com/article/2014/04/18/pfizer-idUSnBw185255a+100+BSW20140418,
20140506 6:27PM UTC,Britain could intervene in Pfizer bid for AstraZeneca: minister,http://www.reuters.com/article/2014/05/06/us-pfizerastrazeneca-cameron-idUSBREA450FD20140506,
20140506 6:23PM UTC,UPDATE 4-Britain could intervene in Pfizer bid for AstraZeneca -minister,http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-lawmakers-idUSL6N0NS2SK20140506,
20140506 12:05PM UTC,AstraZeneca fights Pfizer bid by predicting sales surge - eventually,http://www.reuters.com/article/2014/05/06/us-astrazeneca-pfizer-idUSBREA3R0H520140506,
20140506 12:02PM UTC,"UK's CBI says vital"" Pfizer makes long-term UK research promise""",http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-cbi-idUSL9N0MF00D20140506,
20140506 12:01PM UTC,UPDATE 1-Britain says may use public interest test in Pfizer bid for AstraZeneca,http://www.reuters.com/article/2014/05/06/pfizerastrazeneca-cable-idUSL6N0NS51T20140506,
20140506 11:34AM UTC,UPDATE 3-AstraZeneca fights Pfizer bid by predicting sales surge - eventually,http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-idUSL6N0NS33720140506,
20140506 11:02AM UTC,Britain says may use public interest test in Pfizer bid for AstraZeneca,http://www.reuters.com/article/2014/05/06/pfizerastrazeneca-cable-idUSS8N0M700Y20140506,
20140506 10:48AM UTC,UK's Osborne says would back Pfizer-AstraZeneca deal if it delivers jobs,http://www.reuters.com/article/2014/05/06/us-pfizer-astrazeneca-osborne-idUSBREA450K220140506,
20140506 10:48AM UTC,Astra CEO says Pfizer bid a threat to new drug pipeline,http://www.reuters.com/article/2014/05/06/us-astrazeneca-pfizer-ceo-idUSBREA450IV20140506,
20140506 10:22AM UTC,British lawmakers raise pressure on Pfizer over AstraZeneca bid,http://www.reuters.com/article/2014/05/06/us-astrazeneca-pfizer-lawmakers-idUSBREA4509V20140506,
20140506 10:14AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/06/the-vanguard-group-idUSnBw066330a+100+BSW20140506,
20140506 10:03AM UTC,UK's Osborne says would back Pfizer-AstraZeneca deal if it delivers jobs,http://www.reuters.com/article/2014/05/06/pfizer-astrazeneca-osborne-idUSL6N0NS4FD20140506,
20140506 9:48AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/06/mfs-investment-managemen-idUSnBw066274a+100+BSW20140506,
20140506 9:19AM UTC,Astra CEO says Pfizer bid a threat to new drug pipeline,http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-ceo-idUSWLB0085020140506,
20140506 8:14AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/06/wellington-management-idUSnBw066076a+100+BSW20140506,
20140506 8:07AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/06/wellington-management-idUSnBw066058a+100+BSW20140506,
20140506 7:57AM UTC,"Britain says talking to Pfizer, AstraZeneca, but deal is for shareholders",http://www.reuters.com/article/2014/05/06/pfizerastrazeneca-cameron-idUSL6N0NS3JC20140506,
20140506 7:30AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/06/invesco-limited-idUSnBw065988a+100+BSW20140506,
20140506 7:29AM UTC,"Second UK lawmaker panel to call Pfizer, AstraZeneca over bid",http://www.reuters.com/article/2014/05/06/us-astrazeneca-pfizer-britain-idUSKBN0DM0OX20140506,
20140506 7:17AM UTC,"Second UK lawmaker panel to call Pfizer, AstraZeneca over bid",http://www.reuters.com/article/2014/05/06/us-astrazeneca-pfizer-britain-idUSBREA450DN20140506,
20140506 7:15AM UTC,"Second UK lawmaker panel to call Pfizer, AstraZeneca over bid",http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-britain-idUSL6N0NS3AP20140506,
20140506 6:13AM UTC,"AstraZeneca, fighting off Pfizer, forecasts $45 bln sales by 2023",http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-idUSFWN0NS00120140506,
20140506 5:29AM UTC,UK lawmakers summon Pfizer and AstraZeneca over takeover deal,http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-lawmakers-idUSL6N0NS2OF20140506,
20140506 3:12AM UTC,Astra gets lift in Pfizer fight as U.S. okays heart pill,http://www.reuters.com/article/2014/05/06/us-astrazeneca-pfizer-epanova-idUSKBN0DM06Q20140506,
20140506 3:08AM UTC,UPDATE 1-Astra gets lift in Pfizer fight as U.S. okays heart pill,http://www.reuters.com/article/2014/05/06/astrazeneca-pfizer-epanova-idUSL6N0NS1G120140506,
20140506 2:00AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/06/the-vanguard-group-idUSnBw056138a+100+BSW20140506,
20140506 2:00AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/06/mfs-investment-managemen-idUSnBw055764a+100+BSW20140506,
20140506 2:00AM UTC,REG-BARCLAYS PLC Form 8.3 Amendment - Pfizer,http://www.reuters.com/article/2014/05/06/barclays-plc-idUSnBw055087a+100+BSW20140506,
20140611 1:19PM UTC,Pfizer says Astra quest failed due to price,http://www.reuters.com/article/2014/06/11/us-pfizer-astra-idUSKBN0EM1ZU20140611,
20140611 1:15PM UTC,Pfizer says Astra quest failed due to price,http://www.reuters.com/article/2014/06/11/pfizer-astra-idUSL2N0OS1CH20140611,
20140611 8:15AM UTC,X-Chem Enters into Multi-Target Collaboration with Pfizer Inc.,http://www.reuters.com/article/2014/06/11/ma-x-chem-idUSnBw115657a+100+BSW20140611,
20140611 8:00AM UTC,Pfizer Announces Over 10 Abstracts for XELJANZÂ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting,http://www.reuters.com/article/2014/06/11/pfizer-idUSnBw115667a+100+BSW20140611,
20140717 2:06PM UTC,"Research and Markets: Global Endometriosis Market 2014-2018 with Abbvie Inc., AstraZeneca plc, Bayer AG & Pfizer Inc. Dominating",http://www.reuters.com/article/2014/07/17/research-and-markets-idUSnBw176202a+100+BSW20140717,
20140717 8:06AM UTC,Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of EliquisÂ® (apixaban) in Patients with NVAF Undergoing Cardioversion,http://www.reuters.com/article/2014/07/17/nj-bristol-myers-pfizer-idUSnBw175643a+100+BSW20140717,
20140822 9:19AM UTC,Pfizer back for AstraZeneca? Year-end move seen most likely,http://www.reuters.com/article/2014/08/21/us-astrazeneca-pfizer-idUSKBN0GL1AH20140821,
20140909 4:15AM UTC,"Sosei Group Announces Positive Results for UltibroÂ® and SeebriÂ® Presented at ERS 2014, and Promotion Agreement with Pfizer in the UK<4565.T>",http://www.reuters.com/article/2014/09/08/sosei-group-idUSnBw085375a+100+BSW20140908,
20140927 3:30PM UTC,Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable,http://www.reuters.com/article/2014/09/26/ny-fitch-ratings-health-idUSnBw265472a+100+BSW20140926,
20140927 3:08PM UTC,Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable,http://www.reuters.com/article/2014/09/26/fitch-affirms-pfizers-idr-at-a-outlook-s-idUSFit76916020140926,
20141015 12:15PM UTC,FDA staff recommend Pfizer keep black box warning on anti-smoking drug,http://www.reuters.com/article/2014/10/14/us-pfizer-fda-chantix-idUSKCN0I321D20141014,
20141015 12:08PM UTC,UPDATE 1-FDA staff recommend Pfizer keep black box warning on anti-smoking drug,http://www.reuters.com/article/2014/10/14/pfizer-fda-chantix-idUSL3N0S94X920141014,
20141015 9:10AM UTC,FDA staff wants Pfizer to keep black box warning on anti-smoking drug,http://www.reuters.com/article/2014/10/14/pfizer-fda-chantix-idUSL3N0S94NC20141014,
20140318 10:00AM UTC,Pfizer Launches 2013 Integrated Annual Review,http://www.reuters.com/article/2014/03/18/pfizer-idUSnBw185879a+100+BSW20140318,
20140318 9:30AM UTC,"The Zacks Analyst Blog Highlights:Royal Dutch Shell, Bayer, Pfizer, Eli Lilly and Alexion Pharmaceuticals",http://www.reuters.com/article/2014/03/18/il-zacks-investments-idUSnPn7mZ3kt+88+PRN20140318,
20140318 8:00AM UTC,"Healthcare Companies Receive Approvals, Recognitions, Agreements, and Announce Senior Level Appointments- Analyst Notes on Pfizer, Boston Scientific, WellPoint, Aetna, and Humana",http://www.reuters.com/article/2014/03/18/bc-analysts-review-idUSnPn1QkqnX+91+PRN20140318,
20140320 8:30AM UTC,Pfizerâ€™s Investigational Vaccine Candidate Bivalent rLP2086 Receives U.S. Food and Drug Administration Breakthrough Therapy Designation for Potential Prevention of Meningococcal B Disease,http://www.reuters.com/article/2014/03/20/pfizer-idUSnBw205693a+100+BSW20140320,
20140320 8:00AM UTC,"Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories",http://www.reuters.com/article/2014/03/20/bc-ar-idUSnPn21yXBx+86+PRN20140320,
20140321 8:00AM UTC,"Healthcare Companies Report Acquisitions, Upcoming Results Schedules, Dividends, and Annual Reviews - Analyst Notes on Pfizer, Magellan Health Services, Prothena, Alere, and KYTHERA",http://www.reuters.com/article/2014/03/21/bc-analysts-review-idUSnPn9TLJkG+9d+PRN20140321,
20140322 11:45AM UTC,Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBRELÂ® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis,http://www.reuters.com/article/2014/03/22/pfizer-idUSnBw225005a+100+BSW20140322,
20140325 5:10PM UTC,Pfizer Invites Public To View And Listen To Webcast Of May 5 Conference Call With Analysts,http://www.reuters.com/article/2014/03/25/pfizer-idUSnBw256597a+100+BSW20140325,
20140325 12:44PM UTC,Pfizer lung cancer drug beats chemo for previously untreated patients,http://www.reuters.com/article/2014/03/25/us-pfizer-cancer-xalkori-idUSBREA2O10K20140325,
20140325 12:24PM UTC,UPDATE 1-Pfizer lung cancer drug beats chemo for previously untreated patients,http://www.reuters.com/article/2014/03/25/pfizer-cancer-xalkori-idUSL1N0MM15O20140325,
20140325 9:40AM UTC,Pfizer lung cancer drug beats chemo for previously untreated patients,http://www.reuters.com/article/2014/03/25/pfizer-cancer-xalkori-idUSL1N0MM0P720140325,
20140325 9:30AM UTC,"The Zacks Analyst Blog Highlights:Bristol-Myers Squibb, Pfizer, Alexion Pharmaceuticals, Gilead Sciences and AGCO",http://www.reuters.com/article/2014/03/25/zacks-equity-research-idUSnPnbygt80+80+PRN20140325,
20140325 8:30AM UTC,Pfizer Reports Positive Phase 3 Study Outcome Of XALKORIÂ® (crizotinib) Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC),http://www.reuters.com/article/2014/03/25/pfizer-idUSnBw255277a+100+BSW20140325,
20140326 8:00AM UTC,Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPINÂ® In Very Young Children Born Small For Gestational Age,http://www.reuters.com/article/2014/03/26/pfizer-idUSnBw265216a+100+BSW20140326,
20140328 6:26PM UTC,Pfizer Statement on U.S. FDA Approval of Over-the-Counter NexiumÂ® 24HR,http://www.reuters.com/article/2014/03/28/pfizer-idUSnBw285805a+100+BSW20140328,
20140328 11:32AM UTC,"Technical Summary on Active Stocks -- Research on Cisco Systems, Pfizer, Vale, and Advanced Micro Devices",http://www.reuters.com/article/2014/03/28/bc-investor-edge-idUSnPn4jljfC+81+PRN20140328,
20140328 8:00AM UTC,"Positive Opinions, Presentation Schedules of Investigational Data, Clinical Study Results, and Stock Price Movements - Analyst Notes on Johnson & Johnson, Merck, Pfizer, Amgen, and Allergan",http://www.reuters.com/article/2014/03/28/bc-analysts-review-idUSnPnbFJ7c4+98+PRN20140328,
20140328 7:56AM UTC,PSE & Pfizer form the Systems-based Pharmaceutics Alliance,http://www.reuters.com/article/2014/03/28/pse-idUSnBw285244a+100+BSW20140328,
20140401 8:30AM UTC,"LabCentral Announces Sponsorship by Pfizer to Support Life-Science Startup Companies in Cambridge, Massachusetts",http://www.reuters.com/article/2014/04/01/ma-labcentral-pfizer-idUSnPntZBCj+4e+PRN20140401,
20140401 7:00AM UTC,EMD Serono Enters into Research Agreement with Pfizer and Broad Institute,http://www.reuters.com/article/2014/04/01/ma-emd-serono-pfizer-idUSnPn79kRPJ+87+PRN20140401,
20140403 12:39PM UTC,AMCP Foundation Launches Initiative to Identify Emerging Medication Management Practices that Can Advance Patient Care and Outcomes; Project Supported by Pfizer,http://www.reuters.com/article/2014/04/03/amcp-pfizer-collab-idUSnPn7n7RvT+85+PRN20140403,
20140403 12:00PM UTC,IntegraGen Announces Collaborative Agreement with Pfizer to Evaluate IntegraGenâ€™s Proprietary Hepatocellular Carcinoma Molecular Signature,http://www.reuters.com/article/2014/04/03/integragen-idUSnBw035360a+100+BSW20140403,
20140403 10:03AM UTC,"Apple, Pfizer, others form 'go slow' U.S. patent lobby group",http://www.reuters.com/article/2014/04/03/us-usa-patents-lobbying-idUSBREA3210R20140403,
20140403 9:00AM UTC,"Apple, Pfizer, others form go slow"" U.S. patent lobby group""",http://www.reuters.com/article/2014/04/03/usa-patents-lobbying-idUSL1N0MU23E20140403,
20140403 8:00AM UTC,"Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis",http://www.reuters.com/article/2014/04/03/bc-ar-idUSnPn5dh9Sg+82+PRN20140403,
20140403 3:03AM UTC,BRIEF-IntegraGen jumps 10 pct on collaboration deal with Pfizer,http://www.reuters.com/article/2014/04/03/integragen-brief-idUSWEB00L5C20140403,
20140403 2:41AM UTC,IntegraGen Announces Collaborative Agreement with Pfizer to Evaluate IntegraGenâ€™s Proprietary Hepatocellular Carcinoma Molecular Signature,http://www.reuters.com/article/2014/04/03/integragen-idUSnBw026868a+100+BSW20140403,
20140406 10:30AM UTC,Pfizer drug doubles time to breast cancer tumor growth in trial,http://www.reuters.com/article/2014/04/06/us-cancer-pfizer-idUSBREA350BJ20140406,
20140406 10:30AM UTC,Pfizer drug doubles time to breast cancer tumor growth in trial,http://www.reuters.com/article/2014/04/06/health-cancer-pfizer-idUSL1N0MY01K20140406,
20140406 10:30AM UTC,Pfizerâ€™s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer,http://www.reuters.com/article/2014/04/06/pfizer-idUSnBw065062a+100+BSW20140406,
20140407 12:27PM UTC,"US STOCKS-Wall Street falls on broad weakness, Pfizer drags",http://www.reuters.com/article/2014/04/07/markets-usa-stocks-idUSL2N0MZ0VQ20140407,
20140407 10:40AM UTC,US STOCKS-Wall St flat as momentum stocks stabilize; Pfizer drags,http://www.reuters.com/article/2014/04/07/markets-usa-stocks-idUSL2N0MZ0MS20140407,
20140407 8:01AM UTC,"NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept",http://www.reuters.com/article/2014/04/07/bc-analysts-review-idUSnPn7vZLT5+8e+PRN20140407,
20140407 3:51AM UTC,Pfizerâ€™s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer,http://www.reuters.com/article/2014/04/07/pfizer-idUSnBw065062a+100+BSW20140407,
20140409 8:01AM UTC,"Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma",http://www.reuters.com/article/2014/04/09/bc-analystsreviewcom-idUSnPn6J2DHy+96+PRN20140409,
20140410 9:30AM UTC,"The Zacks Analyst Blog Highlights:Teva Pharmaceutical Industries, GlaxoSmithKline, Pfizer, Dr. Reddy's Laboratories and Seagate Technology",http://www.reuters.com/article/2014/04/10/zacks-equity-research-idUSnPn9m9CS4+86+PRN20140410,
20140411 10:15AM UTC,"Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest",http://www.reuters.com/article/2014/04/11/bc-ar-idUSnPn6f9F2L+85+PRN20140411,
20140411 9:00AM UTC,"Pfizerâ€™s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts",http://www.reuters.com/article/2014/04/11/dc-phrma-idUSnBw115017a+100+BSW20140411,
20140411 7:49AM UTC,"Research and Markets: Global Pain Management Drugs Market 2014-2018 with Abbott Labs, Eli Lilly, Endo Health Solutions, Pfizer & Purdue Pharma Dominating",http://www.reuters.com/article/2014/04/11/research-and-markets-idUSnBw115288a+100+BSW20140411,
20140414 12:34PM UTC,"Research and Markets: Global Depression Drugs Market 2014-2018 with GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Dominating",http://www.reuters.com/article/2014/04/14/research-and-markets-idUSnBw146107a+100+BSW20140414,
20140417 12:56PM UTC,UPDATE 2-Teva settles patent suit with Pfizer over Celebrex,http://www.reuters.com/article/2014/04/17/teva-pharm-ind-pfizer-idUSL3N0N93FI20140417,
20140417 10:48AM UTC,"Teva, Pfizer settle patent lawsuit over blockbuster painkiller",http://www.reuters.com/article/2014/04/17/us-teva-pharm-ind-pfizer-idUSBREA3G14M20140417,
20140417 9:18AM UTC,"Teva, Pfizer settle patent lawsuit over painkiller Celebrex",http://www.reuters.com/article/2014/04/17/teva-pharm-ind-pfizer-idUSL3N0N93E220140417,
20140417 8:37AM UTC,Teva Settles Patent Litigation with Pfizer on CelebrexÂ®,http://www.reuters.com/article/2014/04/17/teva-pharmaceutical-idUSnBw175673a+100+BSW20140417,
20140420 10:04AM UTC,Pfizer considers $100 billion bid for AstraZeneca: report,http://www.reuters.com/article/2014/04/20/us-pfizer-astrazeneca-bid-idUSBREA3J08T20140420,
20140420 10:00AM UTC,UPDATE 1-Pfizer considers $100 bln bid for AstraZeneca - report,http://www.reuters.com/article/2014/04/20/pfizer-astrazeneca-bid-idUSL6N0NC0HC20140420,
20140420 6:44AM UTC,Pfizer mulls $100 bln bid for AstraZeneca - report,http://www.reuters.com/article/2014/04/20/pfizer-astrazeneca-bid-idUSL6N0NC0AV20140420,
20140421 7:28PM UTC,Pfizer agrees to $190 million settlement over generic Neurontin,http://www.reuters.com/article/2014/04/21/us-usa-antitrust-pfizer-idUSBREA3K17420140421,
20140421 7:10PM UTC,UPDATE 1-Pfizer agrees to $190 mln settlement over generic Neurontin,http://www.reuters.com/article/2014/04/21/usa-antitrust-pfizer-idUSL2N0ND1EK20140421,
20140421 5:57PM UTC,AstraZeneca cancer pipeline seen as draw for Pfizer,http://www.reuters.com/article/2014/04/21/us-astrazeneca-bid-idUSBREA3K0EU20140421,
20140421 5:51PM UTC,UPDATE 3-AstraZeneca cancer pipeline seen as draw for Pfizer,http://www.reuters.com/article/2014/04/21/astrazeneca-bid-idUSL6N0ND27Y20140421,
20140421 4:50PM UTC,Pfizer agrees to $190 mln settlement over generic Neurontin,http://www.reuters.com/article/2014/04/21/usa-antitrust-pfizer-idUSL2N0ND17020140421,
20140421 2:42PM UTC,"Kaplan Fox Announces $190 Million Settlement with Pfizer, Inc. and Warner-Lambert Co.",http://www.reuters.com/article/2014/04/21/kaplan-fox-settlement-idUSnPn7gNwVk+8a+PRN20140421,
20140421 9:30AM UTC,"The Zacks Analyst Blog Highlights:JPMorgan, Pfizer, Coca-Cola, Johnson & Johnson and IBM",http://www.reuters.com/article/2014/04/21/zacks-equity-research-idUSnPn4db1FB+83+PRN20140421,
20140421 8:00AM UTC,"Promotional Campaigns, Equity Awards, Stock Price Movements, New Launches, and Company Events - Analyst Notes on Pfizer, Intuitive Surgical, HCA Holdings, General Electric and John Deere",http://www.reuters.com/article/2014/04/21/bc-ar-idUSnPn1sdh8f+80+PRN20140421,
20140421 6:55AM UTC,AstraZeneca cancer pipeline seen as draw for Pfizer,http://www.reuters.com/article/2014/04/21/astrazeneca-bid-idUSL6N0ND1BM20140421,
20140422 1:14PM UTC,"Active Equities under the Scanner -- Research on JPMorgan Chase, Pfizer, General Motors, and Nokia",http://www.reuters.com/article/2014/04/22/bc-investor-edge-idUSnPn27kkKr+82+PRN20140422,
20140422 8:00AM UTC,Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis,http://www.reuters.com/article/2014/04/22/pfizer-idUSnBw225398a+100+BSW20140422,
20140422 5:47AM UTC,"Novartis shake-up, Pfizer-AstraZeneca report lifts pharma stocks",http://www.reuters.com/article/2014/04/22/europe-pharmaceuticals-activity-idUSL6N0NE1R020140422,
20140422 3:08AM UTC,BRIEF-Astrazeneca shares up 8 pct higher after Pfizer takeover approach,http://www.reuters.com/article/2014/04/22/astrazenecashares-brief-idUSL9E7I501I20140422,
20140424 2:06PM UTC,"Research and Markets: Global Hypertension Drugs Market 2014-2018 with Actelion, AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Sanofi Dominating",http://www.reuters.com/article/2014/04/24/research-and-markets-idUSnBw246415a+100+BSW20140424,
20140424 10:50AM UTC,Pfizer Hosts Annual Meeting of Shareholders Declares 26-Cent Second-Quarter 2014 Dividend,http://www.reuters.com/article/2014/04/24/pfizer-idUSnBw246056a+100+BSW20140424,
20140424 2:53AM UTC,"AstraZeneca flags cancer advances, silent on Pfizer bid talk",http://www.reuters.com/article/2014/04/24/us-astrazeneca-idUSBREA3N0DS20140424,
20140424 2:25AM UTC,"AstraZeneca flags cancer advances, silent on Pfizer bid talk",http://www.reuters.com/article/2014/04/24/astrazeneca-idUSASM0006ER20140424,
20140425 8:01AM UTC,"Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts",http://www.reuters.com/article/2014/04/25/bc-analysts-review-idUSnPn6mtjBd+82+PRN20140425,
20140427 8:11PM UTC,Pfizer may declare interest in AstraZeneca this week: FT,http://www.reuters.com/article/2014/04/28/us-pfizer-astrazeneca-bid-idUSBREA3R00D20140428,
20140427 8:10PM UTC,Pfizer may declare interest in AstraZeneca this week -FT,http://www.reuters.com/article/2014/04/28/pfizer-astrazeneca-bid-idUSL6N0NJ19M20140428,
20140428 7:33PM UTC,"S&P; 500, Dow end up after late rebound; Apple, Pfizer lift",http://www.reuters.com/article/2014/04/28/us-markets-stocks-idUSBREA360QI20140428,
20140428 7:02PM UTC,Pfizer move to join tax-driven deal-making raises red flags in U.S,http://www.reuters.com/article/2014/04/28/us-usa-tax-pfizer-analysis-idUSBREA3R1FL20140428,
20140428 5:30PM UTC,"US STOCKS-S&P; 500, Dow end up after late rebound; Apple, Pfizer lift",http://www.reuters.com/article/2014/04/28/markets-usa-stocks-idUSL2N0NK1X420140428,
20140428 5:28PM UTC,Pfizer chases AstraZeneca for potential $100 billion deal,http://www.reuters.com/article/2014/04/28/us-astrazeneca-pfizer-idUSBREA3R0H520140428,
20140428 4:44PM UTC,"US STOCKS-S&P; 500 ends up with Apple, Pfizer; Nasdaq dips",http://www.reuters.com/article/2014/04/28/markets-usa-stocks-idUSL2N0NK1QU20140428,
20140428 4:01PM UTC,"AstraZeneca rejects Pfizer talks, says confident in strategy",http://www.reuters.com/article/2014/04/28/us-astrazeneca-pfizer-statement-idUSKBN0DE11T20140428,
20140428 3:05PM UTC,UPDATE 7-Pfizer chases AstraZeneca for potential $100 bln deal,http://www.reuters.com/article/2014/04/28/astrazeneca-pfizer-idUSL6N0NK19420140428,
20140428 11:36AM UTC,Pfizer needs to do more to win AstraZeneca,http://www.reuters.com/article/2014/04/28/idUS223114581720140428,
20140428 11:22AM UTC,US STOCKS-Wall St boosted by merger flurry; Pfizer lifts Dow,http://www.reuters.com/article/2014/04/28/markets-usa-stocks-idUSL2N0NK0WD20140428,
20140428 10:08AM UTC,Pfizer's move on Astra fuels fears for British science,http://www.reuters.com/article/2014/04/28/us-astrazeneca-pfizer-britain-idUSBREA3R0NV20140428,
20140428 10:07AM UTC,UPDATE 1-Pfizer's move on Astra fuels fears for British science,http://www.reuters.com/article/2014/04/28/astrazeneca-pfizer-britain-idUSL6N0NK3A220140428,
20140428 9:36AM UTC,BRIEF-Pfizer says big incentive for re-approaching Astra is potential lower tax rate,http://www.reuters.com/article/2014/04/28/pfizer-brief-idUSWEN00D2N20140428,
20140428 7:00AM UTC,"Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Possible Combination With AstraZeneca",http://www.reuters.com/article/2014/04/28/pfizer-idUSnBw285661a+100+BSW20140428,
20140428 6:49AM UTC,Pfizer talking to UK government about AstraZeneca,http://www.reuters.com/article/2014/04/28/astrazeneca-pfizer-britain-idUSWLB0082520140428,
20140428 5:54AM UTC,"AstraZeneca rejects Pfizer talks, says confident in strategy",http://www.reuters.com/article/2014/04/28/us-astrazeneca-pfizer-statement-idUSBREA3R0LZ20140428,
20140428 5:51AM UTC,"AstraZeneca rejects Pfizer talks, says confident in strategy",http://www.reuters.com/article/2014/04/28/astrazeneca-pfizer-statement-idUSFWN0N901120140428,
20140428 5:43AM UTC,REG-INVESCO Limited Form 8 (OPD) - Pfizer Inc,http://www.reuters.com/article/2014/04/28/invesco-limited-idUSnBw285678a+100+BSW20140428,
20140428 3:27AM UTC,AstraZeneca shares leap 15 percent as Pfizer confirms bid interest,http://www.reuters.com/article/2014/04/28/us-astrazeneca-shares-idUSBREA3R0IN20140428,
20140428 2:14AM UTC,Pfizer confirms desire to buy AstraZeneca,http://www.reuters.com/article/2014/04/28/astrazeneca-pfizer-idUSASM0006FK20140428,
20140428 2:08AM UTC,Pfizer Confirms Prior Discussions with AstraZeneca Regarding a Possible Combination and Its Continuing Interest in a Possible Merger Transaction,http://www.reuters.com/article/2014/04/28/pfizer-idUSnBw275064a+100+BSW20140428,
20140429 3:56PM UTC,Pfizer CEO flies in to pitch Astra deal to UK government,http://www.reuters.com/article/2014/04/29/us-astrazeneca-pfizer-ceo-idUSBREA3S11X20140429,
20140429 3:52PM UTC,Pfizer CEO flies in to pitch Astra deal to UK government,http://www.reuters.com/article/2014/04/29/astrazeneca-pfizer-ceo-idUSL6N0NL6UO20140429,
20140429 3:36PM UTC,"Research and Markets: Global Glaucoma Therapeutics Market 2014-2018: Allergan Inc., Merck & Co. Inc., Novartis AG & Pfizer Dominate the Industry",http://www.reuters.com/article/2014/04/29/research-and-markets-idUSnBw296970a+100+BSW20140429,
20140429 10:34AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/04/29/the-vanguard-group-idUSnBw296366a+100+BSW20140429,
20140429 10:08AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/04/29/mfs-investment-managemen-idUSnBw296305a+100+BSW20140429,
20140429 10:03AM UTC,Pfizer may have to pay more cash and top $105 billion to win AstraZeneca,http://www.reuters.com/article/2014/04/29/us-astrazeneca-pfizer-investors-idUSBREA3S0M520140429,
20140429 9:59AM UTC,Pfizer may have to pay more cash and top $105 bln to win AstraZeneca,http://www.reuters.com/article/2014/04/29/astrazeneca-pfizer-investors-idUSL6N0NL1O420140429,
20140429 9:50AM UTC,"Financial Results, Dividend Declarations, and Earnings Release Schedules - Analyst Notes on Gilead, Pfizer, Mallinckrodt, Intuitive Surgical and Chicago Bridge & Iron",http://www.reuters.com/article/2014/04/29/bc-analysts-review-idUSnPnnY0SC+4b+PRN20140429,
20140429 9:49AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/04/29/wellington-management-idUSnBw296265a+100+BSW20140429,
20140429 9:46AM UTC,"Fitch: Pfizer, AstraZeneca Combo Would Achieve Strategic Aims",http://www.reuters.com/article/2014/04/29/ny-fitch-ratings-pharma-idUSnBw296251a+100+BSW20140429,
20140429 9:12AM UTC,"RPT-Fitch: Pfizer, AstraZeneca Combo Would Achieve Strategic Aims",http://www.reuters.com/article/2014/04/29/fitch-pfizer-astrazeneca-combo-would-ach-idUSFit69871320140429,
20140429 8:42AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/04/29/invesco-limited-idUSnBw296097a+100+BSW20140429,
20140429 5:55AM UTC,REG-Norges Bank Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/04/29/norges-bank-idUSnBw295876a+100+BSW20140429,
20140429 5:49AM UTC,REG-Norges Bank Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/04/29/norges-bank-idUSnBw295870a+100+BSW20140429,
20140429 2:46AM UTC,Pfizer tax arbitrage will hasten more deals,http://www.reuters.com/article/2014/04/29/idUS144032313320140429,
20140429 1:34AM UTC,Pfizer's weak drug pipeline fuels hunger for AstraZeneca,http://www.reuters.com/article/2014/04/29/us-astrazeneca-pfizer-pipeline-analysis-idUSBREA3S03M20140429,
20140429 1:11AM UTC,Pfizer's weak drug pipeline fuels hunger for AstraZeneca,http://www.reuters.com/article/2014/04/29/us-astrazeneca-pfizer-pipeline-analysis-idUSKBN0DF09P20140429,
20140429 12:20PM UTC,Breakingviews: Pfizerâ€™s tax arbitrage bid,http://www.reuters.com/news/video/videoStory?storyID=84405615,
20140430 6:35PM UTC,UK lawmakers plan to probe Pfizer pursuit of AstraZeneca,http://www.reuters.com/article/2014/04/30/us-astrazeneca-pfizer-lawmakers-idUSBREA3T14X20140430,
20140430 6:29PM UTC,UPDATE 2-UK lawmakers plan to probe Pfizer pursuit of AstraZeneca,http://www.reuters.com/article/2014/04/30/astrazeneca-pfizer-lawmakers-idUSL6N0NM5RP20140430,
20140430 11:36AM UTC,UK lawmakers plan to probe Pfizer pursuit of AstraZeneca,http://www.reuters.com/article/2014/04/30/us-astrazeneca-pfizer-lawmakers-idUSBREA3T0AH20140430,
20140430 10:22AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/04/30/mfs-investment-managemen-idUSnBw306127a+100+BSW20140430,
20140430 10:19AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/04/30/the-vanguard-group-idUSnBw306121a+100+BSW20140430,
20140430 10:03AM UTC,"GSK says staying on sidelines in Astra, Pfizer fight",http://www.reuters.com/article/2014/04/30/us-astrazeneca-pfizer-gsk-idUSBREA3T0KV20140430,
20140430 10:01AM UTC,"GSK says staying on sidelines in Astra, Pfizer fight",http://www.reuters.com/article/2014/04/30/astrazeneca-pfizer-gsk-idUSL6N0NM4XC20140430,
20140430 9:20AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/04/30/invesco-limited-idUSnBw306009a+100+BSW20140430,
20140430 9:11AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/04/30/wellington-management-idUSnBw305991a+100+BSW20140430,
20140430 6:30AM UTC,"Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert",http://www.reuters.com/article/2014/04/30/idUSnMKWDzXWwa+1ec+MKW20140430,
20140430 6:26AM UTC,UK lawmakers plan to probe Pfizer pursuit of AstraZeneca,http://www.reuters.com/article/2014/04/30/astrazeneca-pfizer-lawmakers-idUSL6N0NM35B20140430,
20140501 11:38PM UTC,UPDATE 2-Pfizer enters takeover discussions with AstraZeneca - WSJ,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-idUSL2N0NN13F20140502,
20140501 3:45PM UTC,"In $100 billion Astra Pfizer fight, R&D; site marks political frontline",http://www.reuters.com/article/2014/05/01/us-astrazeneca-pfizer-rd-idUSBREA400I820140501,
20140501 3:44PM UTC,"UPDATE 1-In $100 bln Astra Pfizer fight, R&D; site marks political frontline",http://www.reuters.com/article/2014/05/01/astrazeneca-pfizer-rd-idUSL6N0NN3F320140501,
20140501 1:40PM UTC,Pfizer prepares sweeter bid for AstraZeneca: report,http://www.reuters.com/article/2014/05/01/us-astrazeneca-pfizer-idUSBREA3R0H520140501,
20140501 1:33PM UTC,UPDATE 1-Pfizer prepares sweeter bid for AstraZeneca -report,http://www.reuters.com/article/2014/05/01/astrazeneca-pfizer-idUSL2N0NN13F20140501,
20140501 1:27PM UTC,Astra has small tactical advantage over Pfizer,http://www.reuters.com/article/2014/05/01/idUS97764180320140501,
20140501 12:58PM UTC,"Astra, Pfizer deal could face Chinese antitrust hurdle",http://www.reuters.com/article/2014/05/01/us-astrazeneca-pfizer-china-idUSBREA400NJ20140501,
20140501 12:45PM UTC,"Astra, Pfizer deal could face Chinese antitrust hurdle",http://www.reuters.com/article/2014/05/01/astrazeneca-pfizer-china-idUSL6N0NN2VR20140501,
20140501 12:01PM UTC,Pfizer prepares sweeter bid for AstraZeneca - report,http://www.reuters.com/article/2014/05/01/astrazeneca-pfizer-idUSL2N0NN0ZG20140501,
20140501 10:38AM UTC,"R&D; site marks political frontline in $100 bln Astra, Pfizer battle",http://www.reuters.com/article/2014/05/01/astrazeneca-pfizer-rd-idUSL6N0NN26L20140501,
20140501 10:33AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/01/mfs-investment-managemen-idUSnBw016086a+100+BSW20140501,
20140501 10:33AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/01/the-vanguard-group-idUSnBw016083a+100+BSW20140501,
20140501 9:53AM UTC,Pfizer's designs on AstraZeneca stir tax envy among rivals,http://www.reuters.com/article/2014/05/01/us-usa-tax-mergers-idUSBREA4003G20140501,
20140501 9:47AM UTC,CORRECTED-Pfizer's designs on AstraZeneca stir tax envy among rivals,http://www.reuters.com/article/2014/05/01/usa-tax-mergers-idUSL2N0NN0KO20140501,
20140501 8:41AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/01/invesco-limited-idUSnBw015890a+100+BSW20140501,
20140501 8:19AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/01/wellington-management-idUSnBw015860a+100+BSW20140501,
20140501 1:00AM UTC,DEALTALK-Pfizer's designs on AstraZeneca stir tax envy among rivals,http://www.reuters.com/article/2014/05/01/usa-tax-mergers-idUSL2N0NM2Y120140501,
20140502 1:22PM UTC,AstraZeneca rejects Pfizer's raised bid of $106 billion,http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-idUSBREA3R0H520140502,
20140502 11:40AM UTC,UPDATE 8-AstraZeneca rejects Pfizer's raised bid of $106 bln,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-idUSL6N0NO0IL20140502,
20140502 11:10AM UTC,Pfizer's science vows to Britain: promise or placebo?,http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-science-idUSBREA410KK20140502,
20140502 11:08AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer,http://www.reuters.com/article/2014/05/02/barclays-plc-idUSnBw025474a+100+BSW20140502,
20140502 11:07AM UTC,Pfizer's science vows to Britain: promise or placebo?,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-science-idUSL6N0NO2CY20140502,
20140502 10:53AM UTC,Pfizer yet to land knockout blow on Astra,http://www.reuters.com/article/2014/05/02/idUS213837091120140502,
20140502 10:03AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/02/the-vanguard-group-idUSnBw025417a+100+BSW20140502,
20140502 9:41AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/02/mfs-investment-managemen-idUSnBw025395a+100+BSW20140502,
20140502 9:22AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/02/invesco-limited-idUSnBw025375a+100+BSW20140502,
20140502 8:44AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/02/wellington-management-idUSnBw025344a+100+BSW20140502,
20140502 8:11AM UTC,Britain says considering Pfizer's reassurances in Astra battle,http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-letter-idUSBREA410D720140502,
20140502 8:08AM UTC,Britain says considering Pfizer's reassurances in Astra battle,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-letter-idUSL6N0NO29U20140502,
20140502 6:48AM UTC,AstraZeneca rejects Pfizer's raised bid of $106 bln,http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-idUSKBN0DI0N220140502,
20140502 6:13AM UTC,AstraZeneca rejects latest Pfizer approach,http://www.reuters.com/article/2014/05/02/us-pfizer-astrazeneca-rejection-idUSBREA4108M20140502,
20140502 6:13AM UTC,AstraZeneca board meeting Friday to weigh new Pfizer bid: sources,http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-board-idUSBREA4108620140502,
20140502 5:59AM UTC,Astrazeneca rejects latest Pfizer approach,http://www.reuters.com/article/2014/05/02/pfizer-astrazeneca-rejection-idUSFWN0NK01520140502,
20140502 5:16AM UTC,AstraZeneca board meeting Friday to weigh new Pfizer bid-sources,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-board-idUSL6N0NO1FM20140502,
20140502 3:48AM UTC,UK government says Pfizer's AstraZeneca bid a decision for shareholders,http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-government-idUSBREA4106620140502,
20140502 3:40AM UTC,UK Govt says Pfizer's AstraZeneca bid a decision for shareholders,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-government-idUSL6N0NO0OO20140502,
20140502 3:27AM UTC,BRIEF-AstraZeneca says board to discuss Pfizer bid,http://www.reuters.com/article/2014/05/02/astrazeneca-brief-idUSFWN0NK01420140502,
20140502 3:06AM UTC,AstraZeneca's shares rise 0.4 pct after Pfizer sweetens offer,http://www.reuters.com/article/2014/05/02/pfizer-astrazeneca-stocks-idUSL6N0NO0RS20140502,
20140502 2:44AM UTC,AstraZeneca says board will review Pfizer offer,http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-response-idUSBREA4105B20140502,
20140502 2:42AM UTC,AstraZeneca says board will review Pfizer offer,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-response-idUSL6N0NO0MH20140502,
20140502 2:38AM UTC,Pfizer commits to UK research hub in Astra battle,http://www.reuters.com/article/2014/05/02/us-pfizer-astrazeneca-cameron-idUSBREA4104P20140502,
20140502 2:21AM UTC,Pfizer commits to UK research hub in Astra battle,http://www.reuters.com/article/2014/05/02/pfizer-astrazeneca-cameron-idUSFWN0NK01120140502,
20140502 2:11AM UTC,Pfizer raises offer for AstraZeneca to 50 pounds/share,http://www.reuters.com/article/2014/05/02/astrazeneca-pfizer-idUSFWN0NK00Z20140502,
20140502 2:11AM UTC,Pfizer Sends Letter to Rt Hon David Cameron MP Regarding Commitments If Proposed Combination with AstraZeneca is Completed,http://www.reuters.com/article/2014/05/02/pfizer-idUSnBw017012a+100+BSW20140502,
20140502 2:08AM UTC,Pfizer Confirms Delivery of Increased Proposal to AstraZeneca,http://www.reuters.com/article/2014/05/02/pfizer-idUSnBw017010a+100+BSW20140502,
20140502 12:01AM UTC,Second Genome Enters Into Agreement with Pfizer Inc. on Microbiome Research Initiative in Obesity,http://www.reuters.com/article/2014/05/02/ca-second-genome-idUSnPn7sV50y+88+PRN20140502,
20140502 10:55AM UTC,"AZ spurns Pfizer, Bayer/Merck deal nears",http://www.reuters.com/news/video/videoStory?storyID=84649386,
20140503 8:11AM UTC,Pfizer U.S. research jobs jeopardized by promises to UK for merger,http://www.reuters.com/article/2014/05/03/us-astrazeneca-pfizer-jobs-analysis-idUSBREA4205520140503,
20140503 8:11AM UTC,Pfizer expected to be patient in face of AstraZeneca rejection,http://www.reuters.com/article/2014/05/03/us-pfizer-astrazeneca-shareholders-idUSBREA4205A20140503,
20140503 8:00AM UTC,Pfizer expected to be patient in face of AstraZeneca rejection,http://www.reuters.com/article/2014/05/03/pfizer-astrazeneca-shareholders-idUSL2N0NN1TT20140503,
20140504 8:01AM UTC,UK's Labour call for inquiry into Pfizer's AstraZeneca bid,http://www.reuters.com/article/2014/05/04/us-astrazeneca-pfizer-politics-idUSBREA4301S20140504,
20140504 7:55AM UTC,UPDATE 2-UK's Labour call for inquiry into Pfizer's AstraZeneca bid,http://www.reuters.com/article/2014/05/04/astrazeneca-pfizer-politics-idUSL6N0NQ06R20140504,
20140504 5:07AM UTC,UK's Labour call for independent inquiry into Pfizer's AstraZeneca bid,http://www.reuters.com/article/2014/05/04/astrazeneca-pfizer-politics-idUSL6N0NQ05Z20140504,
20140505 4:02PM UTC,Pfizer signals open to hostile option for AstraZeneca,http://www.reuters.com/article/2014/05/05/us-pfizer-astrazeneca-idUSBREA440N720140505,
20140505 1:09PM UTC,Pfizer sales way off mark as company pursues AstraZeneca,http://www.reuters.com/article/2014/05/05/us-pfizer-results-idUSBREA4409J20140505,
20140505 12:52PM UTC,UPDATE 3-Pfizer sales way off mark as company pursues AstraZeneca,http://www.reuters.com/article/2014/05/05/pfizer-results-idUSL2N0NR09420140505,
20140505 12:01PM UTC,"BRIEF-Pfizer days researchers would have massive presence"" in U.S. after Astra merger""",http://www.reuters.com/article/2014/05/05/pfizer-brief-idUSWEN00D7320140505,
20140505 9:30AM UTC,"The Zacks Analyst Blog Highlights: Pfizer, Allergan, Mallinckrodt, Perrigo and Sallie Mae",http://www.reuters.com/article/2014/05/05/il-zacks-investment-idUSnPnkvBg9+44+PRN20140505,
20140505 7:15AM UTC,"Pfizer 1st-quarter sales disappoint, generics drag results",http://www.reuters.com/article/2014/05/05/pfizer-results-idUSL2N0NR08O20140505,
20140505 12:01AM UTC,RPT-Pfizer expected to be patient in face of AstraZeneca rejection,http://www.reuters.com/article/2014/05/05/pfizer-astrazeneca-shareholders-idUSL2N0NO21320140505,
20140505 10:30AM UTC,Pfizer's profit drops 15 pct,http://www.reuters.com/news/video/videoStory?storyID=84807399,
20140507 12:34PM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/07/barclays-plc-idUSnBw076402a+100+BSW20140507,
20140507 11:56AM UTC,AstraZeneca takeover would benefit science: Pfizer,http://www.reuters.com/article/2014/05/07/us-astrazeneca-pfizer-idUSBREA3R0H520140507,
20140507 11:56AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/07/barclays-plc-idUSnBw076329a+100+BSW20140507,
20140507 10:34AM UTC,British PM tells Pfizer wants more commitments for AstraZeneca deal,http://www.reuters.com/article/2014/05/07/us-astrazeneca-pfizer-cameron-idUSBREA460C320140507,
20140507 10:33AM UTC,UPDATE 1-British PM tells Pfizer wants more commitments for AstraZeneca deal,http://www.reuters.com/article/2014/05/07/astrazeneca-pfizer-idUSL6N0NT42S20140507,
20140507 10:25AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/07/the-vanguard-group-idUSnBw076163a+100+BSW20140507,
20140507 9:30AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc - AMENDMENT,http://www.reuters.com/article/2014/05/07/barclays-plc-idUSnBw076041a+100+BSW20140507,
20140507 9:19AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/07/mfs-investment-managemen-idUSnBw076023a+100+BSW20140507,
20140507 8:42AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/07/wellington-management-idUSnBw075986a+100+BSW20140507,
20140507 8:41AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/07/barclays-plc-idUSnBw075982a+100+BSW20140507,
20140507 8:37AM UTC,"Stock Prices Updates, Study Results, Financial Results, and Share Repurchase Program - Analyst Notes on Gilead, Pfizer, Pharmacyclics, Intuitive Surgical and Mallinckrodt",http://www.reuters.com/article/2014/05/07/bc-analystsreviewcom-idUSnPn617kMP+83+PRN20140507,
20140507 7:35AM UTC,British PM: I want more commitments from Pfizer in potential AstraZeneca takeover,http://www.reuters.com/article/2014/05/07/pfizerastrazeneca-cameron-commitments-idUSS8N0M701320140507,
20140507 7:29AM UTC,British PM says wants assessment on Pfizer takeover bid for AstraZeneca,http://www.reuters.com/article/2014/05/07/pfizer-astrazeneca-cameron-idUSS8N0M701220140507,
20140507 6:42AM UTC,UK should consider takeover test for Pfizer-AstraZeneca -Cameron's spokesman,http://www.reuters.com/article/2014/05/07/astrazeneca-pfizer-cameron-idUSL6N0NT31Y20140507,
20140507 6:20AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/07/invesco-limited-idUSnBw075764a+100+BSW20140507,
20140507 3:54AM UTC,Pfizer says AstraZeneca takeover would benefit science,http://www.reuters.com/article/2014/05/07/astrazeneca-pfizer-idUSL6N0NT26A20140507,
20140507 11:57AM UTC,British PM's message for Pfizer,http://www.reuters.com/news/video/videoStory?storyID=84984796,
20140508 11:50PM UTC,"INDIA PRESS-Pfizer, Roche end association with US-India Business Council-Economic Times",http://www.reuters.com/article/2014/05/09/india-press-pfizer-idUSL3N0NV18W20140509,
20140508 10:23PM UTC,"Maryland, Delaware governors concerned about Pfizer-Astra deal",http://www.reuters.com/article/2014/05/09/us-pfizer-astrazeneca-governors-idUSBREA4800A20140509,
20140508 10:23PM UTC,"UPDATE 1-Maryland, Delaware governors concerned about Pfizer-Astra deal",http://www.reuters.com/article/2014/05/09/pfizer-astrazeneca-governors-idUSL2N0NV04320140509,
20140508 8:27PM UTC,"Maryland, Delaware governors concerned about Pfizer-Astra deal",http://www.reuters.com/article/2014/05/09/pfizer-astrazeneca-governors-idUSL2N0NU2O820140509,
20140508 3:55PM UTC,Swedish PM worried Pfizer would cut AstraZeneca jobs: report,http://www.reuters.com/article/2014/05/08/us-astrazeneca-sweden-pm-idUSBREA470W120140508,
20140508 3:54PM UTC,Swedish PM worried Pfizer would cut AstraZeneca jobs -report,http://www.reuters.com/article/2014/05/08/astrazeneca-sweden-pm-idUSL6N0NU6IC20140508,
20140508 3:51PM UTC,UK research foundation concerned about Pfizer bid for AstraZeneca: FT,http://www.reuters.com/article/2014/05/08/us-astrazeneca-pfizer-idUSBREA3R0H520140508,
20140508 3:49PM UTC,UK research foundation concerned about Pfizer bid for AstraZeneca-FT,http://www.reuters.com/article/2014/05/08/astrazeneca-pfizer-idUSL3N0NU6OF20140508,
20140508 10:51AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/08/the-vanguard-group-idUSnBw086157a+100+BSW20140508,
20140508 10:10AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/08/barclays-plc-idUSnBw086062a+100+BSW20140508,
20140508 9:46AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc - Amendment,http://www.reuters.com/article/2014/05/08/barclays-plc-idUSnBw086015a+100+BSW20140508,
20140508 9:45AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/08/mfs-investment-managemen-idUSnBw086014a+100+BSW20140508,
20140508 9:28AM UTC,"Fitch Solutions: CDS Sentiment Souring for Pfizer, Improving for AstraZeneca",http://www.reuters.com/article/2014/05/08/ny-fitch-solutions-cds-idUSnBw085980a+100+BSW20140508,
20140508 9:25AM UTC,"RPT-Fitch Solutions: CDS Sentiment Souring for Pfizer, Improving for AstraZeneca",http://www.reuters.com/article/2014/05/08/fitch-solutions-cds-sentiment-souring-fo-idUSFit69981920140508,
20140508 7:56AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/08/wellington-management-idUSnBw085795a+100+BSW20140508,
20140508 6:57AM UTC,UPDATE 1-AstraZeneca shares gain on talk of sweetened Pfizer bid,http://www.reuters.com/article/2014/05/08/astrazeneca-pfizer-idUSL6N0NU33X20140508,
20140508 6:35AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/08/invesco-limited-idUSnBw085696a+100+BSW20140508,
20140508 4:11AM UTC,AstraZeneca shares gain on speculation of new Pfizer bid,http://www.reuters.com/article/2014/05/08/astrazeneca-pfizer-idUSL6N0NU2CW20140508,
20140508 2:10AM UTC,Pfizer unlikely to avoid China anti-trust therapy,http://www.reuters.com/article/2014/05/08/idUS379488413720140508,
20140509 10:37AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc - Amendment,http://www.reuters.com/article/2014/05/09/barclays-plc-idUSnBw095545a+100+BSW20140509,
20140509 10:30AM UTC,Pfizer Announces Positive Phase 2 Study Results for Investigational Meningococcal B Vaccine,http://www.reuters.com/article/2014/05/09/pfizer-idUSnBw095521a+100+BSW20140509,
20140509 9:33AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/09/the-vanguard-group-idUSnBw095448a+100+BSW20140509,
20140509 9:28AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/09/barclays-plc-idUSnBw095441a+100+BSW20140509,
20140509 9:28AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/09/mfs-investment-managemen-idUSnBw095443a+100+BSW20140509,
20140509 8:57AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/09/wellington-management-idUSnBw095407a+100+BSW20140509,
20140509 8:28AM UTC,"Pfizer under fire in Europe, U.S. as it weighs next Astra move",http://www.reuters.com/article/2014/05/09/us-astrazeneca-pfizer-astra-idUSBREA480E020140509,
20140509 8:23AM UTC,"Pfizer under fire in Europe, U.S. as it weighs next Astra move",http://www.reuters.com/article/2014/05/09/astrazeneca-pfizer-idUSL6N0NV1NQ20140509,
20140509 8:11AM UTC,Pfizer signs rare diseases deal with UK universities,http://www.reuters.com/article/2014/05/09/us-astrazeneca-pfizer-rare-diseases-idUSKBN0DP0TN20140509,
20140509 8:00AM UTC,Pfizer signs rare diseases deal with UK universities,http://www.reuters.com/article/2014/05/09/astrazeneca-pfizer-rare-diseases-idUSL6N0NV2FZ20140509,
20140509 7:36AM UTC,Britain wants binding pledges from Pfizer on AstraZeneca bid,http://www.reuters.com/article/2014/05/09/us-astrazeneca-pfizer-clegg-idUSBREA480AT20140509,
20140509 7:24AM UTC,UPDATE 1-Britain wants binding pledges from Pfizer on AstraZeneca bid,http://www.reuters.com/article/2014/05/09/astrazeneca-pfizer-clegg-idUSL6N0NV2PN20140509,
20140509 6:43AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/09/invesco-limited-idUSnBw095257a+100+BSW20140509,
20140509 6:11AM UTC,Britain wants binding pledges from Pfizer on AstraZeneca bid,http://www.reuters.com/article/2014/05/09/astrazeneca-pfizer-clegg-idUSL6N0NV1S820140509,
20140509 9:03AM UTC,Pfizer to mount UK charm offensive,http://www.reuters.com/news/video/videoStory?storyID=85146020,
20140509 6:15AM UTC,Pfizer challenge to UK government would be â€œdaftâ€ - Clegg,http://www.reuters.com/news/video/videoStory?storyID=85140336,
20140510 5:11PM UTC,"Under fire, Pfizer hits back as it weighs next Astra move",http://www.reuters.com/article/2014/05/10/us-astrazeneca-pfizer-read-idUSBREA4905P20140510,
20140510 5:11PM UTC,Fear of Pfizer-AstraZeneca job cuts voiced by U.S. lawmakers,http://www.reuters.com/article/2014/05/10/us-astrazeneca-pfizer-usa-workers-idUSBREA4908O20140510,
20140510 4:57PM UTC,Fear of Pfizer-AstraZeneca job cuts voiced by U.S. lawmakers,http://www.reuters.com/article/2014/05/10/astrazeneca-pfizer-usa-workers-idUSL2N0NW0G620140510,
20140510 11:07AM UTC,UK finance minister ready for 'hard negotiation' with Pfizer,http://www.reuters.com/article/2014/05/10/us-astrazeneca-pfizer-osborne-idUSBREA4902T20140510,
20140510 10:59AM UTC,"UPDATE 1-Under fire, Pfizer hits back as weighs next Astra move",http://www.reuters.com/article/2014/05/10/astrazeneca-pfizer-read-idUSL6N0NW0EC20140510,
20140510 8:59AM UTC,"Pfizer CEO defends Astra deal, says committed to UK science",http://www.reuters.com/article/2014/05/10/us-astrazeneca-pfizer-read-idUSBREA4904F20140510,
20140510 8:42AM UTC,"Pfizer CEO defends Astra deal, says committed to UK science",http://www.reuters.com/article/2014/05/10/astrazeneca-pfizer-read-idUSL6N0NW0BX20140510,
20140510 6:03AM UTC,"UK finance minister ready for hard negotiation"" with Pfizer""",http://www.reuters.com/article/2014/05/10/astrazeneca-pfizer-osborne-idUSL6N0NW06F20140510,
20140511 10:52AM UTC,UK's Cameron says making good progress on Pfizer guarantees,http://www.reuters.com/article/2014/05/11/us-astrazeneca-pfizer-cameron-idUSBREA4A06920140511,
20140511 10:00AM UTC,UK's Cameron says making good progress on Pfizer guarantees,http://www.reuters.com/article/2014/05/11/astrazeneca-pfizer-cameron-idUSL6N0NX0H320140511,
20140512 8:23PM UTC,Pfizer considers raising bid for AstraZeneca -Bloomberg,http://www.reuters.com/article/2014/05/13/pfizer-astrazeneca-idUSL3N0NY6LA20140513,
20140512 6:49PM UTC,Pfizer Prices $4.5 Billion Debt Offering,http://www.reuters.com/article/2014/05/12/pfizer-idUSnBw126749a+100+BSW20140512,
20140512 10:31AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/12/the-vanguard-group-idUSnBw126042a+100+BSW20140512,
20140512 10:10AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/12/barclays-plc-idUSnBw125998a+100+BSW20140512,
20140512 9:40AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/12/mfs-investment-managemen-idUSnBw125938a+100+BSW20140512,
20140512 8:56AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/12/wellington-management-idUSnBw125868a+100+BSW20140512,
20140512 7:22AM UTC,Pfizer defends 'powerhouse' Astra deal as CEO braces for grilling,http://www.reuters.com/article/2014/05/12/us-astrazeneca-pfizer-idUSBREA3R0H520140512,
20140512 7:19AM UTC,"UPDATE 2-Pfizer defends powerhouse"" Astra deal as CEO braces for grilling""",http://www.reuters.com/article/2014/05/12/astrazeneca-pfizer-idUSL6N0NY1AW20140512,
20140512 7:11AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/12/invesco-limited-idUSnBw125708a+100+BSW20140512,
20140512 5:33AM UTC,RPT-Pfizer says its commitments to UK legally binding,http://www.reuters.com/article/2014/05/12/astrazeneca-pfizer-commitments-idUSL6N0NY26O20140512,
20140512 5:31AM UTC,Pfizer says its commitments to UK legally binding,http://www.reuters.com/article/2014/05/12/idUSFWN0NU01N20140512,
20140512 2:42AM UTC,Pfizer R&D; head presses case for AstraZeneca deal,http://www.reuters.com/article/2014/05/12/astrazeneca-pfizer-idUSL6N0NY14020140512,
20140513 7:05PM UTC,Call for 10-year Pfizer pledge as CEO faces new grilling,http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-idUSL6N0NZ68Q20140513,
20140513 1:03PM UTC,UK lawmakers give Pfizer stick as it waves carrot at AstraZeneca,http://www.reuters.com/article/2014/05/13/us-astrazeneca-pfizer-idUSBREA3R0H520140513,
20140513 11:28AM UTC,"Pfizer pursuit of Astra 'tax-driven', says Swedish finance minister",http://www.reuters.com/article/2014/05/13/us-sweden-astrazeneca-idUSBREA4C0IP20140513,
20140513 11:27AM UTC,"Pfizer pursuit of Astra tax-driven"""," says Swedish finance minister""",http://www.reuters.com/article/2014/05/13/sweden-astrazeneca-idUSL6N0NZ4M520140513
20140513 10:08AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/13/the-vanguard-group-idUSnBw136176a+100+BSW20140513,
20140513 9:44AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/13/barclays-plc-idUSnBw136130a+100+BSW20140513,
20140513 9:43AM UTC,UPDATE 6-UK lawmakers give Pfizer stick as it waves carrot at AstraZeneca,http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-idUSL6N0NZ1XB20140513,
20140513 9:25AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/13/mfs-investment-managemen-idUSnBw136096a+100+BSW20140513,
20140513 8:19AM UTC,"UK minister says intervention on AstraZeneca, Pfizer 'tricky'",http://www.reuters.com/article/2014/05/13/us-astrazeneca-pfizer-cable-idUSBREA4C0D220140513,
20140513 8:17AM UTC,"UK minister says intervention on AstraZeneca, Pfizer tricky""""",http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-cable-idUSWLB0086Y20140513,
20140513 8:00AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/13/wellington-management-idUSnBw135979a+100+BSW20140513,
20140513 7:14AM UTC,AstraZeneca CEO says would consider a compelling Pfizer offer,http://www.reuters.com/article/2014/05/13/us-astrazeneca-pfizer-soriot-idUSBREA4C0AF20140513,
20140513 7:11AM UTC,AstraZeneca CEO says would consider a compelling Pfizer offer,http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-soriot-idUSWLB0087420140513,
20140513 6:46AM UTC,AstraZeneca CEO sees reputational risk from Pfizer tax plan,http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-soriot-idUSWLB0086W20140513,
20140513 6:29AM UTC,AstraZeneca says Pfizer bid approach 'opportunistic',http://www.reuters.com/article/2014/05/13/us-astrazeneca-pfizer-opportunistic-idUSBREA4C09X20140513,
20140513 6:28AM UTC,"AstraZeneca says Pfizer bid approach opportunistic""""",http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-opportunistic-idUSFWN0NU02Q20140513,
20140513 5:59AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/13/invesco-limited-idUSnBw135825a+100+BSW20140513,
20140513 5:46AM UTC,Pfizer sees no antitrust hurdles from buying AstraZeneca,http://www.reuters.com/article/2014/05/13/us-astrazeneca-pfizer-antitrust-idUSBREA4C08E20140513,
20140513 5:45AM UTC,Pfizer sees no antitrust hurdles from buying AstraZeneca,http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-antitrust-idUSWLB0087120140513,
20140513 5:19AM UTC,Pfizer CEO: R&D; spend of new group would fall after Astra deal,http://www.reuters.com/article/2014/05/13/us-astrazeneca-pfizer-read-idUSBREA4C07P20140513,
20140513 5:15AM UTC,Pfizer CEO: R&D; spend of new group would fall after Astra deal,http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-read-idUSWLB0086V20140513,
20140513 4:46AM UTC,"WATCH LIVE STREAM: Pfizer, AstraZeneca, Unions quizzed by parliament",http://www.reuters.com/article/2014/05/13/idUSL6N0NZ2E520140513,
20140513 3:21AM UTC,UPDATE 1-Pfizer boss enters lion's den of UK politics to sell AstraZeneca deal,http://www.reuters.com/article/2014/05/13/astrazeneca-pfizer-idUSL6N0NY3LZ20140513,
20140513 2:31AM UTC,Pfizer keen to engage with AstraZeneca board,http://www.reuters.com/article/2014/05/13/us-pfizer-astrazeneca-idUSBREA4C01I20140513,
20140513 2:15AM UTC,Pfizer says keen to engage with AstraZeneca board,http://www.reuters.com/article/2014/05/13/pfizer-astrazeneca-idUSASM0006OT20140513,
20140513 2:05AM UTC,Pfizerâ€™s Possible Offer for AstraZeneca plc (â€œAstraZenecaâ€) Represents Compelling Shareholder Value,http://www.reuters.com/article/2014/05/13/pfizer-idUSnBw126807a+100+BSW20140513,
20140513 11:54AM UTC,UK MPs quiz Pfizer boss over Astra,http://www.reuters.com/news/video/videoStory?storyID=85407195,
20140514 6:55PM UTC,Senators urge tough U.S. review of Pfizer bid for AstraZeneca,http://www.reuters.com/article/2014/05/14/us-pfizer-astrazeneca-review-idUSBREA4D0T920140514,
20140514 6:09PM UTC,UPDATE 2-Senators urge tough U.S. review of Pfizer bid for AstraZeneca,http://www.reuters.com/article/2014/05/14/pfizer-astrazeneca-review-idUSL1N0O01UO20140514,
20140514 5:36PM UTC,"AstraZeneca leaves door ajar to Pfizer, despite hurdles",http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-soriot-idUSKBN0DU20K20140514,
20140514 5:17PM UTC,"AstraZeneca leaves door ajar to Pfizer, despite hurdles",http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-soriot-idUSBREA4D0UL20140514,
20140514 4:25PM UTC,Pfizer pledges to ringfence key new drugs in AstraZeneca deal,http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-idUSBREA3R0H520140514,
20140514 4:09PM UTC,Senators urge U.S. anti-trust review of Pfizer-AstraZeneca plan,http://www.reuters.com/article/2014/05/14/us-pfizer-astrazeneca-review-idUSBREA4D0S420140514,
20140514 4:04PM UTC,Senators urge U.S. anti-trust review of Pfizer-AstraZeneca plan,http://www.reuters.com/article/2014/05/14/pfizer-astrazeneca-review-idUSL1N0O01SM20140514,
20140514 12:58PM UTC,"UPDATE 1-UK lawmaker stirs political row with Pfizer rapist"" comments""",http://www.reuters.com/article/2014/05/14/astrazeneca-pfizer-labour-idUSL6N0O060I20140514,
20140514 12:55PM UTC,"Astra CEO sees price, Pfizer structure as deal hurdles",http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-soriot-idUSBREA4D0IA20140514,
20140514 12:36PM UTC,UK lawmaker stirs political row with Pfizer 'rapist' comments,http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-labour-idUSBREA4D0KZ20140514,
20140514 12:34PM UTC,"UK lawmaker stirs political row with Pfizer rapist"" comments""",http://www.reuters.com/article/2014/05/14/astrazeneca-pfizer-labour-idUSL6N0O05N120140514,
20140514 11:27AM UTC,"Health Care Sector Equities Technical Analysis -- Research on CombiMatrix, Quintiles Transnational Holdings, Pfizer, and GW Pharma",http://www.reuters.com/article/2014/05/14/bc-investor-edge-idUSnPn8PFP6n+9c+PRN20140514,
20140514 10:35AM UTC,Fitch Assigns an 'A+' Rating to Pfizer's Notes Offering,http://www.reuters.com/article/2014/05/14/ny-fitch-ratings-pfizer-idUSnBw146103a+100+BSW20140514,
20140514 10:00AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/14/barclays-plc-idUSnBw146024a+100+BSW20140514,
20140514 10:00AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/14/the-vanguard-group-idUSnBw146020a+100+BSW20140514,
20140514 9:33AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/14/mfs-investment-managemen-idUSnBw145976a+100+BSW20140514,
20140514 8:26AM UTC,Swedish unions urge government to oppose Pfizer bid for Astra,http://www.reuters.com/article/2014/05/14/us-astrazeneca-sweden-unions-idUSBREA4D0BV20140514,
20140514 8:25AM UTC,Swedish unions urge government to oppose Pfizer bid for Astra,http://www.reuters.com/article/2014/05/14/astrazeneca-sweden-unions-idUSL6N0O03R820140514,
20140514 8:16AM UTC,UPDATE 2-Pfizer pledges to ringfence key new drugs in AstraZeneca deal,http://www.reuters.com/article/2014/05/14/astrazeneca-pfizer-idUSL6N0O02S120140514,
20140514 7:42AM UTC,J&J; taps British science quietly where Pfizer storms in,http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-jj-idUSBREA4D09T20140514,
20140514 7:41AM UTC,J&J; taps British science quietly where Pfizer storms in,http://www.reuters.com/article/2014/05/14/astrazeneca-pfizer-jj-idUSL6N0NY44920140514,
20140514 7:38AM UTC,UK's Cameron wants 'best possible' Pfizer guarantees on AstraZeneca,http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-cameron-idUSBREA4D09P20140514,
20140514 7:37AM UTC,"UK's Cameron wants best possible"" Pfizer guarantees on AstraZeneca""",http://www.reuters.com/article/2014/05/14/astrazeneca-pfizer-cameron-idUSL6N0O03VQ20140514,
20140514 6:01AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/14/invesco-limited-idUSnBw145674a+100+BSW20140514,
20140515 12:41PM UTC,Promising cancer drug data helps AstraZeneca in Pfizer fight,http://www.reuters.com/article/2014/05/15/us-health-cancer-astrazeneca-idUSKBN0DV1E520140515,
20140515 12:39PM UTC,UPDATE 3-Promising cancer drug data helps AstraZeneca in Pfizer fight,http://www.reuters.com/article/2014/05/15/health-cancer-astrazeneca-idUSL1N0O108420140515,
20140515 11:27AM UTC,"American College of Physicians, CECity, and Pfizer collaborate to increase adult immunization rates",http://www.reuters.com/article/2014/05/15/acp-adult-vaccines-idUSnPn5cfhV3+82+PRN20140515,
20140515 11:13AM UTC,Sweden's finance minister says ready to hear Pfizer out on Astra bid,http://www.reuters.com/article/2014/05/15/astrazeneca-pfizer-borg-idUSL6N0O152K20140515,
20140515 11:04AM UTC,"Research and Markets: Global PVA (Polyvinyl Alcohol) Drugs Market 2014-2018 with Actavis plc, Novo Nordisk A/S, Pfizer Inc. & Shionogi & Co. Ltd. Dominating",http://www.reuters.com/article/2014/05/15/research-and-markets-idUSnBw156009a+100+BSW20140515,
20140515 10:44AM UTC,Promising cancer drug data helps AstraZeneca in Pfizer fight,http://www.reuters.com/article/2014/05/15/us-cancer-astrazeneca-idUSBREA4E07P20140515,
20140515 10:28AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/15/barclays-plc-idUSnBw155951a+100+BSW20140515,
20140515 10:02AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/15/the-vanguard-group-idUSnBw155922a+100+BSW20140515,
20140515 9:42AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/15/mfs-investment-managemen-idUSnBw155885a+100+BSW20140515,
20140515 8:03AM UTC,"Pfizer move on Astra threatens UK science, lawmakers say",http://www.reuters.com/article/2014/05/15/us-astrazeneca-pfizer-lawmakers-idUSBREA4E0EC20140515,
20140515 8:02AM UTC,"Pfizer move on Astra threatens UK science, lawmakers say",http://www.reuters.com/article/2014/05/15/astrazeneca-pfizer-lawmakers-idUSL6N0O13XX20140515,
20140515 7:57AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/15/wellington-management-idUSnBw155750a+100+BSW20140515,
20140515 7:09AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/15/invesco-limited-idUSnBw155709a+100+BSW20140515,
20140515 3:29AM UTC,EU's Almunia: Pfizer has not discussed AstraZeneca bid with regulators,http://www.reuters.com/article/2014/05/15/pfizer-astrazeneca-eu-idUSL6N0O04L520140515,
20140516 1:48PM UTC,UPDATE 1-Pfizer to apply for early U.S. approval of breast cancer drug,http://www.reuters.com/article/2014/05/16/pfizer-cancer-idUSL1N0O214C20140516,
20140516 1:02PM UTC,Pfizer to apply for early U.S. approval of breast cancer drug,http://www.reuters.com/article/2014/05/16/us-pfizer-breastcancer-drugs-idUSKBN0DW1HL20140516,
20140516 12:47PM UTC,Pfizer to apply for early U.S. approval of breast cancer drug,http://www.reuters.com/article/2014/05/16/pfizer-cancer-idUSL1N0O213620140516,
20140516 12:12PM UTC,Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1,http://www.reuters.com/article/2014/05/16/pfizer-idUSnBw165736a+100+BSW20140516,
20140516 10:50AM UTC,Sweden fights back as Pfizer move on Astra threatens jobs,http://www.reuters.com/article/2014/05/16/us-astrazeneca-pfizer-sweden-idUSBREA4F06G20140516,
20140516 10:12AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/16/barclays-plc-idUSnBw165520a+100+BSW20140516,
20140516 9:38AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/16/the-vanguard-group-idUSnBw165485a+100+BSW20140516,
20140516 9:33AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/16/mfs-investment-managemen-idUSnBw165480a+100+BSW20140516,
20140516 8:53AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/16/wellington-management-idUSnBw165447a+100+BSW20140516,
20140516 8:44AM UTC,UPDATE 2-Sweden fights back as Pfizer move on Astra threatens jobs,http://www.reuters.com/article/2014/05/16/astrazeneca-pfizer-sweden-idUSL6N0O21M720140516,
20140516 7:57AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/16/invesco-limited-idUSnBw165398a+100+BSW20140516,
20140516 7:40AM UTC,"FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals",http://www.reuters.com/article/2014/05/16/bc-ar-idUSnPnDX0ls+58+PRN20140516,
20140516 4:45AM UTC,Sweden fights back as Pfizer move on Astra threatens jobs,http://www.reuters.com/article/2014/05/16/us-astrazeneca-pfizer-sweden-idUSBREA4F06C20140516,
20140516 3:29AM UTC,Swedish ministers urge Astra owners to consider Pfizer rebuff,http://www.reuters.com/article/2014/05/16/astrazeneca-pfizer-sweden-idUSL6N0O21HZ20140516,
20140518 7:58PM UTC,UPDATE 4-Pfizer raises bid for AstraZeneca to $117 billion,http://www.reuters.com/article/2014/05/18/astrazeneca-pfizer-idUSL6N0O413J20140518,
20140518 6:57PM UTC,Pfizer raises bid for AstraZeneca to $117 billion,http://www.reuters.com/article/2014/05/18/us-astrazeneca-pfizer-idUSBREA3R0H520140518,
20140518 5:03PM UTC,Pfizer Makes Final Proposal to AstraZeneca,http://www.reuters.com/article/2014/05/18/pfizer-idUSnBw185047a+100+BSW20140518,
20140518 4:52PM UTC,Pfizer raises offer for AstraZeneca to 55 pounds a share,http://www.reuters.com/article/2014/05/18/astrazeneca-pfizer-offer-idUSL6N0O418220140518,
20140518 2:27PM UTC,Pfizer planning to make sweetened bid for AstraZeneca PLC: WSJ,http://www.reuters.com/article/2014/05/18/us-pfizer-astrazeneca-idUSBREA4H08M20140518,
20140518 2:26PM UTC,Pfizer planning to make sweetened bid for AstraZeneca PLC: WSJ,http://www.reuters.com/article/2014/05/18/pfizer-astrazeneca-idUSL1N0O40CP20140518,
20140518 8:30AM UTC,Clock ticking for Pfizer to raise AstraZeneca bid,http://www.reuters.com/article/2014/05/18/astrazeneca-pfizer-idUSL6N0O408J20140518,
20140518 6:27AM UTC,AstraZeneca arrays academic assets in Pfizer defense,http://www.reuters.com/article/2014/05/18/us-astrazeneca-pfizer-cambridge-idUSBREA4H03K20140518,
20140518 6:21AM UTC,AstraZeneca arrays academic assets in Pfizer defence,http://www.reuters.com/article/2014/05/18/astrazeneca-pfizer-cambridge-idUSL6N0O302L20140518,
20140519 6:41PM UTC,Statement from Pfizer Inc.,http://www.reuters.com/article/2014/05/19/pfizer-idUSnBw196781a+100+BSW20140519,
20140519 6:37PM UTC,AstraZeneca rejects Pfizer's take-it-or-leave-it offer,http://www.reuters.com/article/2014/05/19/us-astrazeneca-pfizer-idUSBREA3R0H520140519,
20140519 6:37PM UTC,Pfizer-AstraZeneca deal not quite dead yet,http://www.reuters.com/article/2014/05/19/us-astrazeneca-pfizer-comeback-idUSBREA4I0UM20140519,
20140519 4:23PM UTC,UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offer,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-idUSL6N0O413J20140519,
20140519 1:36PM UTC,UK takeover rules block higher Pfizer offer before Astra deadline,http://www.reuters.com/article/2014/05/19/us-astrazeneca-pfizer-rules-idUSBREA4I0KL20140519,
20140519 1:35PM UTC,UK takeover rules block higher Pfizer offer before Astra deadline,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-rules-idUSL6N0O53W020140519,
20140519 1:02PM UTC,GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighs,http://www.reuters.com/article/2014/05/19/markets-global-idUSL1N0O511220140519,
20140519 11:48AM UTC,GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighs,http://www.reuters.com/article/2014/05/19/markets-global-idUSL1N0O50IR20140519,
20140519 10:26AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/19/barclays-plc-idUSnBw196019a+100+BSW20140519,
20140519 10:23AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/19/the-vanguard-group-idUSnBw196009a+100+BSW20140519,
20140519 9:31AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/19/mfs-investment-managemen-idUSnBw195901a+100+BSW20140519,
20140519 9:14AM UTC,AstraZeneca chairman sees no prospect of last-minute Pfizer deal,http://www.reuters.com/article/2014/05/19/us-astrazeneca-pfizer-chairman-idUSBREA4I0B120140519,
20140519 9:12AM UTC,INTERVIEW-AstraZeneca chairman sees no prospect of last-minute Pfizer deal,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-chairman-idUSL6N0O535F20140519,
20140519 8:14AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/19/wellington-management-idUSnBw195773a+100+BSW20140519,
20140519 6:42AM UTC,"British PM Cameron says government talking to Pfizer, AstraZeneca",http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-cameron-idUSL6N0NU37C20140519,
20140519 6:16AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/19/invesco-limited-idUSnBw195656a+100+BSW20140519,
20140519 6:06AM UTC,Jupiter 'disappointed' at AstraZeneca's rejection of Pfizer bid,http://www.reuters.com/article/2014/05/19/us-jupiter-astrazeneca-idUSBREA4I06P20140519,
20140519 6:05AM UTC,British lawmaker expects Pfizer to court AstraZeneca shareholders,http://www.reuters.com/article/2014/05/19/us-astrazeneca-pfizer-britain-idUSBREA4I06L20140519,
20140519 6:04AM UTC,"Jupiter disappointed"" at AstraZeneca's rejection of Pfizer bid""",http://www.reuters.com/article/2014/05/19/idUSL6N0O526C20140519,
20140519 6:04AM UTC,British lawmaker expects Pfizer to court AstraZeneca shareholders,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-britain-idUSL6N0O524120140519,
20140519 5:05AM UTC,Shareholders disappointed by AstraZeneca rejection of Pfizer,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-shareholders-idUSL6N0O51VS20140519,
20140519 4:36AM UTC,Swedish Fin Min Borg urges caution on new Pfizer bid for AstraZeneca,http://www.reuters.com/article/2014/05/19/sweden-finmin-idUSS3N0M103D20140519,
20140519 4:09AM UTC,AstraZeneca weighs on Europe shares as it rejects Pfizer bid,http://www.reuters.com/article/2014/05/19/markets-europe-stocks-idUSL6N0O51LA20140519,
20140519 4:02AM UTC,Aberdeen Asset Management says Pfizer could do better on price,http://www.reuters.com/article/2014/05/19/us-astrazeneca-pfizer-aberdeen-idUSBREA4I04520140519,
20140519 4:02AM UTC,Aberdeen Asset Management says Pfizer could do better on price,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-aberdeen-idUSL6N0O51L220140519,
20140519 3:12AM UTC,AstraZeneca weighs on Europe shares as it rejects Pfizer bid,http://www.reuters.com/article/2014/05/19/markets-europe-stocks-idUSL6N0O51C220140519,
20140519 3:08AM UTC,AstraZeneca falls 14 pct after rejecting Pfizer offer,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-stocks-idUSL6N0O51DR20140519,
20140519 2:15AM UTC,AstraZeneca rejects 55 pounds/share Pfizer offer,http://www.reuters.com/article/2014/05/19/astrazeneca-pfizer-rejection-idUSFWN0NK01D20140519,
20140519 2:14PM UTC,So why did AstraZeneca reject Pfizer?,http://www.reuters.com/news/video/videoStory?storyID=85836697,
20140519 9:49AM UTC,Pfizer's bid is too bitter for Astra,http://www.reuters.com/news/video/videoStory?storyID=85817847,
20140520 4:00PM UTC,GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial,http://www.reuters.com/article/2014/05/20/md-glycomimetics-idUSnBw206812a+100+BSW20140520,
20140520 3:50PM UTC,"Schroders, Fidelity reveal investor split as Astra rejects Pfizer",http://www.reuters.com/article/2014/05/20/us-astrazeneca-pfizer-shareholders-idUSBREA4J09520140520,
20140520 3:50PM UTC,Pfizer-AstraZeneca bankers set to miss up to $340 million in fees,http://www.reuters.com/article/2014/05/20/us-astrazenica-pfizer-bankers-idUSBREA4J0RG20140520,
20140520 3:46PM UTC,REFILE-Pfizer-AstraZeneca bankers set to miss up to $340 mln in fees,http://www.reuters.com/article/2014/05/20/astrazenica-pfizer-bankers-idUSL6N0O546I20140520,
20140520 3:46PM UTC,"UPDATE 4-Schroders, Fidelity reveal investor split as Astra rejects Pfizer",http://www.reuters.com/article/2014/05/20/astrazeneca-pfizer-idUSL1N0O61QL20140520,
20140520 3:11PM UTC,"REFILE-UPDATE 3-Schroders, Fidelity reveal investor split as Astra rejects Pfizer",http://www.reuters.com/article/2014/05/20/astrazeneca-pfizer-idUSL6N0O638O20140520,
20140520 1:34PM UTC,AstraZeneca says no negotiation with suitor Pfizer allowed under UK rules,http://www.reuters.com/article/2014/05/20/us-astrazeneca-clarification-idUSBREA4J0PU20140520,
20140520 1:33PM UTC,AstraZeneca says no negotiation with suitor Pfizer allowed under UK rules,http://www.reuters.com/article/2014/05/20/astrazeneca-clarification-idUSFWN0O600120140520,
20140520 11:32AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/20/barclays-plc-idUSnBw206420a+100+BSW20140520,
20140520 10:20AM UTC,AstraZeneca 'did the right thing' rejecting Pfizer: Fidelity,http://www.reuters.com/article/2014/05/20/us-astrazeneca-pfizer-fidelity-idUSBREA4J0IA20140520,
20140520 10:17AM UTC,"AstraZeneca did the right thing"" rejecting Pfizer - Fidelity""",http://www.reuters.com/article/2014/05/20/astrazeneca-pfizer-fidelity-idUSL6N0O646U20140520,
20140520 9:53AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/20/mfs-investment-managemen-idUSnBw206196a+100+BSW20140520,
20140520 9:41AM UTC,Loophole offers Pfizer risky way back into AZ deal,http://www.reuters.com/article/2014/05/20/idUS408733517820140520,
20140520 9:30AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/20/the-vanguard-group-idUSnBw206170a+100+BSW20140520,
20140520 9:17AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/20/wellington-management-idUSnBw206148a+100+BSW20140520,
20140520 6:55AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/20/invesco-limited-idUSnBw205902a+100+BSW20140520,
20140520 5:55AM UTC,AstraZeneca shareholder urges board back into talks with Pfizer,http://www.reuters.com/article/2014/05/20/astrazeneca-pfizer-shareholders-idUSL6N0O62GC20140520,
20140521 3:11PM UTC,"Research and Markets: Global Neuropathic Pain Report 2014: Current and Future Players - Pfizer, Eli Lilly, Grnenthal, Endo Health Solutions, Janssen, Daiichi Sankyo & Convergence Pharmaceuticals",http://www.reuters.com/article/2014/05/21/research-and-markets-idUSnBw216478a+100+BSW20140521,
20140521 2:23PM UTC,See you later? Slim Pfizer deal hopes prop up AstraZeneca,http://www.reuters.com/article/2014/05/21/us-astrazeneca-pfizer-idUSBREA3R0H520140521,
20140521 12:13PM UTC,Astra-Pfizer needs a fresh start later in the year,http://www.reuters.com/article/2014/05/21/idUS278117953220140521,
20140521 11:45AM UTC,See you later? Slim Pfizer deal hopes prop up AstraZeneca,http://www.reuters.com/article/2014/05/21/astrazeneca-pfizer-idUSL6N0O72IS20140521,
20140521 9:47AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/21/the-vanguard-group-idUSnBw215880a+100+BSW20140521,
20140521 9:25AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/21/mfs-investment-managemen-idUSnBw215851a+100+BSW20140521,
20140521 7:35AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/21/invesco-limited-idUSnBw215687a+100+BSW20140521,
20140521 7:29AM UTC,"Schroders, Fidelity reveal investor split as Astra rejects Pfizer",http://www.reuters.com/article/2014/05/21/us-astrazeneca-pfizer-shareholders-idUSBREA4J09520140521,
20140522 6:33PM UTC,BlackRock wants new Astra-Pfizer talks at later date: sources,http://www.reuters.com/article/2014/05/22/us-astrazeneca-pfizer-blackrock-idUSBREA4L18R20140522,
20140522 6:30PM UTC,BlackRock wants new Astra-Pfizer talks at later date-sources,http://www.reuters.com/article/2014/05/22/astrazeneca-pfizer-blackrock-idUSL6N0O864S20140522,
20140522 10:24AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/22/barclays-plc-idUSnBw225896a+100+BSW20140522,
20140522 10:01AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/22/the-vanguard-group-idUSnBw225846a+100+BSW20140522,
20140522 9:42AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/22/mfs-investment-managemen-idUSnBw225798a+100+BSW20140522,
20140522 8:00AM UTC,BioRestorative Therapies Signs Research Agreement with Pfizer Inc.,http://www.reuters.com/article/2014/05/22/fl-biorestorative-idUSnBw225072a+100+BSW20140522,
20140522 5:54AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/22/invesco-limited-idUSnBw225481a+100+BSW20140522,
20140522 4:14AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/22/barclays-plc-idUSnBw225420a+100+BSW20140522,
20140523 10:12AM UTC,REG-The Vanguard Group Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/2014/05/23/the-vanguard-group-idUSnBw235321a+100+BSW20140523,
20140523 10:11AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/23/barclays-plc-idUSnBw235320a+100+BSW20140523,
20140523 9:35AM UTC,Pfizer psoriasis drug succeeds in late-stage trial,http://www.reuters.com/article/2014/05/23/us-pfizer-study-psoriasis-idUSKBN0E31AQ20140523,
20140523 9:33AM UTC,Pfizer psoriasis drug succeeds in late-stage trial,http://www.reuters.com/article/2014/05/23/pfizer-study-psoriasis-idUSL3N0O93KO20140523,
20140523 9:13AM UTC,Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis,http://www.reuters.com/article/2014/05/23/pfizer-idUSnBw235280a+100+BSW20140523,
20140523 8:45AM UTC,REG-INVESCO Limited Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/23/invesco-limited-idUSnBw235257a+100+BSW20140523,
20140523 8:44AM UTC,REG-MFS Investment Manag Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/23/mfs-investment-managemen-idUSnBw235255a+100+BSW20140523,
20140526 9:22PM UTC,How AstraZeneca escaped Pfizer's clutches this time,http://www.reuters.com/article/2014/05/27/us-astrazeneca-pfizer-insight-idUSBREA4P0IN20140527,
20140526 7:09PM UTC,How AstraZeneca escaped Pfizer's clutches this time,http://www.reuters.com/article/2014/05/26/us-astrazeneca-pfizer-insight-idUSBREA4P0IN20140526,
20140526 7:01PM UTC,INSIGHT-How AstraZeneca escaped Pfizer's clutches this time,http://www.reuters.com/article/2014/05/26/astrazeneca-pfizer-idUSL6N0O91K920140526,
20140526 11:55AM UTC,Pfizer walks away from $118 billion AstraZeneca takeover fight,http://www.reuters.com/article/2014/05/26/us-astrazeneca-pfizer-idUSBREA3R0H520140526,
20140526 11:53AM UTC,UPDATE 2-Pfizer walks away from $118 bln AstraZeneca takeover fight,http://www.reuters.com/article/2014/05/26/astrazeneca-pfizer-idUSL6N0OC3HI20140526,
20140526 11:17AM UTC,AstraZeneca welcomes Pfizer climbdown in takeover fight,http://www.reuters.com/article/2014/05/26/us-astrazeneca-pfizer-climbdown-idUSBREA4P0CC20140526,
20140526 11:10AM UTC,AstraZeneca welcomes Pfizer climbdown in takeover fight,http://www.reuters.com/article/2014/05/26/astrazeneca-pfizer-climbdown-idUSL6N0OC3NW20140526,
20140526 10:14AM UTC,Pfizer walks away from $118 bln AstraZeneca deal,http://www.reuters.com/article/2014/05/26/astrazeneca-pfizer-idUSL6N0OC2GW20140526,
20140526 10:05AM UTC,Statement from Pfizer Inc.,http://www.reuters.com/article/2014/05/26/ny-pfizer-idUSnBw265174a+100+BSW20140526,
20140527 4:08PM UTC,"ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R)",http://www.reuters.com/article/2014/05/27/idUSnGNXcdVfXy+1ca+GNW20140527,
20140527 10:07AM UTC,REG-BARCLAYS PLC Form 8.3 - Pfizer Inc,http://www.reuters.com/article/2014/05/27/barclays-plc-idUSnBw275975a+100+BSW20140527,
20140527 8:30AM UTC,Pfizer Brings Frequent Heartburn Relief Over-the-Counter with New NexiumÂ® 24HR,http://www.reuters.com/article/2014/05/27/pfizer-idUSnBw275752a+100+BSW20140527,
20140527 7:20AM UTC,"Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics",http://www.reuters.com/article/2014/05/27/bc-a-idUSnPn4q7rSK+83+PRN20140527,
20140527 5:10AM UTC,AstraZeneca shares fall after Pfizer walks away,http://www.reuters.com/article/2014/05/27/us-astrazeneca-pfizer-stocks-idUSKBN0E70NG20140527,
20140527 4:34AM UTC,UPDATE 1-AstraZeneca shares fall after Pfizer walks away,http://www.reuters.com/article/2014/05/27/astrazeneca-pfizer-stocks-idUSL6N0OD1PL20140527,
20140527 3:31AM UTC,How AstraZeneca escaped Pfizer's clutches this time,http://www.reuters.com/article/2014/05/27/us-astrazeneca-pfizer-insight-idUSKBN0E70G020140527,
20140527 3:15AM UTC,Pfizer walks away from $118 billion AstraZeneca takeover fight,http://www.reuters.com/article/2014/05/27/us-astrazeneca-pfizer-idUSKBN0E70D520140527,
20140527 9:35AM UTC,Maybe Pfizer's offer won't be the last?,http://www.reuters.com/news/video/videoStory?storyID=86395333,
20140528 4:14PM UTC,"Italy seeks anti-trust compensation from Roche, Novartis, Pfizer",http://www.reuters.com/article/2014/05/28/us-itally-pharma-compensation-idUSKBN0E820N20140528,
20140528 4:08PM UTC,"UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, Pfizer",http://www.reuters.com/article/2014/05/28/italy-pharma-compensation-idUSL6N0OE50N20140528,
20140528 1:36PM UTC,"Italy seeks anti-trust compensation from Roche, Novartis, Pfizer",http://www.reuters.com/article/2014/05/28/itally-pharma-compensation-idUSR1N0N000120140528,
20140529 12:28PM UTC,Cancer meeting a showcase for AstraZeneca drugs prized by Pfizer,http://www.reuters.com/article/2014/05/29/us-health-cancer-astrazeneca-idUSKBN0E91S320140529,
20140529 11:14AM UTC,"Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research",http://www.reuters.com/article/2014/05/29/pfizer-idUSnBw295910a+100+BSW20140529,
20140529 8:00AM UTC,Pfizer and the Avon Foundation for Women Announce $1 Million Grants Program to Address Gaps in Support for People Living with Metastatic Breast Cancer,http://www.reuters.com/article/2014/05/29/pfizer-idUSnBw295254a+100+BSW20140529,
20140529 4:12AM UTC,BRIEF-Hisun Pharma says unit's JV with Pfizer Luxembourg has started production,http://www.reuters.com/article/2014/05/29/hisun-brief-idUSL3N0OF21X20140529,
20140602 10:56AM UTC,Pfizer to pay $325 million in Neurontin settlement,http://www.reuters.com/article/2014/06/02/us-pfizer-neurontin-settlement-idUSKBN0ED1IS20140602,
20140602 10:49AM UTC,Pfizer to pay $325 mln in Neurontin settlement,http://www.reuters.com/article/2014/06/02/pfizer-neurontin-settlement-idUSL1N0OJ0Q920140602,
20140602 9:30AM UTC,"The Zacks Analyst Blog Highlights: McDonald's, Pfizer, AstraZeneca, Chevron and ExxonMobil",http://www.reuters.com/article/2014/06/02/zacks-analyst-blog-idUSnPn4xXrfV+89+PRN20140602,
20140603 8:30AM UTC,"Data Review on Active Stocks -- Research on SIRIUS XM, Twitter, Pfizer, and Vale",http://www.reuters.com/article/2014/06/03/bc-i-idUSnPn8hx0yM+81+PRN20140603,
20140604 10:00AM UTC,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,http://www.reuters.com/article/2014/06/04/pfizer-idUSnBw045124a+100+BSW20140604,
20140604 6:00AM UTC,KineMed Collaboration with Pfizer Inc. in Diabetes is Extended,http://www.reuters.com/article/2014/06/04/ca-kinemed-idUSnBw045044a+100+BSW20140604,
20140605 11:10AM UTC,Six Organizations Receive Grants From NCCN and Pfizer for Health Care Quality Improvement Programs in Rare Cancers,http://www.reuters.com/article/2014/06/05/idUSnMKWM3MCSa+1ee+MKW20140605,
20140605 9:30AM UTC,"Rite Aid, PHH, Novartis, Pfizer and GlaxoSmithKline highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/06/05/il-zacks-investment-idUSnPn4sjtXL+83+PRN20140605,
20140605 6:10AM UTC,"Study Results, Updated Organization Structures, Appointments, and Technical Updates - Analyst Notes on Johnson & Johnson, Pfizer, Teva, Express Scripts and Idenix Pharmaceuticals",http://www.reuters.com/article/2014/06/05/bc-ar-idUSnPn7gWV5M+8d+PRN20140605,
20140612 11:35AM UTC,"Merck, Pfizer, HSBC could be big winners from shareholder case",http://www.reuters.com/article/2014/06/12/us-usa-court-halliburton-analysis-idUSKBN0EN10620140612,
20140612 9:15AM UTC,"Dyadic Appoints Michael Tarnok, Chairman Of Keryx And Former Pfizer Senior Vice President, To Board Of Directors",http://www.reuters.com/article/2014/06/12/fl-dyadic-elect-idUSnPn5GCnpq+98+PRN20140612,
20140612 9:00AM UTC,BioTime Subsidiary Asterias Biotherapeutics Appoints Former Pfizer Senior Executive Pedro Lichtinger as President and Chief Executive Officer,http://www.reuters.com/article/2014/06/12/ca-biotime-idUSnBw125407a+100+BSW20140612,
20140613 8:47AM UTC,Drug-linked payouts: complex fix for Pfizer's next Astra bid?,http://www.reuters.com/article/2014/06/13/us-astrazeneca-pfizer-idUSKBN0EO19120140613,
20140613 8:42AM UTC,DEALTALK-Drug-linked payouts: complex fix for Pfizer's next Astra bid?,http://www.reuters.com/article/2014/06/13/astrazeneca-pfizer-idUSL5N0OT2S120140613,
20140616 1:55PM UTC,Xybion Announces Pristima Selected by Pfizer Inc. for its Drug Safety R&D; Data Management Solution,http://www.reuters.com/article/2014/06/16/nj-xybion-idUSnBw166311a+100+BSW20140616,
20140616 9:30AM UTC,"The Zacks Analyst Blog Highlights: Johnson & Johnson, GlaxoSmithKline, Pfizer  and Gilead Sciences",http://www.reuters.com/article/2014/06/16/il-zacks-analyst-blog-idUSnPn4G8CBR+97+PRN20140616,
20140616 8:00AM UTC,"Pfizer Opens New State-of-the-Art Research and Development Site in Cambridge, Massachusetts",http://www.reuters.com/article/2014/06/16/pfizer-idUSnBw165643a+100+BSW20140616,
20140617 10:48AM UTC,"Novartis, Pfizer seek U.S. approval of meningitis vaccines",http://www.reuters.com/article/2014/06/17/us-pfizer-novartis-meningitis-idUSKBN0ES1QF20140617,
20140617 10:40AM UTC,"Novartis, Pfizer seek U.S. approval of meningitis vaccines",http://www.reuters.com/article/2014/06/17/pfizer-novartis-meningitis-idUSL2N0OY0I420140617,
20140617 9:30AM UTC,"RF Micro Devices, Select Income Reality, TriQuint Semi, Medtronic,Covidien, Johnson & Johnson, iShares U.S. Medical Devices ETF, Pfizer and AstraZeneca highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/06/17/il-zacksinvestment-idUSnPn8HB3Xt+9a+PRN20140617,
20140617 8:00AM UTC,Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine,http://www.reuters.com/article/2014/06/17/pfizer-idUSnBw175782a+100+BSW20140617,
20140618 5:01PM UTC,Two-Year Results From Pfizerâ€™s XELJANZÂ® (Tofacitinib Citrate) ORAL Start Study Published in The New England Journal of Medicine,http://www.reuters.com/article/2014/06/18/pfizer-idUSnBw186305a+100+BSW20140618,
20140618 6:45AM UTC,French biotech Cellectis surges as Pfizer signs cancer drug deal,http://www.reuters.com/article/2014/06/18/us-pfizer-cellectis-idUSKBN0ET0OO20140618,
20140618 6:37AM UTC,UPDATE 2-French biotech Cellectis surges as Pfizer signs cancer drug deal,http://www.reuters.com/article/2014/06/18/pfizer-cellectis-idUSL5N0OZ1FA20140618,
20140618 3:15AM UTC,BRIEF-Cellectis shares rise 50 pct after Pfizer deal,http://www.reuters.com/article/2014/06/18/cellectis-brief-idUSWEB00OIS20140618,
20140618 2:43AM UTC,Pfizer signs cancer immunotherapy deal with France's Cellectis,http://www.reuters.com/article/2014/06/18/pfizer-cellectis-idUSL5N0OZ17C20140618,
20140618 1:00AM UTC,Pfizer and Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration,http://www.reuters.com/article/2014/06/18/cellectis-idUSnBw176809a+100+BSW20140618,
20140618 1:00AM UTC,Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration,http://www.reuters.com/article/2014/06/18/pfizer-idUSnBw176813a+100+BSW20140618,
20140620 6:20AM UTC,"Settlements, Statements, FDA Submissions and Approvals - Analyst Notes on Valeant, Pfizer, Actavis, Allergan and Teva",http://www.reuters.com/article/2014/06/20/bc-analystsreviewcom-idUSnPnsl8vX+41+PRN20140620,
20140624 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of July 29 Conference Call with Analysts,http://www.reuters.com/article/2014/06/24/pfizer-idUSnBw245041a+100+BSW20140624,
20140626 11:20AM UTC,Pfizer Declares 26-Cent Third-Quarter 2014 Dividend,http://www.reuters.com/article/2014/06/26/pfizer-idUSnBw265962a+100+BSW20140626,
20140626 9:45AM UTC,James C. Smith Elected to Pfizerâ€™s Board of Directors,http://www.reuters.com/article/2014/06/26/pfizer-idUSnBw265774a+100+BSW20140626,
20140627 7:26AM UTC,"Pfizer, Bristol clot drug wins EU green light for wider use",http://www.reuters.com/article/2014/06/27/us-europe-medicine-pfizer-bristol-myers-idUSKBN0F212720140627,
20140627 7:01AM UTC,"Pfizer, Bristol clot drug wins EU green light for wider use",http://www.reuters.com/article/2014/06/27/europe-medicine-pfizer-bristol-myers-idUSL6N0P828W20140627,
20140627 5:50AM UTC,"Conference Call Schedules, Disclosures, Partnerships, and Acquisitions - Analyst Notes on Pfizer, Covidien, UnitedHealth Group, Alexion and Abbott",http://www.reuters.com/article/2014/06/27/bc-analystsreviewcom-idUSnPn5ZqB5N+95+PRN20140627,
20140701 6:30AM UTC,"Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus",http://www.reuters.com/article/2014/07/01/bc-a-idUSnPn8Ng46p+90+PRN20140701,
20140707 10:20AM UTC,CliniWorks Forms a Strategic Alliance with Pfizer to Develop a Population Health Management Platform with Advanced Analytics and Patient Care Capabilities,http://www.reuters.com/article/2014/07/07/ma-cliniworks-idUSnBw075589a+100+BSW20140707,
20140707 7:30AM UTC,"Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics",http://www.reuters.com/article/2014/07/07/bc-i-idUSnPnJ04X7+52+PRN20140707,
20140707 6:40AM UTC,"Kosher Certifications, Biologic License Applications, Positive Study Results, Development Programs, and Product Acquisitions - Analyst Notes on Pfizer, Novartis, Sanofi, Zogenix and Impax",http://www.reuters.com/article/2014/07/07/bc-analysts-review-idUSnPn2vBGf6+8c+PRN20140707,
20140707 5:20AM UTC,"Research and Markets: Global Hypercholesterolemia Market 2014-2018 With AbbVie, Astrazeneca, Merck & Co. & Pfizer Dominating",http://www.reuters.com/article/2014/07/07/research-and-markets-idUSnBw075358a+100+BSW20140707,
20140708 8:30PM UTC,Pfizer wins dismissal of U.S. investor class action ahead of trial,http://www.reuters.com/article/2014/07/09/us-pfizer-classaction-idUSKBN0FE01I20140709,
20140708 8:27PM UTC,Pfizer wins dismissal of U.S. investor class action ahead of trial,http://www.reuters.com/article/2014/07/09/pfizer-classaction-idUSL2N0PJ2L220140709,
20140708 3:52PM UTC,"Research and Markets: Global Contraceptives Market 2014-2018 with Actavis, Bayer AG, J&J;'s, Janssen Pharma, Merck & Co., Pfizer, & Teva Pharmaceutical Leading the Way",http://www.reuters.com/article/2014/07/08/research-and-markets-idUSnBw086623a+100+BSW20140708,
20140708 9:00AM UTC,Epilepsy Foundation Collaborating on Personalized Drug Discovery Platform for Epilepsy With Intellimedix and Pfizer Inc.,http://www.reuters.com/article/2014/07/08/idUSnMKWxWfVqa+1d4+MKW20140708,
20140715 9:44AM UTC,"Research and Markets: Global Postmenopausal Vaginal Atrophy Drugs Market 2014-2018 with Actavis, Novo Nordisk, Pfizer & Shionogi & Co. Dominating",http://www.reuters.com/article/2014/07/15/research-and-markets-idUSnBw156011a+100+BSW20140715,
20140716 9:26AM UTC,"Pfizer to Acquire InnoPharma, Inc.",http://www.reuters.com/article/2014/07/16/pfizer-idUSnBw165762a+100+BSW20140716,
20140716 8:11AM UTC,Pfizer says clotting drug's once-weekly dose reduces bleeding rate,http://www.reuters.com/article/2014/07/16/pfizer-study-idUSL4N0PR3MQ20140716,
20140716 7:00AM UTC,Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIXÂ®) Once-Weekly Prophylaxis For Hemophilia B,http://www.reuters.com/article/2014/07/16/pfizer-idUSnBw165229a+100+BSW20140716,
20140718 9:30AM UTC,"Pep Boys, Buenaventura, Pfizer, Mylan and AstraZeneca highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/07/18/il-zacks-investment-idUSnPn27cfYD+83+PRN20140718,
20140722 4:05PM UTC,Puma Biotechnology Announces Amendment to Neratinib Licensing Agreement with Pfizer,http://www.reuters.com/article/2014/07/22/ca-puma-biotech-idUSnBw225057a+100+BSW20140722,
20140723 8:30AM UTC,"Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx",http://www.reuters.com/article/2014/07/23/bc-ar-idUSnPn2GBRfC+9d+PRN20140723,
20140725 10:27AM UTC,AstraZeneca results to get lift from bid foe Pfizer,http://www.reuters.com/article/2014/07/25/us-astrazeneca-results-idUSKBN0FU1IS20140725,
20140725 9:30AM UTC,"The Zacks Analyst Blog Highlights:Starbucks, Dunkin' Brands, Bristol-Myers Squibb, AstraZeneca and Pfizer",http://www.reuters.com/article/2014/07/25/zacks-blog-idUSnPn4qvW2S+85+PRN20140725,
20140725 9:30AM UTC,"Zacks Industry Outlook Highlights: Pfizer, AstraZeneca, AbbVie, Shire and Mylan",http://www.reuters.com/article/2014/07/25/il-zacks-industry-idUSnPn4NCSLn+9e+PRN20140725,
20140728 9:30AM UTC,"Tesla, Whole Foods, Pfizer and ExxonMobil are part of Zacks Earnings Preview",http://www.reuters.com/article/2014/07/28/zacks-equity-research-idUSnPn4TMZfV+9d+PRN20140728,
20140728 1:36AM UTC,Pfizer's need for deal looms larger with earnings report,http://www.reuters.com/article/2014/07/28/us-pfizer-strategy-idUSKBN0FX0AR20140728,
20140729 4:35PM UTC,Pfizer leaves investors guessing on intentions for Astra,http://www.reuters.com/article/2014/07/29/us-pfizer-results-idUSKBN0FY11Z20140729,
20140729 4:24PM UTC,UPDATE 3-Pfizer leaves investors guessing on intentions for Astra,http://www.reuters.com/article/2014/07/29/pfizer-results-idUSL2N0Q40JW20140729,
20140729 2:30PM UTC,"TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit",http://www.reuters.com/article/2014/07/29/md-scrs-new-program-idUSnPn9zNCvw+8c+PRN20140729,
20140729 12:51PM UTC,Pfizer leaves investors guessing on intentions for Astra,http://www.reuters.com/article/2014/07/29/uk-pfizer-results-idUSKBN0FY1TG20140729,
20140729 11:15AM UTC,"BRIEF-Pfizer says looking at other deals, declines comment on interest in AstraZeneca",http://www.reuters.com/article/2014/07/29/pfizer-brief-idUSWEN00DQM20140729,
20140729 7:28AM UTC,Pfizer beats forecasts as oncology drugs grow,http://www.reuters.com/article/2014/07/29/pfizer-results-idUSL2N0Q30PF20140729,
20140729 11:39AM UTC,Generics eat into Pfizer's sales,http://www.reuters.com/news/video/videoStory?storyID=90992146,
20140730 9:39AM UTC,Pfizer to buy Baxter's vaccines unit for $635 million,http://www.reuters.com/article/2014/07/30/us-baxter-intl-pfizer-vaccine-idUSKBN0FZ19R20140730,
20140730 9:38AM UTC,UPDATE 1-Pfizer to buy Baxter's vaccines unit for $635 mln,http://www.reuters.com/article/2014/07/30/baxter-intl-pfizer-vaccine-idUSL4N0Q54WA20140730,
20140730 9:09AM UTC,CORRECTED-Pfizer to buy two Baxter vaccines for $635 mln,http://www.reuters.com/article/2014/07/30/baxter-intl-pfizer-vaccine-idUSL4N0Q54S520140730,
20140730 8:02AM UTC,Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer,http://www.reuters.com/article/2014/07/30/il-baxter-international-idUSnBw305367a+100+BSW20140730,
20140730 8:00AM UTC,Pfizer Enters Into Agreement to Acquire Baxterâ€™s Portfolio of Marketed Vaccines,http://www.reuters.com/article/2014/07/30/pfizer-idUSnBw305390a+100+BSW20140730,
20140731 12:13PM UTC,Pfizerâ€™s Stake in Cellectisâ€™ Capital is Welcomed by Its Shareholders,http://www.reuters.com/article/2014/07/31/cellectis-idUSnBw316114a+100+BSW20140731,
20140731 9:10AM UTC,"Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer",http://www.reuters.com/article/2014/07/31/bc-a-idUSnPn4vKVW5+8e+PRN20140731,
20140731 6:51AM UTC,AstraZeneca raises forecasts after seeing off Pfizer,http://www.reuters.com/article/2014/07/31/us-astrazeneca-results-idUSKBN0G00KP20140731,
20140731 6:45AM UTC,UPDATE 3-AstraZeneca raises forecasts after seeing off Pfizer,http://www.reuters.com/article/2014/07/31/astrazeneca-results-idUSL6N0Q625D20140731,
20140731 5:31AM UTC,"BRIEF-Astra CEO says Nov. 18 investor day to focus on progress, no comment on Pfizer",http://www.reuters.com/article/2014/07/31/astrazeneca-results-ceo-idUSWLB008LV20140731,
20140731 2:18AM UTC,AstraZeneca smashes forecasts in Q2 after seeing off Pfizer,http://www.reuters.com/article/2014/07/31/idUSASM00071C20140731,
20140801 11:31AM UTC,ICON: Pfizer and Roche Join ADDPLAN DF Consortium,http://www.reuters.com/article/2014/08/01/icon-idUSnBw015592a+100+BSW20140801,
20140801 10:37AM UTC,Pfizer says threats to managers force staff lockout at Mumbai factory,http://www.reuters.com/article/2014/08/01/us-pfizer-india-lockout-idUSKBN0G14EX20140801,
20140801 10:33AM UTC,CORRECTED-Pfizer says threats to managers force staff lockout at Mumbai factory,http://www.reuters.com/article/2014/08/01/pfizer-india-lockout-idUSL4N0Q74P520140801,
20140801 10:04AM UTC,"Pfizer bid for GSK has some merits"""," says Berenberg""",http://www.reuters.com/article/2014/08/01/us-gsk-pfizer-idUSKBN0G14CE20140801
20140806 1:38PM UTC,Pfizer to pay $35 million to U.S. states to settle Rapamune claims,http://www.reuters.com/article/2014/08/06/us-pfizer-rapamune-idUSKBN0G620E20140806,
20140806 1:30PM UTC,Pfizer to pay $35 mln to U.S. states to settle Rapamune claims,http://www.reuters.com/article/2014/08/06/pfizer-rapamune-idUSL2N0QC1IG20140806,
20140806 12:10PM UTC,BRIEF-Pfizer reaches $35 mln settlement over marketing of Rapamune,http://www.reuters.com/article/2014/08/06/pfizer-brief-idUSWEN00DUN20140806,
20140808 9:10AM UTC,"Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health",http://www.reuters.com/article/2014/08/08/bc-analysts-review-idUSnPn5mGvGH+8b+PRN20140808,
20140808 7:00AM UTC,INSIGHT-Pfizer confronts surge of lawsuits over Lipitor,http://www.reuters.com/article/2014/08/08/pfizer-lipitor-lawsuits-idUSL2N0QD30520140808,
20140808 1:22AM UTC,Pfizer confronts surge of lawsuits over Lipitor,http://www.reuters.com/article/2014/08/08/us-pfizer-lipitor-lawsuits-insight-idUSKBN0G80E520140808,
20140808 1:00AM UTC,INSIGHT-Pfizer confronts surge of lawsuits over Lipitor,http://www.reuters.com/article/2014/08/08/pfizer-lipitor-lawsuits-idUSL2N0PT25D20140808,
20140812 5:01PM UTC,Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy LyricaÂ® Studies Conducted in China,http://www.reuters.com/article/2014/08/12/pfizer-idUSnBw125109a+100+BSW20140812,
20140812 2:13PM UTC,Pfizer to help 23andMe unravel genetic ties to bowel disease,http://www.reuters.com/article/2014/08/12/health-23andme-pfizer-idUSL2N0QI1G420140812,
20140812 1:59PM UTC,Pfizer to help 23andMe unravel genetic ties to bowel disease,http://www.reuters.com/article/2014/08/12/us-health-23andme-pfizer-idUSKBN0GC1P120140812,
20140812 9:00AM UTC,"Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics",http://www.reuters.com/article/2014/08/12/bc-investor-edgecom-idUSnPn7gZCVr+8e+PRN20140812,
20140812 9:00AM UTC,23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease,http://www.reuters.com/article/2014/08/12/ca-23andme-pfizer-idUSnPn3z4jF1+82+PRN20140812,
20140813 5:01PM UTC,Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy LyricaÂ® Studies Conducted in China,http://www.reuters.com/article/2014/08/12/pfizer-idUSnBw125109a+100+BSW20140812,
20140813 2:13PM UTC,Pfizer to help 23andMe unravel genetic ties to bowel disease,http://www.reuters.com/article/2014/08/12/health-23andme-pfizer-idUSL2N0QI1G420140812,
20140813 1:59PM UTC,Pfizer to help 23andMe unravel genetic ties to bowel disease,http://www.reuters.com/article/2014/08/12/us-health-23andme-pfizer-idUSKBN0GC1P120140812,
20140813 9:00AM UTC,"Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics",http://www.reuters.com/article/2014/08/12/bc-investor-edgecom-idUSnPn7gZCVr+8e+PRN20140812,
20140813 9:00AM UTC,23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease,http://www.reuters.com/article/2014/08/12/ca-23andme-pfizer-idUSnPn3z4jF1+82+PRN20140812,
20140814 5:43PM UTC,Advisory Committee on Immunization Practices Votes to Recommend Pfizerâ€™s Prevnar 13Â® Vaccine in Adults Aged 65 Years and Older,http://www.reuters.com/article/2014/08/13/pfizer-idUSnBw136259a+100+BSW20140813,
20140815 5:01PM UTC,Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine,http://www.reuters.com/article/2014/08/14/pfizer-idUSnBw146232a+100+BSW20140814,
20140819 8:00AM UTC,Pfizer Announces Submission of Palbociclib New Drug Application to the FDA,http://www.reuters.com/article/2014/08/18/pfizer-idUSnBw185046a+100+BSW20140818,
20140820 9:20AM UTC,"Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana",http://www.reuters.com/article/2014/08/19/bc-ar-idUSnPn6HW9f2+98+PRN20140819,
20140821 8:00AM UTC,Bristol-Myers Squibb and Pfizer to Present New Data on EliquisÂ® (apixaban) at the ESC Congress 2014,http://www.reuters.com/article/2014/08/20/pfizer-idUSnBw205354a+100+BSW20140820,
20140823 10:34AM UTC,"Research and Markets: Global Hodgkins Lymphoma Therapeutics Market 2014-2018: Bristol Myers Squibb, F. Hoffmann-La Roche, Merck & Co & Pfizer Dominate the Industry",http://www.reuters.com/article/2014/08/22/research-and-markets-idUSnBw225420a+100+BSW20140822,
20140827 12:36PM UTC,Pfizer to test Xalkori lung cancer drug with Merck immunotherapy,http://www.reuters.com/article/2014/08/26/us-pfizer-merck-cancer-idUSKBN0GQ16N20140826,
20140827 12:27PM UTC,RPT-UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy,http://www.reuters.com/article/2014/08/26/pfizer-merck-cancer-idUSL1N0QW1DT20140826,
20140827 10:52AM UTC,UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy,http://www.reuters.com/article/2014/08/26/pfizer-merck-cancer-idUSL1N0QW0QB20140826,
20140827 9:30AM UTC,"The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Johnson & Johnson, Allergan and EA Sports",http://www.reuters.com/article/2014/08/26/il-zacks-investment-idUSnPn5xbgJr+82+PRN20140826,
20140827 9:07AM UTC,Pfizer to test Xalkori lung cancer drug with Merck immunotherapy,http://www.reuters.com/article/2014/08/26/pfizer-merck-cancer-idUSL1N0QW0ND20140826,
20140827 8:00AM UTC,Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen,http://www.reuters.com/article/2014/08/26/pfizer-idUSnBw265402a+100+BSW20140826,
20140828 9:10AM UTC,"Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard",http://www.reuters.com/article/2014/08/27/bc-analystsreviewcom-idUSnPn45sbND+83+PRN20140827,
20140829 1:15PM UTC,"Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSOâ„¢ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease",http://www.reuters.com/article/2014/08/28/pfizer-idUSnBw285911a+100+BSW20140828,
20140829 8:00AM UTC,Pfizerâ€™s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation,http://www.reuters.com/article/2014/08/28/pfizer-idUSnBw285051a+100+BSW20140828,
20140903 8:59AM UTC,"Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors",http://www.reuters.com/article/2014/09/02/us-astrazeneca-pfizer-exclusive-idUSKBN0GX1C720140902,
20140904 10:00AM UTC,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,http://www.reuters.com/article/2014/09/03/pfizer-idUSnBw035058a+100+BSW20140903,
20140905 9:20AM UTC,"Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher",http://www.reuters.com/article/2014/09/04/bc-analysts-review-idUSnPn44MqzD+89+PRN20140904,
20140905 2:28AM UTC,BRIEF-Vectura says partner Novartis signs marketing deal with Pfizer UK,http://www.reuters.com/article/2014/09/04/vectura-grp-brief-idUSFWN0QZ02M20140904,
20140910 5:22AM UTC,"Research and Markets: Global Infectious Disease Treatment Market 2014-2018: Key Vendors Are F. Hoffmann-La Roche, Gilead Sciences, GSK, J&J; Merck & Pfizer",http://www.reuters.com/article/2014/09/09/research-and-markets-idUSnBw095467a+100+BSW20140909,
20140913 6:16PM UTC,"Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor",http://www.reuters.com/article/2014/09/12/us-lipitor-lawsuit-idUSKBN0H72FS20140912,
20140913 6:13PM UTC,"UPDATE 1-Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor",http://www.reuters.com/article/2014/09/12/lipitor-lawsuit-idUSL1N0RD2JF20140912,
20140913 5:05PM UTC,"UPDATE 1-Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor",http://www.reuters.com/article/2014/09/12/lipitor-lawsuit-idUSL1N0RD26A20140912,
20140913 3:37PM UTC,"BRIEF-Pfizer, Ranbaxy win dismissal of lawsuit by direct purchaser"" plaintiffs over generic Lipitor""",http://www.reuters.com/article/2014/09/12/lipitor-brief-idUSWEN00DYU20140912,
20140913 9:10AM UTC,"Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale",http://www.reuters.com/article/2014/09/12/bc-analysts-review-idUSnPn4d4VsH+85+PRN20140912,
20140917 9:01AM UTC,MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for Parkinson's Disease,http://www.reuters.com/article/2014/09/16/idUSnMKWsswdNa+1c2+MKW20140916,
20140920 8:00AM UTC,Pfizer Foundation Provides $2 Million In Grants To Support â€˜Last-Mileâ€™ Vaccine Coverage In Africa,http://www.reuters.com/article/2014/09/19/pfizer-idUSnBw195069a+100+BSW20140919,
20140923 10:10AM UTC,"Research and Markets: Global Erectile Dysfunction Drugs Market 2014-2018: Leading Vendors are Apricus Biosciences, Bayer, Dong-A Socio Holdings, Eli Lily, Pfizer & Vivus",http://www.reuters.com/article/2014/09/22/research-and-markets-idUSnBw225870a+100+BSW20140922,
20140923 9:05AM UTC,"Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo",http://www.reuters.com/article/2014/09/22/bc-analysts-review-idUSnPn7QRSyc+9c+PRN20140922,
20140923 8:00AM UTC,Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers,http://www.reuters.com/article/2014/09/22/nj-bristol-myers-pfizer-idUSnBw225247a+100+BSW20140922,
20140924 2:46PM UTC,Pfizer approaches Actavis to gauge interest in deal: Bloomberg,http://www.reuters.com/article/2014/09/23/us-actavis-m-a-idUSKCN0HI28120140923,
20140924 2:42PM UTC,Pfizer approaches Actavis to gauge interest in deal-Bloomberg,http://www.reuters.com/article/2014/09/23/actavis-ma-idUSL3N0RO4M420140923,
20140924 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts,http://www.reuters.com/article/2014/09/23/pfizer-idUSnBw235109a+100+BSW20140923,
20140924 5:35AM UTC,"Research and Markets: Global Non-small Cell Lung Cancer Market 2014-2018: AstraZeneca, Celgene, Eli Lilly, F. Hoffmann-La Roche & Pfizer Dominates the Market",http://www.reuters.com/article/2014/09/23/research-and-markets-idUSnBw235425a+100+BSW20140923,
20140924 4:34AM UTC,"Research and Markets: Global Pneumococcal Vaccines Market 2014-2018: GlaxoSmithKline, Merck & Pfizer Dominate the Industry",http://www.reuters.com/article/2014/09/23/research-and-markets-idUSnBw235390a+100+BSW20140923,
20140925 2:06PM UTC,World Heart Federation Announces a Donation from Bristol-Myers Squibb and Pfizer for a Program to Help Improve Experiences for People with Atrial Fibrillation (AF),http://www.reuters.com/article/2014/09/24/bc-world-heart-federatio-idUSnPnbSNV9z+9c+PRN20140924,
20140925 8:30AM UTC,"Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics",http://www.reuters.com/article/2014/09/24/bc-investor-edge-idUSnPn3QyGT0+96+PRN20140924,
20140926 8:00AM UTC,Pfizer Completes Acquisition Of InnoPharma,http://www.reuters.com/article/2014/09/25/pfizer-idUSnBw255030a+100+BSW20140925,
20140926 7:03AM UTC,"Research and Markets: Acute Coronary Syndrome - Current and Future Players: Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GSK, Janssen Pharma, Merck, Pfizer & Sanofi",http://www.reuters.com/article/2014/09/25/research-and-markets-idUSnBw255354a+100+BSW20140925,
20140928 6:51AM UTC,Pfizer drug effective in patients with rare lung cancer: study,http://www.reuters.com/article/2014/09/27/us-health-cancer-pfizer-idUSKCN0HM0AB20140927,
20140928 6:45AM UTC,Pfizer drug effective in patients with rare lung cancer -study,http://www.reuters.com/article/2014/09/27/health-cancer-pfizer-idUSL2N0RQ21U20140927,
20140930 8:00PM UTC,Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study<4151.T>,http://www.reuters.com/article/2014/09/30/pfizer-idUSnBw296117a+100+BSW20140930,
20140930 2:06PM UTC,"Research and Markets: Global Therapeutic Vaccines Market Outlook 2019 Featuring GSK, Merck, Novartis, Pfizer, Sanofi Avnetis & Serum Institute",http://www.reuters.com/article/2014/09/29/research-and-markets-idUSnBw296373a+100+BSW20140929,
20140930 9:00AM UTC,Plandai Biotechnology Expects Pfizer Viagra Patent Ruling Will Aid in Developing All-Natural Substitute to Treat Erectile Dysfunction,http://www.reuters.com/article/2014/09/29/idUSnMKWsPZZba+1dc+MKW20140929,
20140930 7:06AM UTC,"Research and Markets: Global Antibiotics Market 2014-2018: AstraZeneca, Eli Lilly, GSK, Johnson & Johnson, Novartis, Pfizer & Sanofi Lead the Market",http://www.reuters.com/article/2014/09/29/research-and-markets-idUSnBw295486a+100+BSW20140929,
20141001 8:50AM UTC,"Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher",http://www.reuters.com/article/2014/09/30/bc-analysts-review-idUSnPnb5mnDF+83+PRN20140930,
20141001 7:00AM UTC,"Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth",http://www.reuters.com/article/2014/09/30/accelovance-new-vp-idUSnPn3P1nz6+90+PRN20140930,
20141009 8:30AM UTC,Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer,http://www.reuters.com/article/2014/10/08/pfizer-idUSnBw085573a+100+BSW20141008,
20141009 8:00AM UTC,"Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine",http://www.reuters.com/article/2014/10/08/pfizer-idUSnBw085157a+100+BSW20141008,
20141010 7:45AM UTC,"Research and Markets: Global Chronic Obstructive Pulmonary Disease (COPD) Market Outlook 2018 Featuring Astra Zeneca, Boehringer Ingelheim, GSK, Novartis & Pfizer",http://www.reuters.com/article/2014/10/09/research-and-markets-idUSnBw095458a+100+BSW20141009,
20141010 6:43AM UTC,"Research and Markets: Global Pancreatic Cancer Market 2014-2018: Key Vendors are Celgene, Eli Lilly, F. Hoffmann-La Roche, Novartis and Pfizer",http://www.reuters.com/article/2014/10/09/research-and-markets-idUSnBw095389a+100+BSW20141009,
20141011 8:55AM UTC,"Marketing Application Update, Acquisitions, Collaborations, FDA Approvals, and Structural Changes - Research Reports on Gilead, BD, Pfizer, AbbVie and Novartis",http://www.reuters.com/article/2014/10/10/bc-analysts-review-idUSnPn2Cg7Md+92+PRN20141010,
20141011 8:00AM UTC,"Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014â„¢",http://www.reuters.com/article/2014/10/10/pfizer-idUSnBw105027a+100+BSW20141010,
20141014 8:00AM UTC,Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review,http://www.reuters.com/article/2014/10/13/pfizer-idUSnBw135092a+100+BSW20141013,
20141017 4:53PM UTC,FDA panel votes to keep severe warning on Pfizer anti-smoking drug,http://www.reuters.com/article/2014/10/16/us-pfizer-fda-chantix-idUSKCN0I52MG20141016,
20141017 4:45PM UTC,UPDATE 1-FDA panel votes to keep severe warning on Pfizer anti-smoking drug,http://www.reuters.com/article/2014/10/16/pfizer-fda-chantix-idUSL3N0SB6DH20141016,
20141017 4:03PM UTC,FDA votes to keep black box warning on Pfizer anti-smoking drug,http://www.reuters.com/article/2014/10/16/pfizer-fda-chantix-idUSL3N0SB6AU20141016,
20141021 9:15AM UTC,"Research and Markets: United States Wound Closure Devices Market Outlook 2020: Key Players are Johnson & Johnson, Baxter International & Pfizer",http://www.reuters.com/article/2014/10/20/research-and-markets-idUSnBw205860a+100+BSW20141020,
20141021 8:51AM UTC,"Research and Markets: United Kingdom Wound Closure Devices Market Outlook 2020: Key Vendors are Johnson & Johnson, Baxter International and Pfizer Inc",http://www.reuters.com/article/2014/10/20/research-and-markets-idUSnBw205772a+100+BSW20141020,
20141021 8:35AM UTC,"Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna",http://www.reuters.com/article/2014/10/20/bc-analysts-review-idUSnPn6sD2Hr+8a+PRN20141020,
20141024 4:38PM UTC,Pfizer board authorizes $11 billion share repurchase,http://www.reuters.com/article/2014/10/23/pfizer-buyback-idUSL2N0SI2XE20141023,
20141024 4:05PM UTC,Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend,http://www.reuters.com/article/2014/10/23/pfizer-idUSnBw236458a+100+BSW20141023,
20141024 11:00AM UTC,"Grantmakers In Aging Receives $1.49 Million Grant From the Pfizer Foundation to Support Age-Friendly"" Communities""",http://www.reuters.com/article/2014/10/23/idUSnMKW6plz8a+1c0+MKW20141023,
20141024 9:00AM UTC,U.S. court upholds patents on Pfizer's cancer drug,http://www.reuters.com/article/2014/10/23/us-pfizer-mylan-cancer-idUSKCN0IC1I520141023,
20141024 8:57AM UTC,U.S. court upholds patents on Pfizer's cancer drug,http://www.reuters.com/article/2014/10/23/pfizer-mylan-cancer-idUSL3N0SI54R20141023,
20141024 8:00AM UTC,Pfizer Wins SUTENTÂ® Patent Case In Delaware District Court,http://www.reuters.com/article/2014/10/23/pfizer-idUSnBw235260a+100+BSW20141023,
20141025 4:11AM UTC,Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes,http://www.reuters.com/article/2014/10/24/us-pfizer-buyback-idUSKCN0ID0NC20141024,
20141028 10:18AM UTC,Pfizer ends deal with Pain Therapeutics to develop Durect's pain drug,http://www.reuters.com/article/2014/10/27/us-durect-pain-therapeutic-drugs-idUSKBN0IG1HE20141027,
20141028 10:11AM UTC,Pfizer ends deal with Pain Therapeutics to develop Durect's pain drug,http://www.reuters.com/article/2014/10/27/durect-pain-therapeutic-drugs-idUSL4N0SM4OX20141027,
20141028 9:30AM UTC,"Ambaraella, Pier One, Pfizer, Teva Pharmaceutical and Ligand Pharmaceuticals highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/10/27/il-zacks-bull-n-bear-idUSnPn1d30M3+82+PRN20141027,
20141028 8:00AM UTC,Pfizer to Discontinue Agreement on REMOXYâ„¢ (oxycodone) Extended-Release Capsules CII,http://www.reuters.com/article/2014/10/27/pfizer-idUSnBw275291a+100+BSW20141027,
20141029 4:37PM UTC,Pfizer executives: new Treasury rules hamstring inversion deals,http://www.reuters.com/article/2014/10/28/us-pfizer-results-inversion-idUSKBN0IH26S20141028,
20141029 11:12AM UTC,BRIEF-Pfizer CEO says inversion deals still one potential option for company,http://www.reuters.com/article/2014/10/28/pfizer-brief-idUSWEN00E8420141028,
20141029 9:26AM UTC,"Pfizer beats sales and profit forecasts, mum on future deals",http://www.reuters.com/article/2014/10/28/us-pfizer-results-idUSKBN0IH10B20141028,
20141029 9:25AM UTC,"UPDATE 2-Pfizer beats sales and profit forecasts, mum on future deals",http://www.reuters.com/article/2014/10/28/pfizer-results-idUSL1N0SN0JI20141028,
20141029 7:17AM UTC,"Pfizer beats Q3 forecasts, mum on likely future deals",http://www.reuters.com/article/2014/10/28/pfizer-results-idUSL1N0SM2IJ20141028,
20141030 4:19PM UTC,Pfizer meningitis vaccine wins U.S. approval,http://www.reuters.com/article/2014/10/29/us-pfizer-meningitis-idUSKBN0II23E20141029,
20141030 4:16PM UTC,UPDATE 2-Pfizer meningitis vaccine wins U.S. approval,http://www.reuters.com/article/2014/10/29/pfizer-meningitis-idUSL1N0SO24V20141029,
20141030 2:44PM UTC,Pfizer Receives FDA Accelerated Approval for TRUMENBAÂ® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults,http://www.reuters.com/article/2014/10/29/pfizer-idUSnBw296319a+100+BSW20141029,
20141030 2:25PM UTC,Pfizer meningitis vaccine wins U.S. approval- FDA,http://www.reuters.com/article/2014/10/29/pfizer-meningitis-idUSL1N0SO23F20141029,
20141030 2:07PM UTC,U.S. Physicians and Payers are Generally Positive About the Efficacy of Pfizer's Xeljanz for Treating RA But They Have Mixed Views About Its Effect on Structural Damage and Safety,http://www.reuters.com/article/2014/10/29/decisionresources-ra-idUSnPnbQTyS9+9a+PRN20141029,
20141030 8:35AM UTC,"Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly",http://www.reuters.com/article/2014/10/29/bc-analysts-review-idUSnPn7HLhYW+9b+PRN20141029,
20141030 8:30AM UTC,Pfizerâ€™s PRISTIQÂ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder,http://www.reuters.com/article/2014/10/29/pfizer-idUSnBw295170a+100+BSW20141029,
20141101 4:55AM UTC,"Research and Markets: Global Pediatric Vaccine Market 2014-2018: Key Vendors are GlaxoSmithKline, Merck, Pfizer and Sanofi",http://www.reuters.com/article/2014/10/31/research-and-markets-idUSnBw315146a+100+BSW20141031,
20141104 9:30AM UTC,"The Zacks Analyst Blog Highlights: Goldman Sachs Group, Visa, DuPont, Merck and Pfizer",http://www.reuters.com/article/2014/11/03/zacks-goldmansachs-idUSnPn5GSwrk+98+PRN20141103,
20141105 8:55AM UTC,"Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix",http://www.reuters.com/article/2014/11/04/bc-investor-edge-idUSnPn3hsvbP+81+PRN20141104,
20141106 11:00AM UTC,Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference,http://www.reuters.com/article/2014/11/05/pfizer-idUSnBw056094a+100+BSW20141105,
20141107 9:30AM UTC,"Quarterly Financial Results, Acquisition Agreement, and Accelerated Drug Approval - Research Reports on Gilead, Covance, Laboratory Corp., Pfizer and AbbVie",http://www.reuters.com/article/2014/11/06/bc-analysts-review-idUSnPn32dhjB+81+PRN20141106,
20141107 6:06AM UTC,Pfizer's India unit reports Q2 loss on plant lockout costs,http://www.reuters.com/article/2014/11/06/pfizer-india-results-idUSL4N0SW52P20141106,
20141107 5:47AM UTC,"Tax changes weaken case for new Pfizer bid, says AstraZeneca CEO",http://www.reuters.com/article/2014/11/06/us-astrazeneca-results-pfizer-idUSKBN0IQ12920141106,
20141107 5:37AM UTC,"Tax changes weaken case for new Pfizer bid, says AstraZeneca CEO",http://www.reuters.com/article/2014/11/06/astrazeneca-results-pfizer-idUSWLA008DY20141106,
20141111 8:00AM UTC,NTT Com Joins Pfizer and Lockheed Martin to Discuss Cloud Computing at Bloombergâ€™s The Year Ahead: 2015<9432.T>,http://www.reuters.com/article/2014/11/10/ny-ntt-communications-idUSnBw105112a+100+BSW20141110,
20141112 10:07AM UTC,"Research and Markets: Global Hospital Pharmaceuticals Market Outlook 2020: AstraZeneca, Bayer, Eli Lilly and Co, GSK, J&J;, Merck Pfizer & Sanofi-Aventis Dominate the $10 Billion Market",http://www.reuters.com/article/2014/11/11/research-and-markets-idUSnBw115990a+100+BSW20141111,
20141113 8:00AM UTC,Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting,http://www.reuters.com/article/2014/11/12/pfizer-idUSnBw125277a+100+BSW20141112,
20141114 11:00AM UTC,"Novel Agreement Expands Access to Pfizerâ€™s Contraceptive, SayanaÂ® Press, for Women Most in Need in the Worldâ€™s Poorest Countries",http://www.reuters.com/article/2014/11/13/pfizer-idUSnBw135617a+100+BSW20141113,
20141114 10:57AM UTC,"Pfizer, Gates Foundation, expand contraceptive access in poor nations",http://www.reuters.com/article/2014/11/13/us-pfizer-gates-contraception-idUSKCN0IX1WF20141113,
20141114 10:55AM UTC,"Pfizer, Gates Foundation, expand contraceptive access in poor nations",http://www.reuters.com/article/2014/11/13/pfizer-gates-contraception-idUSL2N0T31BC20141113,
20141115 7:46AM UTC,AstraZeneca not only game in town for deal-hungry Pfizer,http://www.reuters.com/article/2014/11/14/us-astrazeneca-m-a-pfizer-idUSKCN0IY1BP20141114,
20141115 7:17AM UTC,DEALTALK-AstraZeneca not only game in town for deal-hungry Pfizer,http://www.reuters.com/article/2014/11/14/astrazeneca-ma-pfizer-idUSL6N0T348W20141114,
20141118 8:52AM UTC,Pfizer says deal makes it 'competitive' in immuno-oncology,http://www.reuters.com/article/2014/11/17/us-merck-pfizer-research-idUSKCN0J11EI20141117,
20141118 8:52AM UTC,Pfizer dampens Astra bid hopes with German Merck cancer deal,http://www.reuters.com/article/2014/11/17/us-merck-pfizer-idUSKCN0J10LR20141117,
20141118 8:00AM UTC,"Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban)",http://www.reuters.com/article/2014/11/17/idUSnGNXbctxvR+1c1+GNW20141117,
20141118 7:55AM UTC,"Research and Markets: Global Epilepsy Market 2014-2018: Reformulation of Marketed Drugs with GSK, Pfizer & UCB Dominating",http://www.reuters.com/article/2014/11/17/research-and-markets-idUSnBw175533a+100+BSW20141117,
20141118 5:35AM UTC,UPDATE 2-Pfizer dampens Astra bid hopes with German Merck cancer deal,http://www.reuters.com/article/2014/11/17/merck-pfizer-idUSL6N0T715V20141117,
20141118 4:27AM UTC,Merck KGaA says Pfizer deal exclusive ,http://www.reuters.com/article/2014/11/17/us-merck-pfizer-exclusivity-idUSKCN0J10R420141117,
20141118 3:40AM UTC,"Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology",http://www.reuters.com/article/2014/11/17/merck-kgaa-idUSnBw175354a+100+BSW20141117,
20141118 3:10AM UTC,"German Merck, Pfizer in cancer immunotherapy deal",http://www.reuters.com/article/2014/11/17/us-merck-pfizer-idUSKCN0J10LP20141117,
20141118 2:53AM UTC,"Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology",http://www.reuters.com/article/2014/11/17/pfizer-idUSnBw165100a+100+BSW20141117,
20141119 12:24PM UTC,"AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer",http://www.reuters.com/article/2014/11/18/us-astrazeneca-medicines-idUSKCN0J20KB20141118,
20141119 9:38AM UTC,"UPDATE 3-AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer",http://www.reuters.com/article/2014/11/18/astrazeneca-medicines-idUSL6N0T80Z020141118,
20141119 9:00AM UTC,Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research,http://www.reuters.com/article/2014/11/18/ca-sanguine-mobileapp-idUSnPn1QdvrK+91+PRN20141118,
20141119 4:59AM UTC,"BRIEF-AstraZeneca CEO says hard to comment"" on whether Pfizer will return""",http://www.reuters.com/article/2014/11/18/astrazeneca-brief-idUSWLA008E920141118,
20141119 11:29AM UTC,AstraZeneca's plans to fend off Pfizer?,http://www.reuters.com/news/video/videoStory?storyID=99556685,
20141121 1:15PM UTC,"TechNavio Names Pfizer, Merck, F. Hoffmann-La Roche as Top Companies in the Global Human Growth Hormone Market",http://www.reuters.com/article/2014/11/20/technavio-research-idUSnBw206127a+100+BSW20141120,
20141202 4:15PM UTC,Onco360 Selected by Pfizer as Limited Distribution Pharmacy Provider; Expands Onco360â€™s Industry-Leading Portfolio to Nearly 40 Products,http://www.reuters.com/article/2014/12/01/ny-onco-idUSnBw016394a+100+BSW20141201,
20141202 7:30AM UTC,Pfizer Completes Acquisition of Baxterâ€™s Marketed Vaccines,http://www.reuters.com/article/2014/12/01/pfizer-idUSnBw015223a+100+BSW20141201,
20141204 5:07PM UTC,Phase 3 Results Published in The New England Journal of Medicine Show Superiority of Pfizerâ€™s XALKORIÂ® (crizotinib) Compared to Platinum-Based Chemotherapy in Previously Untreated Patients With ALK-Positive Advanced Non-S,http://www.reuters.com/article/2014/12/03/pfizer-idUSnBw036481a+100+BSW20141203,
20141204 4:37PM UTC,"Diplomat selected as a limited-distribution pharmacy partner by Pfizer; Diplomat to dispense XalkoriÂ®, BosulifÂ®, SutentÂ® and InlytaÂ®",http://www.reuters.com/article/2014/12/03/mi-diplomat-pfizer-idUSnPn9mH7dZ+89+PRN20141203,
20141204 1:51PM UTC,WADA signs deal with Pfizer to share PED information,http://www.reuters.com/article/2014/12/03/us-doping-wada-pfizer-idUSKCN0JH28X20141203,
20141209 11:53AM UTC,"Pfizer employees join the movement to end hunger; Partnering with Stop Hunger Now, Pfizer is slated to package more than 50,000 meals",http://www.reuters.com/article/2014/12/08/idUSnGNX5Mz63Q+1d1+GNW20141208,
20141209 10:36AM UTC,Pfizer bets on gene therapy as technology comes of age,http://www.reuters.com/article/2014/12/08/us-pfizer-gene-therapy-idUSKBN0JM1MK20141208,
20141209 9:48AM UTC,Pfizer bets on gene therapy as technology comes of age,http://www.reuters.com/article/2014/12/08/pfizer-gene-therapy-idUSL6N0TS2TP20141208,
20141209 8:00AM UTC,Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform,http://www.reuters.com/article/2014/12/08/pfizer-idUSnBw085444a+100+BSW20141208,
20141209 7:30AM UTC,Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.,http://www.reuters.com/article/2014/12/08/spark-therapeutics-idUSnPn3RcJr9+94+PRN20141208,
20141210 4:18PM UTC,"Research and Markets: Global Lung Cancer Therapeutics Market 2015-2019: Key Vendors are AstraZeneca, Celgene, Eli Lilly, F. Hoffmann-La Roche and Pfizer",http://www.reuters.com/article/2014/12/09/research-and-markets-idUSnBw096599a+100+BSW20141209,
20141210 4:15PM UTC,"Research and Markets: Global Human Growth Hormone Market 2015-2019: Key Vendors are F. Hoffmann-La Roche, Merck Serono, Novo Nordisk and Pfizer",http://www.reuters.com/article/2014/12/09/research-and-markets-idUSnBw096595a+100+BSW20141209,
20141210 11:00AM UTC,Robbins Geller Rudman & Dowd LLP Announces Pendency of Pfizer Inc. Securities Class Action,http://www.reuters.com/article/2014/12/09/ny-robbins-geller-rudman-idUSnBw095010a+100+BSW20141209,
20141210 10:30AM UTC,New Data at ASH 2014 Highlight Progress of Pfizerâ€™s Growing Portfolio in Blood Cancers,http://www.reuters.com/article/2014/12/09/pfizer-idUSnBw095981a+100+BSW20141209,
20141211 2:47PM UTC,"Pfizer Awards $299,997 Grant to Community Health Center, Inc.'s Weitzman Institute",http://www.reuters.com/article/2014/12/10/idUSnMKWDbf1wa+1e0+MKW20141210,
20141211 9:00AM UTC,Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause,http://www.reuters.com/article/2014/12/10/pfizer-idUSnBw105703a+100+BSW20141210,
20141212 10:01AM UTC,FDA warns Pfizer's antipsychotic could cause fatal skin reaction,http://www.reuters.com/article/2014/12/11/us-pfizer-fda-antipsychotic-idUSKBN0JP1Q620141211,
20141212 9:57AM UTC,FDA warns Pfizer's antipsychotic could cause fatal skin reaction,http://www.reuters.com/article/2014/12/11/pfizer-fda-antipsychotic-idUSL3N0TV4MH20141211,
20141213 9:30AM UTC,"MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/12/12/zacks-mimedxgroup-idUSnPn7rhDDv+86+PRN20141212,
20141213 9:10AM UTC,"Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines",http://www.reuters.com/article/2014/12/12/bc-investor-edge-idUSnPnb3yN9p+84+PRN20141212,
20141216 6:30PM UTC,Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology,http://www.reuters.com/article/2014/12/15/pfizer-idUSnBw156571a+100+BSW20141215,
20141216 12:06PM UTC,Pfizer Declares First-Quarter 2015 Dividend,http://www.reuters.com/article/2014/12/15/pfizer-idUSnBw156084a+100+BSW20141215,
20141216 8:00AM UTC,OPKO and Pfizer Enter into Global Agreement for OPKOâ€™s Long-Acting Human Growth Hormone (hGH-CTP),http://www.reuters.com/article/2014/12/15/pfizer-idUSnBw155419a+100+BSW20141215,
20141217 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts,http://www.reuters.com/article/2014/12/16/pfizer-idUSnBw165024a+100+BSW20141216,
20141217 8:00AM UTC,Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis,http://www.reuters.com/article/2014/12/16/pfizer-idUSnBw165526a+100+BSW20141216,
20141217 7:45AM UTC,Jacobs Designs Award-Winning Facility for Pfizer,http://www.reuters.com/article/2014/12/16/ca-jacobs-engineering-idUSnBw165228a+100+BSW20141216,
20141218 8:00AM UTC,Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy,http://www.reuters.com/article/2014/12/17/pfizer-idUSnBw175086a+100+BSW20141217,
20141219 8:00AM UTC,Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia,http://www.reuters.com/article/2014/12/18/pfizer-idUSnBw185035a+100+BSW20141218,
20141220 11:30AM UTC,Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVEÂ® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus,http://www.reuters.com/article/2014/12/19/ca-ligand-pharmaceutical-idUSnBw195681a+100+BSW20141219,
20141220 9:10AM UTC,"Factors Moving Markets: Complementary Research on GlaxoSmithKline, Cintas, Deere, Thermo Fisher and Pfizer",http://www.reuters.com/article/2014/12/19/bc-analysts-review-idUSnPnbsMwlR+89+PRN20141219,
20141221 8:10AM UTC,AstraZeneca CEO says new Pfizer bid unlikely: Swedish daily DI,http://www.reuters.com/article/2014/12/20/us-astrazeneca-pfizer-idUSKBN0JY0CD20141220,
20141221 8:06AM UTC,AstraZeneca CEO says new Pfizer bid unlikely-Swedish daily DI,http://www.reuters.com/article/2014/12/20/astrazeneca-pfizer-idUSL6N0U408A20141220,
20141223 9:31PM UTC,THAILAND PRESS-Pfizer expects pharma recovery in 2015- Bangkok Post,http://www.reuters.com/article/2014/12/23/thailand-press-idUSL3N0U717X20141223,
20150106 7:30AM UTC,Pfizer Acquires Redvax GmbH,http://www.reuters.com/article/2015/01/05/pfizer-idUSnBw055460a+100+BSW20150105,
20150107 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,http://www.reuters.com/article/2015/01/06/pfizer-idUSnBw065947a+100+BSW20150106,
20150107 7:30AM UTC,CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments,http://www.reuters.com/article/2015/01/06/cytomx-seriesc-pfizer-idUSnPnbX5qqZ+91+PRN20150106,
20150109 11:22AM UTC,"Pfizer, FDA in talks on prescription details for key breast cancer drug",http://www.reuters.com/article/2015/01/08/us-pfizer-cancer-idUSKBN0KH1MT20150108,
20150109 11:20AM UTC,"Pfizer, FDA in talks on prescription details for key breast cancer drug",http://www.reuters.com/article/2015/01/08/pfizer-cancer-idUSL1N0UN1DW20150108,
20150109 8:30AM UTC,Pfizer Provides Update on IBRANCEÂ® (palbociclib),http://www.reuters.com/article/2015/01/08/pfizer-idUSnBw085536a+100+BSW20150108,
20150109 7:30AM UTC,Repligen Receives Milestone Payment From Pfizer,http://www.reuters.com/article/2015/01/08/idUSnGNX2v1D0Y+1c5+GNW20150108,
20150113 10:47AM UTC,Pfizer partners with DNA research firm to study lupus disease,http://www.reuters.com/article/2015/01/12/us-pfizer-lupus-23andme-idUSKBN0KL1M420150112,
20150113 10:45AM UTC,Pfizer partners with DNA research firm to study lupus disease,http://www.reuters.com/article/2015/01/12/pfizer-lupus-23andme-idUSL3N0UR48X20150112,
20150113 9:00AM UTC,23andMe Announces Collaboration with Pfizer Inc. to Conduct Genetic Research Through 23andMe's Research Platform,http://www.reuters.com/article/2015/01/12/23andme-pfizer-idUSnPn1tQWx1+8c+PRN20150112,
20150113 8:00AM UTC,HemoShear Announces Collaboration with Pfizer Inc. To Help Identify and Predict Drug-Induced Vascular Injury for Early Stage Compounds,http://www.reuters.com/article/2015/01/12/va-hemoshear-pfizer-idUSnPn6tvxsJ+81+PRN20150112,
20150114 3:05PM UTC,"Pfizer developing PCSK9 pill, vaccine to lower cholesterol",http://www.reuters.com/article/2015/01/13/us-healthcare-pfizer-cholesterol-idUSKBN0KM27A20150113,
20150115 9:57AM UTC,"Research and Markets: United States Epilepsy Market 2015-2019 with GlaxoSmithKline, Pfizer & UCB Dominating",http://www.reuters.com/article/2015/01/14/research-and-markets-idUSnBw145650a+100+BSW20150114,
20150116 5:40AM UTC,"Research and Markets: Global Acute Myeloid Leukemia Therapeutics Market 2015-2019 With Bristol Myers Squibb, Celgene, Johnson & Johnson & Pfizer Dominating",http://www.reuters.com/article/2015/01/15/research-and-markets-idUSnBw155287a+100+BSW20150115,
20150116 3:42AM UTC,"Research and Markets: APAC Epilepsy Therapeutics Market 2015-2019 with Eisai, GlaxoSmithKline, Pfizer & UCB Dominating",http://www.reuters.com/article/2015/01/15/research-and-markets-idUSnBw155205a+100+BSW20150115,
20150117 2:01PM UTC,"Research and Markets: Global Psoriasis Therapeutics Market 2015-2019 with Abbvie, Amgen, Janssen Pharmaceuticals & Pfizer Dominating",http://www.reuters.com/article/2015/01/16/research-and-markets-idUSnBw165762a+100+BSW20150116,
20150121 7:47AM UTC,"Research and Markets: Global Anxiety Disorders Market 2015-2019 with Eli Lilly and Company, GlaxoSmithKline & Pfizer Dominating",http://www.reuters.com/article/2015/01/20/research-and-markets-idUSnBw205573a+100+BSW20150120,
20150121 12:03AM UTC,"MSF slams expensive vaccines, urges GSK and Pfizer to cut prices",http://www.reuters.com/article/2015/01/20/us-health-vaccines-prices-idUSKBN0KT0A820150120,
20150121 12:00AM UTC,"MSF slams expensive vaccines, urges GSK and Pfizer to cut prices",http://www.reuters.com/article/2015/01/20/health-vaccines-prices-idUSL6N0UV3O220150120,
20150122 6:45AM UTC,Pfizer and the Avon Foundation for Women Award 23 Grants Totaling $1 Million in Funding to Support Patients Living With Metastatic Breast Cancer,http://www.reuters.com/article/2015/01/21/avon-pfizer-grants-idUSnPn4Y78C0+92+PRN20150121,
20150127 4:12PM UTC,Pfizer Commits to Further Reduce Price for Prevenar 13 in the Worldâ€™s Poorest Countries Through 2025,http://www.reuters.com/article/2015/01/26/pfizer-idUSnBw266477a+100+BSW20150126,
20150127 4:05PM UTC,Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 billion,http://www.reuters.com/article/2015/01/26/us-health-vaccines-price-idUSKBN0KZ2FX20150126,
20150127 4:00PM UTC,Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bln,http://www.reuters.com/article/2015/01/26/health-vaccines-price-idUSL6N0V52VY20150126,
20150128 2:59PM UTC,Pfizer to pay $400 million to avert investor class action trial,http://www.reuters.com/article/2015/01/27/pfizer-classaction-idUSL1N0V622N20150127,
20150128 2:54PM UTC,"Pfizer's 2015 forecast disappoints, crimped by generics, dollar",http://www.reuters.com/article/2015/01/27/us-pfizer-results-idUSKBN0L01CP20150127,
20150128 2:54PM UTC,Pfizer to pay $400 million to avert investor class action trial,http://www.reuters.com/article/2015/01/27/us-pfizer-classaction-idUSKBN0L02JU20150127,
20150128 2:47PM UTC,Pfizer to pay $400 million to avert investor class action trial,http://www.reuters.com/article/2015/01/27/pfizer-classaction-idUSL1N0V61YR20150127,
20150128 11:13AM UTC,BRIEF-Pfizer CEO says company doesn't need to do a big deal,http://www.reuters.com/article/2015/01/27/pfizer-brief-idUSWEN00EMP20150127,
20150128 7:51AM UTC,"UPDATE 1-Pfizer's 2015 forecast disappoints, crimped by generics, dollar",http://www.reuters.com/article/2015/01/27/pfizer-results-idUSL1N0V60PL20150127,
20150128 7:26AM UTC,"Pfizer's 2015 forecast disappoints, crimped by generics, dollar",http://www.reuters.com/article/2015/01/27/pfizer-results-idUSL1N0V60N120150127,
20150130 10:28AM UTC,"Global Ankylosing Spondylitis Market 2015-2019: Key Vendors are Abbvie, Amgen, Janssen Pharmaceuticals, Merck & Co and Pfizer",http://www.reuters.com/article/2015/01/29/idUSnGNX8Ykrpf+1d0+GNW20150129,
20150130 8:15AM UTC,OPKO and Pfizer Receive Regulatory Clearance for Global Agreement,http://www.reuters.com/article/2015/01/29/pfizer-idUSnBw295625a+100+BSW20150129,
20150203 9:10AM UTC,"Pharma Equities Under the Scanner - Pfizer, Sanofi, Eli Lilly, AstraZeneca, and Zogenix",http://www.reuters.com/article/2015/02/02/bc-investor-edge-idUSnPn9WpKm9+94+PRN20150202,
20150204 6:00PM UTC,Pfizer Receives U.S. FDA Accelerated Approval of IBRANCEÂ® (palbociclib),http://www.reuters.com/article/2015/02/03/ny-pfizer-idUSnBw036839a+100+BSW20150203,
20150204 5:42PM UTC,U.S. FDA approves Pfizer's high profile breast cancer drug,http://www.reuters.com/article/2015/02/03/us-pfizer-fda-cancer-idUSKBN0L72GN20150203,
20150204 5:42PM UTC,UPDATE 2-U.S. FDA approves Pfizer's high profile breast cancer drug,http://www.reuters.com/article/2015/02/03/pfizer-fda-cancer-idUSL1N0VD2RF20150203,
20150204 4:09PM UTC,U.S. FDA approves Pfizer's high profile breast cancer drug,http://www.reuters.com/article/2015/02/03/pfizer-fda-cancer-idUSL1N0VD2LP20150203,
20150206 11:38PM UTC,Pfizer to buy Hospira for $15 billion to bolster hospital products,http://www.reuters.com/article/2015/02/06/us-hospira-m-a-pfizer-idUSKBN0L91FF20150206,
20150206 7:39PM UTC,Pfizer's Hospira deal bets on price spike for specialty generics,http://www.reuters.com/article/2015/02/06/us-hospira-m-a-pfizer-idUSKBN0LA00J20150206,
20150206 6:54PM UTC,Pfizer's Hospira deal bets on price spike for specialty generics,http://www.reuters.com/article/2015/02/05/hospira-ma-pfizer-idUSL1N0VF2IY20150205,
20150206 6:28PM UTC,"Wall St climbs with energy rebound, Pfizer deal",http://www.reuters.com/article/2015/02/05/us-markets-stocks-usa-idUSKBN0L91KP20150205,
20150206 4:52PM UTC,"US STOCKS-Wall St climbs with energy rebound, Pfizer deal",http://www.reuters.com/article/2015/02/05/markets-stocks-usa-idUSL1N0VF36O20150205,
20150206 4:27PM UTC,"US STOCKS-Wall St climbs with energy rebound, Pfizer deal",http://www.reuters.com/article/2015/02/05/markets-stocks-usa-idUSL1N0VF2YQ20150205,
20150206 4:25PM UTC,Pfizer to buy Hospira for $15 billion to bolster hospital products,http://www.reuters.com/article/2015/02/05/us-hospira-m-a-pfizer-idUSKBN0L91FF20150205,
20150206 3:20PM UTC,Pfizerâ€™s generics injection lifts mood for breakup,http://www.reuters.com/article/2015/02/05/idUS375047273620150205,
20150206 2:48PM UTC,"US STOCKS-Wall St climbs with energy bounce, Pfizer deal",http://www.reuters.com/article/2015/02/05/markets-stocks-usa-idUSL1N0VF2HK20150205,
20150206 1:41PM UTC,Breakingviews: Pfizer's generics injection lifts mood for breakup,http://www.reuters.com/article/2015/02/05/hospira-ma-breakingviews-idUSL1N0VF2AF20150205,
20150206 1:27PM UTC,SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Hospira Inc. Regarding the Fairness of the Sale of the Company to Pfizer,http://www.reuters.com/article/2015/02/05/ny-law-ofc-vincent-wong-idUSnBw056243a+100+BSW20150205,
20150206 1:12PM UTC,"US STOCKS-Wall St gains with energy bounce, Pfizer deal",http://www.reuters.com/article/2015/02/05/markets-stocks-usa-idUSL1N0VF25H20150205,
20150206 12:16PM UTC,Pfizer to buy Hospira for $15 bln to bolster hospital products,http://www.reuters.com/article/2015/02/05/hospira-ma-idUSL1N0VF0Z520150205,
20150206 11:58AM UTC,UPDATE 3-Pfizer to buy Hospira for $15 bln to bolster hospital products,http://www.reuters.com/article/2015/02/05/hospira-ma-idUSL4N0VF5E020150205,
20150206 11:40AM UTC,"EQUITY ALERT: The Rosen Law Firm Announces Investigation of Hospira, Inc. Concerning its Proposed Sale to Pfizer Inc. â€“ HSP",http://www.reuters.com/article/2015/02/05/ny-rosen-law-firm-idUSnBw056048a+100+BSW20150205,
20150206 11:31AM UTC,"US STOCKS-Wall St buoyed by oil after claims data, Pfizer deal",http://www.reuters.com/article/2015/02/05/markets-stocks-usa-idUSL1N0VF1RB20150205,
20150206 11:26AM UTC,HOSPIRA INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Pfizer Inc.,http://www.reuters.com/article/2015/02/05/tx-powers-taylor-idUSnBw056019a+100+BSW20150205,
20150206 10:39AM UTC,"INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Hospira Inc. In Connection With the Fairness of the Sale of the Company to Pfizer",http://www.reuters.com/article/2015/02/05/ny-levi-korsinsky-idUSnBw055940a+100+BSW20150205,
20150206 10:08AM UTC,"Block & Leviton LLP Investigates Hospira, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Pfizer Inc.",http://www.reuters.com/article/2015/02/05/blockleviton-alert-idUSnPn58Ngbv+88+PRN20150205,
20150206 10:06AM UTC,"US STOCKS-Wall St climbs with oil after claims data, Pfizer deal",http://www.reuters.com/article/2015/02/05/markets-stocks-usa-idUSL1N0VF1IY20150205,
20150206 9:44AM UTC,BRIEF-Pfizer says Hospira deal would not delay possible breakup of Pfizer by 2017,http://www.reuters.com/article/2015/02/05/pfizer-brief-idUSWEN00ERH20150205,
20150206 7:11AM UTC,Pfizer to buy Hospira for about $15 bln,http://www.reuters.com/article/2015/02/05/hospira-ma-pfizer-idUSL4N0VF5CF20150205,
20150206 7:10AM UTC,"Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizerâ€™s Proposed Acquisition of Hospira",http://www.reuters.com/article/2015/02/05/pfizer-idUSnBw055457a+100+BSW20150205,
20150206 7:00AM UTC,Pfizer To Acquire Hospira,http://www.reuters.com/article/2015/02/05/pfizer-idUSnBw055368a+100+BSW20150205,
20150206 5:40AM UTC,BRIEF-AstraZeneca CEO says 55 stg/shr Pfizer offer would likely never have happened,http://www.reuters.com/article/2015/02/05/astrazeneca-results-idUSWLA008FM20150205,
20150206 3:17PM UTC,Pfizer's premium bet on generic drugmaker,http://www.reuters.com/news/video/videoStory?storyID=103718413,
20150206 12:26PM UTC,Breakingviews: Pfizer booster shot,http://www.reuters.com/news/video/videoStory?storyID=103708737,
20150207 7:30PM UTC,"HOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc. - HSP",http://www.reuters.com/article/2015/02/07/faruqi-faruqi-investi-idUSnPnbzv5nD+81+PRN20150207,
20150207 7:30PM UTC,"HOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc. - HSP",http://www.reuters.com/article/2015/02/07/faruqi-hospira-sale-idUSnPn9vCxzG+89+PRN20150207,
20150207 1:59PM UTC,SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Hospira Inc. Regarding the Fairness of the Sale of the Company to Pfizer - HSP,http://www.reuters.com/article/2015/02/06/vincentwong-investiga-idUSnPn4Knptc+90+PRN20150206,
20150207 1:06PM UTC,Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable,http://www.reuters.com/article/2015/02/06/ny-fitch-ratings-pfizer-idUSnBw065689a+100+BSW20150206,
20150207 12:56PM UTC,Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable,http://www.reuters.com/article/2015/02/06/idUSFit91313020150206,
20150207 10:44AM UTC,"Research and Markets: Global Migraine Drugs Market 2015-2019 with Abbott, Allergan, Eisai, Endo, GlaxoSmithKline, Impax Laboratories & Pfizer Dominating",http://www.reuters.com/article/2015/02/06/research-and-markets-idUSnBw065505a+100+BSW20150206,
20150207 8:41AM UTC,"INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Hospira Inc. In Connection With the Fairness of the Sale of the Company to Pfizer -- HSP",http://www.reuters.com/article/2015/02/06/levi-hospira-alert-idUSnPnrgqbL+41+PRN20150206,
20150207 8:39AM UTC,"Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Hospira, Inc. Concerning its Proposed Sale to Pfizer --HSP",http://www.reuters.com/article/2015/02/06/ny-bgg-law-vs-hsp-idUSnPnc39cRR+83+PRN20150206,
20150207 7:00AM UTC,RPT-Pfizer's Hospira deal bets on price spike for specialty generics,http://www.reuters.com/article/2015/02/06/hospira-ma-pfizer-idUSL1N0VF3LC20150206,
20150210 6:00PM UTC,"Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co",http://www.reuters.com/article/2015/02/09/us-pfizer-share-repurchase-idUSKBN0LD2J420150209,
20150210 5:58PM UTC,"Pfizer in $5 bln accelerated buyback deal with Goldman, Sachs & Co",http://www.reuters.com/article/2015/02/09/pfizer-share-repurchase-idUSL4N0VJ6TN20150209,
20150210 5:27PM UTC,Pfizer Commences $5 Billion Accelerated Share Repurchase,http://www.reuters.com/article/2015/02/09/pfizer-idUSnBw096340a+100+BSW20150209,
20150210 11:53AM UTC,"UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Launches an Investigation of the Board of Directors of Hospira Inc. In Connection With the Fairness of the Sale of the Company to Pfizer -- HSP",http://www.reuters.com/article/2015/02/09/ny-levi-korsinsky-idUSnBw095949a+100+BSW20150209,
20150210 10:00AM UTC,Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Investor Conference,http://www.reuters.com/article/2015/02/09/pfizer-idUSnBw095045a+100+BSW20150209,
20150210 8:00AM UTC,Newly Approved IbranceÂ® (Palbociclib) from Pfizer Available Through Onco360,http://www.reuters.com/article/2015/02/09/ky-onco-idUSnBw095273a+100+BSW20150209,
20150211 11:00AM UTC,"WeissLaw LLP: Hospira, Inc. Acquisition By Pfizer Inc. May Not Be In The Best Interest of HSP Shareholders",http://www.reuters.com/article/2015/02/10/weisslaw-investigates-idUSnPn7BfjFb+92+PRN20150210,
20150211 9:12AM UTC,Labcyte Commends Institute for Molecular Medicine Finland â€“ Pfizer Leukemia Study Results,http://www.reuters.com/article/2015/02/10/ca-labcyte-idUSnBw105354a+100+BSW20150210,
20150212 12:49PM UTC,SHAREHOLDER ALERT: The Law Offices of Vincent Wong Commences an Investigation of the Board of Directors of Hospira Inc. Regarding the Fairness of the Sale of the Company to Pfizer â€“ HSP,http://www.reuters.com/article/2015/02/11/ny-law-offc-vincent-wong-idUSnBw116143a+100+BSW20150211,
20150212 9:00AM UTC,Alzheimer's Drug Discovery Foundation Teams Up with Pfizer's Centers for Therapeutic Innovation to Support Discovery of Drugs for Alzheimer's Disease,http://www.reuters.com/article/2015/02/11/addf-alz-discovery-idUSnPnm0LlP+45+PRN20150211,
20150214 10:27AM UTC,Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride),http://www.reuters.com/article/2015/02/13/ny-pfizer-idUSnBw135520a+100+BSW20150213,
20150218 7:30PM UTC,"HOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. (HSP) Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc.",http://www.reuters.com/article/2015/02/18/ny-faruqi-faruqi-idUSnBw176742a+100+BSW20150218,
20150221 3:20PM UTC,"UPDATE 1-Sanofi's new boss could earn more than Total's, less than Pfizer's",http://www.reuters.com/article/2015/02/20/sanofi-bayer-pay-idUSL5N0VU4AJ20150220,
20150224 11:06AM UTC,"UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Hospira Inc. of Class Action Against the Board of the Company in Connection With the Fairness of the Sale of the Company to Pfizer -- HSP",http://www.reuters.com/article/2015/02/23/idUSnGNX4DQf8V+1d9+GNW20150223,
20150225 2:34PM UTC,"Clinical Research Informatics World Commences With Keynote Address by Pfizer's Global Head of Clinical Innovation and Informatics, Dr. Barbara Tardiff",http://www.reuters.com/article/2015/02/24/idUSnMKWCyW6za+1e8+MKW20150224,
20150225 10:00AM UTC,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,http://www.reuters.com/article/2015/02/24/pfizer-idUSnBw245010a+100+BSW20150224,
20150225 8:00AM UTC,"Pfizer Announces Positive Top-line Results Of A Phase 2 Study Of TRUMENBAÂ® (Meningococcal Group B Vaccine) Co-Administered With Routine Meningococcal (A, C, Y, and W) And Tetanus, Diptheria And Pertussis (Tdap) Vaccines In ",http://www.reuters.com/article/2015/02/24/pfizer-idUSnBw245082a+100+BSW20150224,
20150227 2:52PM UTC,"Pfizer, Novartis say meningitis vaccine scope too narrow",http://www.reuters.com/article/2015/02/26/us-pfizer-meningitis-idUSKBN0LU2C820150226,
20150227 2:50PM UTC,"UPDATE 1-Pfizer, Novartis say meningitis vaccine scope too narrow",http://www.reuters.com/article/2015/02/26/pfizer-meningitis-idUSL1N0W02GV20150226,
20150227 12:59PM UTC,Pfizer laments narrow recommendation for meningitis vaccine,http://www.reuters.com/article/2015/02/26/pfizer-meningitis-idUSL1N0W02E220150226,
20150228 3:52AM UTC,"Research and Markets: Global Congestive Heart Failure Drugs Market 2015-2019 with AstraZeneca, Bristol-Myers Squibb, GSK, Merck & Co., Mylan, Novartis, Pfizer, Sanofi & Valeant Pharmaceuticals Dominating",http://www.reuters.com/article/2015/02/27/research-and-markets-idUSnBw275153a+100+BSW20150227,
20150304 8:35AM UTC,Pfizer Receives European Approval for New Indication for Prevenar 13 for Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults,http://www.reuters.com/article/2015/03/03/pfizer-idUSnBw035764a+100+BSW20150303,
20150305 9:00AM UTC,Contextual Genomics and the Personalized Medicine Initiative Welcome Pfizer Canada to Consortium for National Access Project for Cancer Testing,http://www.reuters.com/article/2015/03/04/contextual-genomics-idUSnBw045067a+100+BSW20150304,
20150310 9:06PM UTC,"FDA warns of seizure, alcohol risk with Pfizer's Chantix",http://www.reuters.com/article/2015/03/10/pfizer-chantix-warning-idUSL1N0WB23M20150310,
20150310 6:39PM UTC,"U.S. FDA warns of seizure, alcohol risk with Pfizer's Chantix",http://www.reuters.com/article/2015/03/09/us-pfizer-chantix-warning-idUSKBN0M527T20150309,
20150310 6:32PM UTC,"UPDATE 1-U.S. FDA warns of seizure, alcohol risk with Pfizer's Chantix",http://www.reuters.com/article/2015/03/09/pfizer-chantix-warning-idUSL1N0WB2A820150309,
20150310 4:29PM UTC,FDA declines to remove serious warning on Pfizer's Chantix,http://www.reuters.com/article/2015/03/09/pfizer-chantix-warning-idUSL1N0WB23M20150309,
20150310 4:25PM UTC,U.S. FDA declines to remove serious warning on Pfizer's Chantix,http://www.reuters.com/article/2015/03/09/pfizer-chantix-warning-idUSL1N0WB21820150309,
20150311 12:34PM UTC,"Research and Markets: Life Science February 2015 Issue - US President's Science Budget, Pfizer's Acquisition of Hospira, China's Redefined Foreign Investment Law, and President Obama's Precision Medicine Initiative",http://www.reuters.com/article/2015/03/10/research-and-markets-idUSnBw106345a+100+BSW20150310,
20150311 10:00AM UTC,"Technical Snapshot on Pharma Stocks -- Pfizer, Zogenix, Sanofi, Nektar Therapeutics, and IGI Laboratories",http://www.reuters.com/article/2015/03/10/bc-investor-edge-idUSnPn625hBf+82+PRN20150310,
20150205 4:12PM UTC,"Research and Markets: Antidepressant Market in the US 2015-2019: Key Vendors are Actavis, Eli Lilly and Company, GlaxoSmithKline, Otsuka Pharmaceutical and Pfizer",http://www.reuters.com/article/2015/02/04/research-and-markets-idUSnBw046493a+100+BSW20150204,
20150205 3:22PM UTC,Pfizer Announces FDA Acceptance For Review Of Supplemental New Drug Application For Oral XELJANZÂ® (tofacitinib citrate) For Adult Patients With Moderate To Severe Chronic Plaque Psoriasis,http://www.reuters.com/article/2015/02/04/pfizer-idUSnBw046379a+100+BSW20150204,
20150205 8:00AM UTC,Pfizer Marks World Cancer Day with Grant to Union for International Cancer Control to Address the Needs of Metastatic Breast Cancer Patients,http://www.reuters.com/article/2015/02/04/pfizer-idUSnBw045238a+100+BSW20150204,
20150313 5:21PM UTC,Pfizer pain drug Lyrica fails study in adolescents with fibromyalgia,http://www.reuters.com/article/2015/03/12/us-pfizer-study-idUSKBN0M82O620150312,
20150313 5:01PM UTC,Pfizer pain drug Lyrica fails study in adolescents with fibromyalgia,http://www.reuters.com/article/2015/03/12/pfizer-study-idUSL4N0WE5WJ20150312,
20150313 4:30PM UTC,Pfizer Reports Top-Line Results From A Phase 4 Study Evaluating LYRICAÂ® Capsules CV As A Treatment For Adolescents With Fibromyalgia,http://www.reuters.com/article/2015/03/12/pfizer-idUSnBw126192a+100+BSW20150312,
20150313 10:21AM UTC,Pfizer hunts for new vaccines to protect young and old,http://www.reuters.com/article/2015/03/12/us-pfizer-vaccines-idUSKBN0M81QN20150312,
20150331 11:00AM UTC,"Dr. Charles Reay Mackay To Join Pfizer as Chief Scientific Officer, Inflammation and Immunology Research Unit",http://www.reuters.com/article/2015/03/30/pfizer-idUSnBw305730a+100+BSW20150330,
20150418 6:54PM UTC,Pfizer wins first U.S. trial over Zoloft birth-defect risk,http://www.reuters.com/article/2015/04/17/us-pfizer-zoloft-idUSKBN0N82HY20150417,
20150418 6:53PM UTC,Pfizer wins first U.S. trial over Zoloft birth-defect risk,http://www.reuters.com/article/2015/04/17/pfizer-zoloft-idUSL2N0XE2JJ20150417,
20150418 6:51PM UTC,UPDATE 2-Pfizer wins first U.S. trial over Zoloft birth-defect risk,http://www.reuters.com/article/2015/04/17/pfizer-zoloft-idUSL2N0XE2GV20150417,
20150418 5:34PM UTC,Pfizer wins first U.S. trial over Zoloft birth-defect risk,http://www.reuters.com/article/2015/04/17/pfizer-zoloft-idUSL2N0XE2FJ20150417,
20150418 7:45AM UTC,"Be on Top of the Latest Developments: Complementary Research on Apple, Ford Motors, Avon Products, Pfizer and Transocean",http://www.reuters.com/article/2015/04/17/bc-analysts-review-idUSnPn6HC2Hx+9a+PRN20150417,
20150506 2:25PM UTC,23andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc.,http://www.reuters.com/article/2015/05/05/ca-23andme-pfizer-idUSnPnYHFKS+5f+PRN20150505,
20150611 8:00AM UTC,Pfizer Builds Upon Robust Body Of Knowledge For XELJANZÂ® (tofacitinib citrate) With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress (EULAR 2015),http://www.reuters.com/article/2015/06/10/pfizer-idUSnBw105559a+100+BSW20150610,
20150804 8:30AM UTC,Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis,http://www.reuters.com/article/pfizer-idUSnBw035640a+100+BSW20150803,
20150822 8:00AM UTC,Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of TRUMENBAÂ® (Meningococcal Group B Vaccine),http://www.reuters.com/article/pfizer-idUSnBw215031a+100+BSW20150821,
20150909 1:53PM UTC,Fitch Rates Pfizer's Exchange Notes Offering 'A+'; Outlook Stable,http://www.reuters.com/article/ny-fitch-ratings-pfizer-idUSnBw086498a+100+BSW20150908,
20150909 8:00AM UTC,Dr. Boris Shor joins Immune Pharmaceuticals from Pfizer to lead new R&D; lab at Alexandria Center for Life Science,http://www.reuters.com/article/immune-pharm-elects-idUSnPn31bzl6+80+PRN20150908,
20151015 5:39PM UTC,FDA declines to expand approval of Pfizer arthritis drug,http://www.reuters.com/article/pfizer-psoriasis-fda-idUSL1N12E2PN20151014,
20151015 5:37PM UTC,FDA declines to expand approval of Pfizer arthritis drug,http://www.reuters.com/article/us-pfizer-psoriasis-fda-idUSKCN0S82QT20151014,
20151015 5:36PM UTC,FDA declines to expand approval of Pfizer arthritis drug,http://www.reuters.com/article/pfizer-psoriasis-fda-idUSL1N12E2OW20151014,
20151015 5:00PM UTC,Pfizer Receives Complete Response Letter from FDA for Oral XELJANZÂ® (tofacitinib citrate) Supplemental New Drug Application for Moderate to Severe Chronic Plaque Psoriasis,http://www.reuters.com/article/pfizer-idUSnBw146500a+100+BSW20151014,
20151120 10:07PM UTC,U.S. unveils new inversion rules; unlikely to thwart Pfizer ,http://www.reuters.com/article/us-usa-tax-inversions-idUSKCN0T830L20151120,
20151120 9:58PM UTC,UPDATE 2-U.S. unveils new inversion rules; unlikely to thwart Pfizer,http://www.reuters.com/article/usa-tax-inversions-idUSL1N13E30720151120,
20151120 5:56PM UTC,U.S. funds optimistic about Allergan piled in before Pfizer bid,http://www.reuters.com/article/us-allergan-pfizer-investors-idUSKCN0T82RV20151119,
20151120 5:56PM UTC,Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources,http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0T827P20151119,
20151120 3:28PM UTC,UPDATE 1-U.S. funds optimistic about Allergan piled in before Pfizer bid,http://www.reuters.com/article/allergan-pfizer-investors-idUSL1N13E29I20151119,
20151120 2:42PM UTC,U.S. funds optimistic about Allergan piled in before Pfizer bid,http://www.reuters.com/article/allergan-pfizer-investors-idUSL1N13E1WR20151119,
20151120 2:27PM UTC,"Pfizerâ€™s $150 bln plan is high-risk, low-benefit",http://www.reuters.com/article/idUS176972332220151119,
20151120 10:09AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw195948a+100+BSW20151119,
20151120 9:34AM UTC,"Pfizer, Allergan in final stage of merger talks: CNBC",http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0T820I20151119,
20151120 9:31AM UTC,"Pfizer, Allergan in final stage of merger talks - CNBC",http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N13E3Z720151119,
20151120 9:18AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG7bF1FS+1cb+ONE20151119,
20151120 8:55AM UTC,IRG Finalizes Purchase of State-of-the-Art Pfizer Campus in New York,http://www.reuters.com/article/industrial-realty-gro-idUSnPn1KLbqs+98+PRN20151119,
20151120 6:35AM UTC,Pfizer-Allergan talks accelerate amid new inversion clamp-down,http://www.reuters.com/article/us-usa-tax-inversions-idUSKCN0T732U20151119,
20151120 3:09AM UTC,Servier and Pfizer get rights to Cellectis cancer cell therapy,http://www.reuters.com/article/us-cellectis-biotech-servier-pfizer-idUSKCN0T80QJ20151119,
20151120 3:01AM UTC,Servier and Pfizer get rights to Cellectis cancer cell therapy,http://www.reuters.com/article/cellectis-biotech-servier-pfizer-idUSL8N13E11520151119,
20151208 9:00PM UTC,BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics,http://www.reuters.com/article/bioatla-pfizerpartner-idUSnPn6cL2Zr+8a+PRN20151208,
20150319 5:04PM UTC,Results of Pfizerâ€™s Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Published in the New England Journal of Medicine,http://www.reuters.com/article/2015/03/18/pfizer-idUSnBw186556a+100+BSW20150318,
20150319 12:00PM UTC,Research and Markets: Pfizer's Xeljanz (tofacitinib) Rheumatoid Arthritis Report - Forecast and Market Analysis to 2023,http://www.reuters.com/article/2015/03/18/research-and-markets-idUSnBw186011a+100+BSW20150318,
20150321 1:00PM UTC,Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials,http://www.reuters.com/article/2015/03/20/pfizer-idUSnBw205722a+100+BSW20150320,
20150324 10:50AM UTC,"Pfizer, Lilly to resume study testing pain drug",http://www.reuters.com/article/2015/03/23/us-pfizer-study-eli-lilly-idUSKBN0MJ16Z20150323,
20150324 10:48AM UTC,"UPDATE 2-Pfizer, Lilly to resume study testing pain drug",http://www.reuters.com/article/2015/03/23/pfizer-study-eli-lilly-idUSL3N0WP50T20150323,
20150324 8:17AM UTC,"Pfizer, Lilly to resume late-stage study testing pain drug",http://www.reuters.com/article/2015/03/23/pfizer-study-eli-lilly-idUSL3N0WP4XD20150323,
20150324 8:00AM UTC,Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab,http://www.reuters.com/article/2015/03/23/pfizer-idUSnBw235203a+100+BSW20150323,
20150327 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,http://www.reuters.com/article/2015/03/26/pfizer-idUSnBw265542a+100+BSW20150326,
20150403 4:01PM UTC,BIND Therapeutics Announces Extension of Global Collaboration with Pfizer Inc. to Develop and Commercialize Multiple Accurins,http://www.reuters.com/article/2015/04/02/ma-bind-therapeutics-idUSnBw026194a+100+BSW20150402,
20150403 2:09AM UTC,Pfizer to shutter vaccines sales business in China,http://www.reuters.com/article/2015/04/02/us-pfizer-china-idUSKBN0MT0EU20150402,
20150403 1:55AM UTC,Pfizer to shutter vaccines sales business in China,http://www.reuters.com/article/2015/04/02/pfizer-china-idUSL3N0WZ1K320150402,
20150404 11:25AM UTC,MEDIA- Pfizer halts China vaccine sales after import license not renewed -FT,http://www.reuters.com/article/2015/04/03/usa-pfizer-idUSL2N0WZ0Y820150403,
20150407 1:00PM UTC,"Kathrin U. Jansen, Ph.D., to Lead Pfizerâ€™s Vaccine Research and Development Unit",http://www.reuters.com/article/2015/04/06/pfizer-idUSnBw065648a+100+BSW20150406,
20150408 8:00AM UTC,"Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORIÂ® (crizotinib)",http://www.reuters.com/article/2015/04/07/pfizer-idUSnBw075267a+100+BSW20150407,
20150408 7:51AM UTC,"Research and Markets: Strategic Importance of Intellectual Property (IP) in M&A; 2015 Featuring Apple, ArcelorMittal, EMC, Ericsson, Google, Microsoft, Motorola, Pfizer, RIM, SONY & Rockstar Consortium",http://www.reuters.com/article/2015/04/07/research-and-markets-idUSnBw075604a+100+BSW20150407,
20150408 7:00AM UTC,GlycoMimetics Provides Update on Pfizerâ€™s Plans to Initiate Phase 3 Trial with Rivipansel in Mid-2015,http://www.reuters.com/article/2015/04/07/md-glycomimetics-idUSnBw075280a+100+BSW20150407,
20150409 6:05AM UTC,"Research and Markets: Global Gaucher Disease Market 2015-2019: Key Players Include Actelion Pharmaceuticals, Genzyme, Pfizer & Shire",http://www.reuters.com/article/2015/04/08/research-and-markets-idUSnBw085467a+100+BSW20150408,
20150410 8:00AM UTC,Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research,http://www.reuters.com/article/2015/04/09/pfizer-idUSnBw095136a+100+BSW20150409,
20150414 5:04PM UTC,Mylan settles Viagra patent litigation with Pfizer,http://www.reuters.com/article/mylan-litigation-pfizer-idUSL2N0XA26J20150413,
20150414 4:37PM UTC,Mylan settles Viagra patent litigation with Pfizer,http://www.reuters.com/article/us-mylan-litigation-pfizer-idUSKBN0N423K20150413,
20150414 4:37PM UTC,UPDATE 1-Mylan settles Viagra patent litigation with Pfizer,http://www.reuters.com/article/mylan-litigation-pfizer-idUSL4N0XA5EZ20150413,
20150414 3:33PM UTC,Mylan settles Viagra patent litigation with Pfizer,http://www.reuters.com/article/mylan-litigation-pfizer-idUSL4N0XA5EE20150413,
20150415 5:42PM UTC,Pfizer spars with Zoloft plaintiffs over deadline for new expert,http://www.reuters.com/article/2015/04/14/products-zoloft-experts-idUSL2N0XB31720150414,
20150415 1:00PM UTC,REGiMMUNE Announces Collaboration With JDRF and Pfizer Inc. for Type 1 Diabetes Prevention and Treatment Promoting Regulatory T-Cells,http://www.reuters.com/article/2015/04/14/idUSnMKWtFdvla+1d0+MKW20150414,
20150415 11:00AM UTC,Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement of Pfizer Inc. Securities Litigation,http://www.reuters.com/article/2015/04/14/ny-robbins-geller-rudman-idUSnBw145001a+100+BSW20150414,
20150415 9:30AM UTC,PharmaCyte Biotech Appoints Former Pfizer and Alchemia Executive to Board of Directors,http://www.reuters.com/article/2015/04/14/idUSnGNX46qKJD+1c7+GNW20150414,
20150416 1:04PM UTC,Approved Pfizer breast cancer drug impresses in latest study,http://www.reuters.com/article/2015/04/15/us-pfizer-cancer-idUSKBN0N623N20150415,
20150416 12:58PM UTC,Approved Pfizer breast cancer drug impresses in latest study,http://www.reuters.com/article/2015/04/15/pfizer-cancer-idUSL2N0XC1GM20150415,
20150416 9:37AM UTC,"AstraZeneca science is on the move, one year on from Pfizer bid",http://www.reuters.com/article/2015/04/15/us-astrazeneca-pfizer-anniversary-idUSKBN0N61LX20150415,
20150416 9:29AM UTC,"AstraZeneca science is on the move, one year on from Pfizer bid",http://www.reuters.com/article/2015/04/15/astrazeneca-pfizer-anniversary-idUSL5N0XA3DG20150415,
20150416 8:00AM UTC,"Pfizer Announces PALOMA-3 Trial For IBRANCEÂ® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy",http://www.reuters.com/article/2015/04/15/pfizer-idUSnBw155239a+100+BSW20150415,
20150417 2:26PM UTC,Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders,http://www.reuters.com/article/2015/04/16/pfizer-idUSnBw166456a+100+BSW20150416,
20150417 8:30AM UTC,Pfizer Launches 2014 Integrated Annual Review,http://www.reuters.com/article/2015/04/16/pfizer-idUSnBw165035a+100+BSW20150416,
20150421 8:00AM UTC,"Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer",http://www.reuters.com/article/pfizer-idUSnBw205369a+100+BSW20150420,
20150421 6:00AM UTC,Pfizer and Provectus Biopharmaceuticals Receive Patent Allowance for Use of PV-10 in Combination with Systemic Immunotherapy Agents in Treatment of Cancer,http://www.reuters.com/article/tn-provectus-idUSnBw205139a+100+BSW20150420,
20150422 10:00AM UTC,Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORIÂ® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer,http://www.reuters.com/article/2015/04/21/pfizer-idUSnBw216132a+100+BSW20150421,
20150422 8:00AM UTC,Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia,http://www.reuters.com/article/2015/04/21/pfizer-idUSnBw215748a+100+BSW20150421,
20150422 2:17PM UTC,Pfizer could bid against Teva for Mylan-CRT Capital's Chiang,http://www.reuters.com/news/video/videoStory?storyID=107067099,
20150423 8:00AM UTC,"Healthcare's Health Scanner: Complementary Research on Pfizer, Mylan, Teva Pharmaceutical, Bristol-Myers Squibb, and Merck & Company",http://www.reuters.com/article/2015/04/22/bc-analysts-review-idUSnPnb6WtKw+8a+PRN20150422,
20150424 2:07PM UTC,Pfizer Hosts Annual Meeting Of Shareholders,http://www.reuters.com/article/2015/04/23/pfizer-idUSnBw236407a+100+BSW20150423,
20150428 10:12AM UTC,Pfizer and The Arthritis Society team up to support Canadians with arthritis,http://www.reuters.com/article/idUSnGNX4gz3RB+1c3+GNW20150427,
20150428 12:00AM UTC,Frost & Sullivan Recognizes Pfizer as CSR Company of the Year in Community Health,http://www.reuters.com/article/idUSnMKWrCX1Za+1da+MKW20150427,
20150429 8:00AM UTC,Pfizer cuts full-year forecast on stronger dollar,http://www.reuters.com/article/2015/04/28/us-pfizer-results-idUSKBN0NJ17B20150428,
20150429 7:55AM UTC,UPDATE 1-Pfizer cuts full-year forecast on stronger dollar,http://www.reuters.com/article/2015/04/28/pfizer-results-idUSL4N0XP5BB20150428,
20150429 7:09AM UTC,Pfizer quarterly revenue falls on stronger dollar,http://www.reuters.com/article/2015/04/28/pfizer-results-idUSL4N0XP4VE20150428,
20150501 12:08PM UTC,Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources,http://www.reuters.com/article/2015/04/30/us-sobi-pfizer-idUSKBN0NL1VQ20150430,
20150502 8:30AM UTC,"What Everybody Ought to Know: Complementary Research on Huntington Bancshares, Wells Fargo, JPMorgan Chase, Regions Financial Corp and Pfizer",http://www.reuters.com/article/2015/05/01/bc-analysts-review-idUSnPn24MWlb+8c+PRN20150501,
20150507 12:48PM UTC,Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat,http://www.reuters.com/article/2015/05/06/pfizer-idUSnBw066267a+100+BSW20150506,
20150507 8:00AM UTC,EMD Serono Initiates Co-Promotion of XALKORIÂ® (crizotinib) with Pfizer in the United States,http://www.reuters.com/article/2015/05/06/emd-serono-xalkori-idUSnPn7mYKTD+8f+PRN20150506,
20150508 8:50AM UTC,"Business Highlights from Financial Sector: Complementary Research on Regions Financial, Itau Unibanco, Wells Fargo, Banco Bradesco and Pfizer",http://www.reuters.com/article/2015/05/07/bc-analysts-review-idUSnPn9DWRBd+9e+PRN20150507,
20150512 4:30PM UTC,Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company,http://www.reuters.com/article/2015/05/11/pfizer-idUSnBw116219a+100+BSW20150511,
20150512 2:07AM UTC,BRIEF-DKSH supports Pfizer's expansion to Laos,http://www.reuters.com/article/2015/05/11/idUSL5N0Y20KC20150511,
20150514 5:01PM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody",http://www.reuters.com/article/2015/05/13/pfizer-idUSnBw136632a+100+BSW20150513,
20150514 5:00PM UTC,Pfizer drug shows early promise in Xalkori-resistant lung cancer-study,http://www.reuters.com/article/2015/05/13/cancer-asco-pfizer-idUSL1N0Y32X820150513,
20150514 1:40PM UTC,Hospira Shareholders Approve Merger of Hospira and Pfizer at Special Meeting,http://www.reuters.com/article/2015/05/13/hospira-pfizermerger-idUSnPn5sT2Bc+8a+PRN20150513,
20150514 9:00AM UTC,"Factors Influencing Business Growth: Complementary Research on Citigroup, JPMorgan Chase, Itau Unibanco, Pfizer, and MannKind",http://www.reuters.com/article/2015/05/13/bc-analysts-review-idUSnPnb1BLQB+8f+PRN20150513,
20150514 6:42AM UTC,Business groups say ADA doesn't entitle blind Pfizer worker to driver,http://www.reuters.com/article/2015/05/13/employment-disability-pfizer-idUSL1N0Y40HI20150513,
20150515 12:27PM UTC,Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira,http://www.reuters.com/article/2015/05/14/pfizer-idUSnBw146035a+100+BSW20150514,
20150515 8:07AM UTC,"Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors",http://www.reuters.com/article/2015/05/14/pfizer-idUSnBw145496a+100+BSW20150514,
20150519 8:29AM UTC,BRIEF-Geratherm Medical: apoplex medical technologies and Pfizer cooperate in field of stroke,http://www.reuters.com/article/2015/05/18/idUSFWN0Y901V20150518,
20150520 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations,http://www.reuters.com/article/2015/05/19/pfizer-idUSnBw195220a+100+BSW20150519,
20150526 1:56PM UTC,"Research and Markets: Global Hemophilia Market Report: 2015 Edition: Market is Intense Among Large Players like with Baxter International, Novo Nordisk and Pfizer",http://www.reuters.com/article/2015/05/25/research-and-markets-idUSnBw255195a+100+BSW20150525,
20150529 5:03PM UTC,FDA approves Pfizer drug to treat very rare lung disease,http://www.reuters.com/article/2015/05/28/us-pfizer-fda-approval-idUSKBN0OD2QB20150528,
20150529 4:56PM UTC,UPDATE 1-FDA approves Pfizer drug to treat very rare lung disease,http://www.reuters.com/article/2015/05/28/pfizer-fda-approval-idUSL1N0YJ2ML20150528,
20150529 4:31PM UTC,FDA app proves Pfizer drug to treat very rare lung disease,http://www.reuters.com/article/2015/05/28/pfizer-fda-approval-idUSL1N0YJ2KT20150528,
20150529 8:30AM UTC,Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer,http://www.reuters.com/article/2015/05/28/pfizer-idUSnBw285491a+100+BSW20150528,
20150529 8:00AM UTC,Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a More Positive View of Their Health,http://www.reuters.com/article/2015/05/28/pfizer-idUSnBw285636a+100+BSW20150528,
20150530 8:30AM UTC,"Pfizerâ€™s RAPAMUNEÂ® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM), A Rare Progressive Lung Disease",http://www.reuters.com/article/2015/05/29/pfizer-idUSnBw295131a+100+BSW20150529,
20150531 1:17PM UTC,Pfizer's Ibrance drug slows progression of breast cancer,http://www.reuters.com/article/2015/05/30/us-cancer-asco-pfizer-breast-idUSKBN0OF0K720150530,
20150531 1:05PM UTC,UPDATE 1-Pfizer's Ibrance drug slows progression of breast cancer,http://www.reuters.com/article/2015/05/30/cancer-asco-pfizer-breast-idUSL1N0YL0CS20150530,
20150531 7:30AM UTC,"Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival in Phase 3 Trial for Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy",http://www.reuters.com/article/2015/05/30/pfizer-idUSnBw305035a+100+BSW20150530,
20150531 7:30AM UTC,Pfizer's Ibrance drug slows progression of breast cancer,http://www.reuters.com/article/2015/05/30/cancer-asco-pfizer-breast-idUSL1N0YJ2PF20150530,
20150603 1:15PM UTC,NCCN Collaborates With Pfizer to Improve Provider Performance and Quality in Treatment of Metastatic Breast Cancer,http://www.reuters.com/article/2015/06/02/idUSnMKWp900Qa+1c2+MKW20150602,
20150603 1:15PM UTC,NCCN Collaborates With Pfizer to Improve Provider Performance and Quality in Treatment of Metastatic Breast Cancer,http://www.reuters.com/article/2015/06/02/idUSnCCN9J50h8+1d0+MKW20150602,
20150603 11:47AM UTC,"Research and Markets: Global Neurodegenerative Diseases Market 2015-2019: Key Vendors are Biogen Idec, Merck Serono, Novartis, Pfizer, Teva Pharmaceutical Industries & UCB",http://www.reuters.com/article/2015/06/02/research-and-markets-idUSnBw026573a+100+BSW20150602,
20150603 9:34AM UTC,Yes Lifecycle Marketing New Hires Former Pfizer and Acxiom Executives to Strengthen Retail Vertical Strategy,http://www.reuters.com/article/2015/06/02/idUSnGNX1xtF7Z+1c5+GNW20150602,
20150605 9:00AM UTC,Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign,http://www.reuters.com/article/2015/06/04/pfizer-idUSnBw045574a+100+BSW20150604,
20150606 10:26AM UTC,"Research and Markets: General Anxiety Disorder Therapeutics Pipeline Review, H1 2015 Featuring Edgemont Pharmaceuticals, LLC, H. Lundbeck A/S & Pfizer Inc.",http://www.reuters.com/article/2015/06/05/research-and-markets-idUSnBw055633a+100+BSW20150605,
20150609 11:00AM UTC,Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology,http://www.reuters.com/article/pfizer-idUSnBw086034a+100+BSW20150608,
20150610 10:08AM UTC,Pfizer CentreSource Lands a Top 3 Position Across All 4 CMO Scorecards in ISR's Latest Contract Manufacturer Quality Benchmarking Report,http://www.reuters.com/article/2015/06/09/idUSnMKW5fNSha+1cc+MKW20150609,
20150612 3:37PM UTC,U.S. jury clears Pfizer in second trial alleging Zoloft birth defects,http://www.reuters.com/article/2015/06/11/pfizer-zoloft-verdict-idUSL1N0YX1XP20150611,
20150612 3:19PM UTC,U.S. jury clears Pfizer in second trial alleging Zoloft birth defects,http://www.reuters.com/article/2015/06/11/us-pfizer-zoloft-verdict-idUSKBN0OR2HL20150611,
20150612 3:18PM UTC,UPDATE 2-U.S. jury clears Pfizer in second trial alleging Zoloft birth defects,http://www.reuters.com/article/2015/06/11/pfizer-zoloft-verdict-idUSL1N0YX1T720150611,
20150612 3:00PM UTC,Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder,http://www.reuters.com/article/2015/06/11/pfizer-idUSnBw116207a+100+BSW20150611,
20150612 1:43PM UTC,U.S. jury clears Pfizer in second trial over Zoloft,http://www.reuters.com/article/2015/06/11/pfizer-zoloft-verdict-idUSL1N0YX1S020150611,
20150616 11:01AM UTC,"CDC Foundation, Pfizer and Quest Diagnostics to Extend Million Hearts(R) Initiative to Local Communities",http://www.reuters.com/article/idUSnMKWp4ktla+1c0+MKW20150615,
20150616 11:01AM UTC,"CDC Foundation, Pfizer and Quest Diagnostics to Extend Million Hearts(R) Initiative to Local Communities",http://www.reuters.com/article/idUSnCCN1QGcM6+1da+MKW20150615,
20150616 10:02AM UTC,"Research and Markets: Infectious Diseases Market in US 2015-2019: with GlaxoSmithKline, Merck and Pfizer",http://www.reuters.com/article/research-and-markets-idUSnBw155885a+100+BSW20150615,
20150616 8:00AM UTC,Pfizer Consumer Healthcare To Expand Caltrate And Centrum Production In China,http://www.reuters.com/article/pfizer-idUSnBw155638a+100+BSW20150615,
20150619 4:01PM UTC,Spark Therapeutics to Present With Pfizer Inc. Preclinical Data on Their Lead SPK-FIX Product Candidate for Hemophilia B at the 2015 International Society of Thrombosis and Haemostasis Congress in June,http://www.reuters.com/article/2015/06/18/idUSnGNX9DSDzK+1dd+GNW20150618,
20150620 10:00AM UTC,"CDC Foundation, Pfizer and CDC Partner to Develop Longitudinal Data Collection System for Sickle Cell Disease",http://www.reuters.com/article/2015/06/19/idUSnMKWDMfP4a+1f4+MKW20150619,
20150620 10:00AM UTC,"CDC Foundation, Pfizer and CDC Partner to Develop Longitudinal Data Collection System for Sickle Cell Disease",http://www.reuters.com/article/2015/06/19/idUSnCCN3s7KrL+1c5+MKW20150619,
20150620 6:13AM UTC,"Research and Markets: Global Travel Vaccines Market 2015-2019: With Janssen Pharmaceuticals, Pfizer and Novartis Dominating",http://www.reuters.com/article/2015/06/19/research-and-markets-idUSnBw195242a+100+BSW20150619,
20150623 2:40PM UTC,"Research and Markets: Global Pneumonia Vaccine Market Outlook 2020 with GlaxoSmithKline, Pfizer and Merck Dominating",http://www.reuters.com/article/2015/06/22/research-and-markets-idUSnBw226250a+100+BSW20150622,
20150623 8:45AM UTC,"Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect of Factor Xa Inhibitor ",http://www.reuters.com/article/2015/06/22/idUSnGNX85zv6Z+1c1+GNW20150622,
20150623 8:04AM UTC,GSK sells two vaccines to Pfizer to ease competition concerns,http://www.reuters.com/article/2015/06/22/us-gsk-pfizer-vaccines-idUSKBN0P219820150622,
20150623 7:45AM UTC,GSK sells two vaccines to Pfizer to ease competition concerns,http://www.reuters.com/article/2015/06/22/gsk-pfizer-vaccines-idUSL8N0Z826K20150622,
20150623 7:00AM UTC,Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline,http://www.reuters.com/article/2015/06/22/pfizer-idUSnBw225533a+100+BSW20150622,
20150624 2:15PM UTC,GlycoMimetics to Receive $20 Million Payment from Pfizer Following Initiation of Phase 3 Trial with Rivipansel,http://www.reuters.com/article/2015/06/23/md-glycomimetics-idUSnBw236403a+100+BSW20150623,
20150624 2:00PM UTC,Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease,http://www.reuters.com/article/2015/06/23/pfizer-idUSnBw236369a+100+BSW20150623,
20150624 10:00AM UTC,Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts,http://www.reuters.com/article/2015/06/23/pfizer-idUSnBw235695a+100+BSW20150623,
20150625 9:09AM UTC,"Research and Markets: Global Heparin Market 2015-2019 - Expected Exploitation of New Therapeutic Use with Aspen, Leo Pharma, Pfizer & Sanofi-Aventis Dominating",http://www.reuters.com/article/2015/06/24/research-and-markets-idUSnBw245775a+100+BSW20150624,
20150626 4:25PM UTC,"Research and Markets: United States Human Growth Hormone Market Study 2015-2019 Features Merck Serono, Pfizer and Novo Nordisk",http://www.reuters.com/article/2015/06/25/research-and-markets-idUSnBw256336a+100+BSW20150625,
20150626 11:20AM UTC,Joseph J. Echevarria Elected To Pfizerâ€™s Board Of Directors,http://www.reuters.com/article/2015/06/25/pfizer-idUSnBw255921a+100+BSW20150625,
20150626 11:15AM UTC,Pfizer Declares 28-Cent Third-Quarter 2015 Dividend,http://www.reuters.com/article/2015/06/25/pfizer-idUSnBw255918a+100+BSW20150625,
20150630 7:00AM UTC,Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the RobitussinÂ® Brand,http://www.reuters.com/article/2015/06/29/tris-pharma-pfizer-idUSnPn6FmW1K+95+PRN20150629,
20150703 4:30PM UTC,Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZÂ® (tofacitinib citrate) Modified Release Tablets,http://www.reuters.com/article/2015/07/02/pfizer-idUSnBw025849a+100+BSW20150702,
20150703 9:30AM UTC,Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D;,http://www.reuters.com/article/2015/07/02/xrpro-sciences-idUSnPn48JC5K+8d+PRN20150702,
20150708 8:00AM UTC,Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery,http://www.reuters.com/article/pfizer-idUSnBw075316a+100+BSW20150707,
20150708 6:55AM UTC,"Zoloft plaintiffs, Pfizer set to spar in second hearing on expert witnesses",http://www.reuters.com/article/products-zoloft-hearing-idUSL1N0ZN0BE20150707,
20150709 8:30AM UTC,Pfizerâ€™s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research,http://www.reuters.com/article/pfizer-idUSnBw085204a+100+BSW20150708,
20150715 3:05PM UTC,Pfizer offers concessions in bid to win EU okay for Hospira deal,http://www.reuters.com/article/hospira-ma-pfizer-eu-idUSL2N0ZU1YT20150714,
20150715 9:52AM UTC,Pfizer offers concessions in bid to win EU okay for Hospira deal,http://www.reuters.com/article/us-hospira-m-a-pfizer-eu-idUSKCN0PO1QC20150714,
20150715 9:50AM UTC,Pfizer offers concessions in bid to win EU okay for Hospira deal,http://www.reuters.com/article/hospira-ma-pfizer-eu-idUSL5N0ZU3JC20150714,
20150716 8:16AM UTC,National Psoriasis Foundation and Pfizer launch partnership for innovative grants,http://www.reuters.com/article/npf-pfizer-grants-idUSnPn9vh52P+81+PRN20150715,
20150716 4:01AM UTC,REFILE-BRIEF-Pfizer's Indian unit intends to close Navi Mumbai plant,http://www.reuters.com/article/pfizer-brief-idUSWNBS010XY20150715,
20150721 9:35AM UTC,"Research and Markets: Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - GlaxoSmithKline, Pfizer & Otsuka Pharmaceutical Dominate the Industry",http://www.reuters.com/article/research-and-markets-idUSnBw205801a+100+BSW20150720,
20150721 9:25AM UTC,"Watch List for Drug Manufacturers - Major Equities -- Pfizer, Bristol-Myers Squibb, Eli Lilly, Kythera Biopharma, and Impax Laboratories",http://www.reuters.com/article/bc-equity-research-insti-idUSnPn7jQ4LG+8b+PRN20150720,
20150723 9:42AM UTC,"Research and Markets: Global Kidney Cancer Drugs Market 2015-2019 with Bayer, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Pfizer Leading the Market",http://www.reuters.com/article/research-and-markets-idUSnBw225809a+100+BSW20150722,
20150723 8:30AM UTC,Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility,http://www.reuters.com/article/pfizer-idUSnBw225655a+100+BSW20150722,
20150727 1:34AM UTC,TABLE-Pfizer India unit Q1 net profit jumps 42 pct y/y,http://www.reuters.com/article/pfizer-india-result-idUSL3N10603620150726,
20150729 10:10AM UTC,"Pfizer's revenue, profit beat as vaccine sales rise",http://www.reuters.com/article/us-pfizer-results-idUSKCN0Q216O20150728,
20150729 10:08AM UTC,"UPDATE 2-Pfizer's revenue, profit beat as vaccine sales rise",http://www.reuters.com/article/pfizer-results-idUSL3N1083XL20150728,
20150729 7:06AM UTC,Pfizer revenue falls 7 percent,http://www.reuters.com/article/pfizer-results-idUSL3N1074H820150728,
20150801 6:06AM UTC,"Research and Markets: Global Statin Market 2015-2019 with AstraZeneca, Merck, Novartis & Pfizer Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw315250a+100+BSW20150731,
20150805 5:46PM UTC,Pfizer wins EU approval for $15 billion Hospira buy,http://www.reuters.com/article/us-hospira-m-a-pfizer-eu-idUSKCN0Q91RD20150804,
20150805 5:44PM UTC,CORRECTED-Pfizer wins EU approval for $15 bln Hospira buy,http://www.reuters.com/article/hospira-ma-pfizer-eu-idUSL5N10F2DO20150804,
20150805 11:36AM UTC,Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira,http://www.reuters.com/article/pfizer-idUSnBw046424a+100+BSW20150804,
20150806 2:30PM UTC,"Research and Markets: Global Syphilis Clinical Trials Review, H1, 2015, Featuring Pfizer Inc., Mylan N.V., Kendle International Inc., & F. Hoffmann-La Roche",http://www.reuters.com/article/research-and-markets-idUSnBw056430a+100+BSW20150805,
20150807 10:47AM UTC,Britain raps Pfizer over huge jump in epilepsy drug price,http://www.reuters.com/article/us-pfizer-britain-epilepsy-idUSKCN0QB0JV20150806,
20150807 7:51AM UTC,UPDATE 3-Britain raps Pfizer over huge jump in epilepsy drug price,http://www.reuters.com/article/pfizer-britain-epilepsy-idUSL5N10H1J320150806,
20150807 5:29AM UTC,"Research and Markets: Investigation Report on China's Atorvastatin Market, 2010-2019 Featuring Ebang Pharmaceutical, Pfizer, Topfond & Beijing Jialin Pharmaceutical",http://www.reuters.com/article/research-and-markets-idUSnBw065563a+100+BSW20150806,
20150807 5:13AM UTC,"Research and Markets: Investigation Report on China's Celecoxib Market, 2010-2019 Featuring Pfizer & Shire",http://www.reuters.com/article/research-and-markets-idUSnBw065539a+100+BSW20150806,
20150807 2:47AM UTC,Britain raps Pfizer over inflated epilepsy drug prices,http://www.reuters.com/article/pfizer-britain-epilepsy-idUSL5N10H18V20150806,
20150807 2:14AM UTC,BRIEF-CMA issues statement of objections to Pfizer and Flynn Pharma in anti-epilepsy drug probe,http://www.reuters.com/article/idUSFWN10G02F20150806,
20150808 1:25PM UTC,"Pfizer, Bristol revive cancer drugs that rev up immune system",http://www.reuters.com/article/us-cancer-immunotherapy-insight-idUSKCN0QC0CZ20150807,
20150808 7:00AM UTC,"RPT - INSIGHT-Pfizer, Bristol revive cancer drugs that rev up immune system",http://www.reuters.com/article/cancer-immunotherapy-idUSL1N10H2PA20150807,
20150808 1:00AM UTC,"INSIGHT-Pfizer, Bristol revive cancer drugs that rev up immune system",http://www.reuters.com/article/cancer-immunotherapy-idUSL1N10G2AJ20150807,
20150811 8:00AM UTC,Gliknik Licensee Pfizer Receives Orphan Drug Designation From U.S. Food and Drug Administration for Drug Candidate Directed Towards Rare Neurological Disorder,http://www.reuters.com/article/gliknik-designation-idUSnPncdnnvJ+81+PRN20150810,
20150813 5:15PM UTC,Plaintiffs' attorneys to get $67 mln in Pfizer securities deal,http://www.reuters.com/article/health-pfizer-idUSL1N10N2VU20150812,
20150814 9:00AM UTC,HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.,http://www.reuters.com/article/ma-hifibio-sas-idUSnBw135673a+100+BSW20150813,
20150814 8:15AM UTC,Pfizer Receives Approval from the Australian Competition and Consumer Commission for Pending Acquisition of Hospira,http://www.reuters.com/article/pfizer-idUSnBw135604a+100+BSW20150813,
20150815 8:35AM UTC,Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition,http://www.reuters.com/article/pfizer-idUSnBw145277a+100+BSW20150814,
20150818 5:41PM UTC,"Research and Markets: Market Analysis of Global Pharmaceutical Industries and Trend Estimation Featuring Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline & Eli Lilly & Company",http://www.reuters.com/article/research-and-markets-idUSnBw176321a+100+BSW20150817,
20150819 2:05PM UTC,"Research and Markets: Global Fibromyalgia Drugs Market 2015-2019 with Actavis, Eli Lilly & Pfizer Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw186381a+100+BSW20150818,
20150821 11:23AM UTC,Pfizer Announces European Medicines Agency Validates Marketing Authorization Application for IBRANCEÂ® (palbociclib) in Combination with Endocrine Therapy for the Treatment of HR+/HER2- Metastatic Breast Cancer,http://www.reuters.com/article/pfizer-idUSnBw205829a+100+BSW20150820,
20150825 8:15AM UTC,Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015,http://www.reuters.com/article/pfizer-idUSnBw245495a+100+BSW20150824,
20150825 8:00AM UTC,Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition,http://www.reuters.com/article/pfizer-idUSnBw245472a+100+BSW20150824,
20150826 8:00AM UTC,Pfizerâ€™s Stephen Baker Joins Innovive Inc,http://www.reuters.com/article/ca-innovive-inc-idUSnBw255561a+100+BSW20150825,
20150827 6:12AM UTC,Alvogen to Acquire Product Portfolio from Pfizer for the U.S. Market,http://www.reuters.com/article/nj-alvogen-idUSnBw265470a+100+BSW20150826,
20150902 3:00PM UTC,"Rheumatologists Plan To Increase Their Use Of Pfizer's Xeljanz, Janssen's Simponi And Roche's Actemra In The Next Month",http://www.reuters.com/article/spherix-global-report-idUSnPn4gDHfc+8c+PRN20150901,
20150903 1:58PM UTC,"Research and Markets: Global TV Ad-spending Market 2015-2019 - Subscription-based Models a Key Trend with AmEx, Comcast, Ford, P&G;, Pfizer & Verizon Comms Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw026256a+100+BSW20150902,
20150904 5:17PM UTC,Pfizer Inc. Commences Exchange Offers for Hospira Notes,http://www.reuters.com/article/pfizer-idUSnBw036545a+100+BSW20150903,
20150904 9:00AM UTC,Pfizer Completes Acquisition of Hospira,http://www.reuters.com/article/pfizer-idUSnBw035752a+100+BSW20150903,
20150904 6:14AM UTC,Research and Markets: 2015 Investigation Report on China's Voriconazole (Pfizer) Market,http://www.reuters.com/article/research-and-markets-idUSnBw035606a+100+BSW20150903,
20150907 7:04PM UTC,Pfizer's quit-smoking drug not linked to depression or heart risks,http://www.reuters.com/article/us-health-smoking-pfizer-idUSKCN0R610420150906,
20150907 7:01PM UTC,Pfizer's quit-smoking drug not linked to depression or heart risks,http://www.reuters.com/article/health-smoking-pfizer-idUSL5N11A2HJ20150906,
20150908 5:58AM UTC,India rejects patent on Pfizer's arthritis drug ,http://www.reuters.com/article/pfizer-india-patent-idUSKCN0R70UD20150907,
20150908 4:59AM UTC,India rejects patent on Pfizer's arthritis drug,http://www.reuters.com/article/us-pfizer-india-patent-idUSKCN0R70UF20150907,
20150908 4:55AM UTC,India rejects patent on Pfizer's arthritis drug,http://www.reuters.com/article/pfizer-india-patent-idUSL4N11D0VI20150907,
20150910 8:00AM UTC,Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent Acute Coronary Syndrome or Undergoing Percutan,http://www.reuters.com/article/nj-bms-idUSnBw095520a+100+BSW20150909,
20150910 1:38AM UTC,Evotec Enters Into Licence and Collaboration Agreement With Pfizer Inc. in Tissue Fibrosis,http://www.reuters.com/article/idUSnGNX2jBfsN+1c9+GNW20150909,
20150910 1:33AM UTC,BRIEF-Evotec enters into licence and collaboration agreement with Pfizer,http://www.reuters.com/article/idUSFWN11E07I20150909,
20150911 10:56AM UTC,Pfizer loses UK patent case over use of Lyrica drug in pain,http://www.reuters.com/article/us-pfizer-britain-lyrica-idUSKCN0RA1G120150910,
20150911 10:00AM UTC,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,http://www.reuters.com/article/pfizer-idUSnBw105116a+100+BSW20150910,
20150911 8:49AM UTC,Pfizer loses UK patent case over use of Lyrica drug in pain,http://www.reuters.com/article/pfizer-britain-lyrica-idUSL1N11G0XC20150910,
20150911 8:42AM UTC,UPDATE 1-Pfizer loses UK patent case over use of Lyrica drug in pain,http://www.reuters.com/article/pfizer-britain-lyrica-idUSL5N11G2J720150910,
20150911 7:49AM UTC,Pfizer loses UK patent case over use of Lyrica drug in pain,http://www.reuters.com/article/pfizer-britain-lyrica-idUSL5N11G2FQ20150910,
20150912 4:00AM UTC,"Merck KGaA, Darmstadt, Germany and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015",http://www.reuters.com/article/pfizer-idUSnBw115109a+100+BSW20150911,
20150916 10:00AM UTC,Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts,http://www.reuters.com/article/pfizer-idUSnBw155250a+100+BSW20150915,
20150916 8:05AM UTC,Quarterly Earnings Analysis - Report on Pfizer,http://www.reuters.com/article/bc-aci-association-idUSnPn9HNSYf+9e+PRN20150915,
20150918 5:11AM UTC,"Research and Markets: Global Ischemic Heart Disease (IHD) Drugs Market 2015-2019 - Key Vendors are AstraZeneca, Bayer, Eli Lilly, Novartis, Pfizer & Sanofi",http://www.reuters.com/article/research-and-markets-idUSnBw175493a+100+BSW20150917,
20150919 8:00AM UTC,Pfizer Inc. Announces Results of Early Tenders and Consents in Exchange Offers,http://www.reuters.com/article/pfizer-idUSnBw185106a+100+BSW20150918,
20150919 6:58AM UTC,"Judge trims poultry-vaccine suit against Zoetis, Pfizer",http://www.reuters.com/article/health-poulvac-idUSL1N11O0EI20150918,
20150922 9:03AM UTC,"Equities Coverage on the Financial and Healthcare Sector - American International Group, Strategic Hotels & Resorts, Can-Fite Biopharma, Pfizer and Merck & Company",http://www.reuters.com/article/bc-aci-association-idUSnPn8vnKyG+85+PRN20150921,
20150922 8:00AM UTC,Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis,http://www.reuters.com/article/pfizer-idUSnBw215635a+100+BSW20150921,
20150923 11:35AM UTC,"XRpro Sciences Completes Name Change to Icagen, Inc. Following Acquisition of Pfizer Ion Channel Platform Assets",http://www.reuters.com/article/icagen-inc-xrpro-idUSnPnb20013+80+PRN20150922,
20150925 5:00PM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab",http://www.reuters.com/article/pfizer-idUSnBw246481a+100+BSW20150924,
20150925 5:00PM UTC,"Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab",http://www.reuters.com/article/pfizer-idUSnBw246460a+100+BSW20150924,
20150925 10:00AM UTC,Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference,http://www.reuters.com/article/pfizer-idUSnBw245131a+100+BSW20150924,
20150925 7:30AM UTC,BIND Therapeutics Announces Pfizer Inc. Exercises Option to Advance Nanoparticle-Based Kinase Inhibitor for Treatment of Solid Tumors,http://www.reuters.com/article/ma-bind-therapeutics-idUSnBw245171a+100+BSW20150924,
20150925 12:01AM UTC,Pfizerâ€™s SayanaÂ® Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection,http://www.reuters.com/article/pfizer-idUSnBw236227a+100+BSW20150924,
20150926 10:10AM UTC,Pfizer Declares 28-Cent Fourth-Quarter 2015 Dividend,http://www.reuters.com/article/pfizer-idUSnBw255458a+100+BSW20150925,
20150926 7:00AM UTC,Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma,http://www.reuters.com/article/pfizer-idUSnBw255228a+100+BSW20150925,
20150926 7:00AM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma",http://www.reuters.com/article/pfizer-idUSnBw255223a+100+BSW20150925,
20151001 5:00PM UTC,Pfizer Partners with Breast Cancer Leaders to Chronicle the Lives of Women with Metastatic Breast Cancer through the Lenses of Prominent Photographers,http://www.reuters.com/article/pfizer-idUSnBw306710a+100+BSW20150930,
20151001 9:05AM UTC,Pfizer lifts FY adjusted profit forecast on Hospira buy,http://www.reuters.com/article/us-pfizer-outlook-idUSKCN0RU1L820150930,
20151001 9:02AM UTC,Pfizer lifts FY adjusted profit forecast on Hospira buy,http://www.reuters.com/article/pfizer-outlook-idUSL3N1204OW20150930,
20151001 8:30AM UTC,"Pfizer Updates 2015 Financial Guidance Solely to Include Hospira Operations In Financial Results From September 3, 2015 Through Year-End 2015",http://www.reuters.com/article/pfizer-idUSnBw305921a+100+BSW20150930,
20151001 7:00AM UTC,"Accelovance Continues Oncology Leadership Growth with Addition of Former Global VP, Oncology from Wyeth/Pfizer and Bayer",http://www.reuters.com/article/accelovance-vp-elect-idUSnPn9DjfR9+92+PRN20150930,
20151002 9:20AM UTC,Corrected-Merck KGaA says avelumab alliance with Pfizer on track,http://www.reuters.com/article/idUSL5N1212WZ20151001,
20151002 8:00AM UTC,Pfizer Completes Acquisition Of Nimenrix And Mencevax From GlaxoSmithKline,http://www.reuters.com/article/pfizer-idUSnBw015799a+100+BSW20151001,
20151002 5:12AM UTC,BRIEF-Merck KGaA says avelumab alliance with Pfizer on track,http://www.reuters.com/article/idUSFWN12007I20151001,
20151003 8:30AM UTC,Pfizer Inc. Announces Final Results of Exchange Offers,http://www.reuters.com/article/pfizer-idUSnBw025334a+100+BSW20151002,
20151008 7:00AM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma",http://www.reuters.com/article/pfizer-idUSnBw075668a+100+BSW20151007,
20151010 1:45PM UTC,"Pfizerâ€™s Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBAÂ® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap",http://www.reuters.com/article/pfizer-idUSnBw095680a+100+BSW20151009,
20151014 7:30AM UTC,Protalix BioTherapeutics Sells Its Share in Collaboration Agreement for ELELYSO and a 6% Equity Stake in Protalix to Pfizer for a Total of $46 Million,http://www.reuters.com/article/idUSnGNX57hQB3+1c6+GNW20151013,
20151016 8:55AM UTC,"Research and Markets: Global Hemophilia B Market 2015-2019 - New Industry Analysis Featuring Baxter, Grifols, Novo Nordisk & Pfizer",http://www.reuters.com/article/research-and-markets-idUSnBw155910a+100+BSW20151015,
20151017 8:30AM UTC,"Pfizer's first to market CDK4/6 inhibitor Ibrance (palbociclib) is prescribed by 70% of surveyed U.S. oncologists just six months after its launch for hormone receptor-positive, HER2-negative, metastatic breast cancer",http://www.reuters.com/article/drg-ibrance-us-survey-idUSnPnb55bGR+83+PRN20151016,
20151020 7:00AM UTC,Pfizerâ€™s Inotuzumab Ozogamicin Receives FDA Breakthrough Therapy Designation for Acute Lymphoblastic Leukemia (ALL),http://www.reuters.com/article/pfizer-idUSnBw195596a+100+BSW20151019,
20151021 5:31AM UTC,"Research and Markets: Asia Oncology Drug Market Outlook to 2019 - Driven by Rising Demand and Intensifying Joint Ventures Between Companies With Roche, Novartis, Pfizer Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw205746a+100+BSW20151020,
20151024 5:29AM UTC,"Research and Markets: European Epilepsy Drugs Market Analysis 2015-2019 With Eisai, GlaxoSmithKline, Pfizer & UCB Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw235227a+100+BSW20151023,
20151024 4:32AM UTC,"Research and Markets: Global Female Contraceptives Market 2015-2019 with Allergan, Merck, Pfizer & Teva Pharmaceutical Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw235209a+100+BSW20151023,
20151028 12:01PM UTC,BRIEF-Pfizer says to begin human trials this year of oral form of pcsk9 inhibitor to treat cholesterol,http://www.reuters.com/article/idUSL1N12R1H520151027,
20151028 10:00AM UTC,HiFiBiOâ€™s Next Generation Antibody Discovery Platform to Be Presented by Pfizer Inc. at PEGS Europe 2015,http://www.reuters.com/article/hifibio-idUSnBw275528a+100+BSW20151027,
20151028 7:21AM UTC,UPDATE 1-Pfizer profit beats as vaccine sales rise,http://www.reuters.com/article/pfizer-results-idUSL3N12R3T720151027,
20151028 6:52AM UTC,Pfizer revenue falls about 2 pct on strong dollar,http://www.reuters.com/article/pfizer-results-idUSL3N12Q4V820151027,
20151029 8:46PM UTC,"Pfizer, Allergan considering a combination - CNBC citing Dow Jones",http://www.reuters.com/article/allergan-ma-pfizer-idUSL1N12T02220151029,
20151030 7:09PM UTC,"Pfizer, Allergan drug merger talks raise tax hackles in U.S.",http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0SN01P20151029,
20151030 7:08PM UTC,Pfizer-Allergan sparks fresh tax inversion angst on Capitol Hill,http://www.reuters.com/article/us-allergan-m-a-congress-idUSKCN0SN31S20151029,
20151030 7:06PM UTC,Pfizer-Allergan sparks fresh tax inversion angst on Capitol Hill,http://www.reuters.com/article/allergan-ma-congress-idUSL1N12T48N20151029,
20151030 6:02PM UTC,"UPDATE 5-Pfizer, Allergan drug merger talks raise tax hackles in U.S.",http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N12T51K20151029,
20151030 5:32PM UTC,Pfizer may overdose on quick and complex deals,http://www.reuters.com/article/idUS343186831120151029,
20151030 10:09AM UTC,Pfizer Announcement Regarding Allergan plc,http://www.reuters.com/article/pfizer-idUSnBw295955a+100+BSW20151029,
20151030 9:30AM UTC,Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.,http://www.reuters.com/article/allergan-pfizer-talks-idUSnPn3PZbRV+9b+PRN20151029,
20151030 8:50AM UTC,BRIEF-Pfizer CEO Ian Read declines to comment on Allergan reports,http://www.reuters.com/article/idUSL1N12T1KX20151029,
20151030 8:30AM UTC,Halozyme Announces First Clinical Dosing Of Pfizer's Rivipansel Using Enhanzeâ„¢ Technology,http://www.reuters.com/article/ca-halo-rivipansel-idUSnPn19JRwD+8d+PRN20151029,
20151030 8:00AM UTC,"Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units",http://www.reuters.com/article/ny-pfizer-idUSnBw295733a+100+BSW20151029,
20151030 7:39AM UTC,"Pfizer needs a big deal, analysts say; Allergan 'makes sense'",http://www.reuters.com/article/us-allergan-m-a-pfizer-analysts-idUSKCN0SN1ET20151029,
20151030 7:34AM UTC,"Pfizer needs a big deal, analysts say; Allergan makes sense""""",http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N12T3Z320151029,
20151030 7:25AM UTC,UPDATE 6-Pfizer said to be in talks with Allergan to forge $330 bln drugs giant,http://www.reuters.com/article/allergan-ma-pfizer-idUSL1N12T02720151029,
20151030 10:38AM UTC,Pfizer in talks with Allergan,http://www.reuters.com/news/video/videoStory?storyID=113115918,
20151031 10:27PM UTC,Pfizer Inc. Announcement under Rule 2.10 of the Irish Takeover Rules â€“ Relevant Securities in Issue,http://www.reuters.com/article/pfizer-idUSnBw306112a+100+BSW20151031,
20151031 11:28AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw305693a+100+BSW20151030,
20151031 9:06AM UTC,Fitch: Pfizer/Allergan Merger Atypical of US Branded Pharma M&A;,http://www.reuters.com/article/ny-fitch-ratings-pfizer-idUSnBw305441a+100+BSW20151030,
20151031 7:55AM UTC,RPT-Pfizer-Allergan sparks fresh tax inversion angst on Capitol Hill,http://www.reuters.com/article/allergan-ma-congress-idUSL1N12U0RV20151030,
20151031 4:39AM UTC,"Pfizer, Allergan drug merger talks raise tax hackles in U.S.",http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0SN01P20151030,
20151103 5:04PM UTC,Factbox: Pfizer-Allergan puts focus on U.S. tax inversion rules,http://www.reuters.com/article/us-pfizer-inversion-fact-idUSKCN0SR2EU20151102,
20151103 12:48PM UTC,"Exclusive: Guggenheim, JPMorgan clinch key roles in Pfizer-Allergan talks",http://www.reuters.com/article/us-allergan-m-a-banks-idUSKCN0SR1YN20151102,
20151103 10:24AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw026214a+100+BSW20151102,
20151103 10:11AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUGbwVtVd+1ca+ONE20151102,
20151104 9:53AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG7n0GSN+1c7+ONE20151103,
20151104 9:32AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw036202a+100+BSW20151103,
20151104 7:39AM UTC,GSK boss silent on report drugmaker rebuffed Pfizer,http://www.reuters.com/article/us-gsk-m-a-pfizer-idUSKCN0SS1F920151103,
20151104 7:37AM UTC,GSK boss silent on report drugmaker rebuffed Pfizer,http://www.reuters.com/article/gsk-ma-pfizer-idUSL8N12Y2SE20151103,
20151104 3:58AM UTC,Pfizer partners with South Africa to produce pneumococcal vaccine,http://www.reuters.com/article/us-safrica-pfizer-idUSKCN0SS0JC20151103,
20151104 3:56AM UTC,UPDATE 1-Pfizer partners with South Africa to produce pneumococcal vaccine,http://www.reuters.com/article/safrica-pfizer-idUSL8N12Y1GF20151103,
20151104 2:31AM UTC,Pfizer partners with South Africa to produce pneumococcal vaccine,http://www.reuters.com/article/safrica-pfizer-idUSL8N12Y11E20151103,
20151105 10:07AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw046122a+100+BSW20151104,
20151105 9:36AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG4t8Jx2+1c4+ONE20151104,
20151105 8:42AM UTC,"Merck KGaA, Pfizer widen development of cancer immunology drug",http://www.reuters.com/article/us-merck-kgaa-pfizer-immunotherapy-idUSKCN0ST1TW20151104,
20151105 8:31AM UTC,"Merck KGaA, Pfizer widen development of cancer immunology drug",http://www.reuters.com/article/merck-kgaa-pfizer-immunotherapy-idUSFWN12Z05020151104,
20151105 8:00AM UTC,Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer,http://www.reuters.com/article/pfizer-idUSnBw045146a+100+BSW20151104,
20151105 8:00AM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer",http://www.reuters.com/article/pfizer-idUSnBw045123a+100+BSW20151104,
20151106 10:03AM UTC,REG-Form 8.3 - Pfizer Inc - Corrected holdings,http://www.reuters.com/article/idUSnHUG40j0TZ+1c3+ONE20151105,
20151106 9:53AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw056014a+100+BSW20151105,
20151106 9:45AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG3Nsw7t+1d0+ONE20151105,
20151106 8:00AM UTC,"Pfizer Expands its Patient Assistance Program, Doubling the Income Eligibility Limit to Benefit Even More Patients Taking Pfizer MedicinesÂ ",http://www.reuters.com/article/pfizer-idUSnBw055581a+100+BSW20151105,
20151107 4:15PM UTC,Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scientific Sessions 2015,http://www.reuters.com/article/pfizer-idUSnBw065652a+100+BSW20151106,
20151107 10:15AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw065569a+100+BSW20151106,
20151107 8:32AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG2ZMZ45+1dc+ONE20151106,
20151107 7:00AM UTC,RPT-Pfizer-Allergan deal would set up US company for a split,http://www.reuters.com/article/allergan-ma-pfizer-portfolio-idUSL1N13102P20151106,
20151107 7:00AM UTC,"RPT-After big spending and hard lobbying, Pfizer eyes new tax home",http://www.reuters.com/article/allergan-ma-pfizer-lobbying-idUSL1N13101720151106,
20151107 1:45AM UTC,Pfizer-Allergan deal would set up U.S. company for a split,http://www.reuters.com/article/us-allergan-m-a-pfizer-portfolio-idUSKCN0SV0JE20151106,
20151107 1:45AM UTC,"After big spending and hard lobbying, Pfizer eyes new tax home",http://www.reuters.com/article/us-allergan-m-a-pfizer-lobbying-idUSKCN0SV0IZ20151106,
20151107 1:00AM UTC,"After big spending and hard lobbying, Pfizer eyes new tax home",http://www.reuters.com/article/allergan-ma-pfizer-lobbying-idUSL1N12Z34E20151106,
20151107 1:00AM UTC,Pfizer-Allergan deal would set up US company for a split,http://www.reuters.com/article/allergan-ma-pfizer-portfolio-idUSL1N12Z24V20151106,
20151110 8:40AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUGbcRGzP+1cd+ONE20151109,
20151111 9:45AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG37xsdS+1c1+ONE20151110,
20151111 9:12AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw106079a+100+BSW20151110,
20151112 9:21AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG6YYLJY+1df+ONE20151111,
20151113 10:28AM UTC,"Research and Markets: Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 with AstraZeneca, Celgene, Eli Lilly, F. Hoffmann-La Roche & Pfizer Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw125939a+100+BSW20151112,
20151113 9:45AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG61QnzT+1c9+ONE20151112,
20151114 5:15PM UTC,Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules  ,http://www.reuters.com/article/us-usa-tax-inversions-idUSKCN0T22IE20151113,
20151114 4:42PM UTC,Pfizer-Allergan deal refocuses market on US tax-inversion rules,http://www.reuters.com/article/usa-tax-inversions-idUSL1N1373DN20151113,
20151114 9:59AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw135484a+100+BSW20151113,
20151114 9:54AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG2kCdZb+1ca+ONE20151113,
20151117 3:51PM UTC,Exclusive: Moelis clinches Pfizer advisory role with help from Eric Cantor - sources,http://www.reuters.com/article/us-pfizer-moelis-idUSKCN0T528320151116,
20151117 12:34PM UTC,How Pfizer has shifted U.S. profits overseas for years,http://www.reuters.com/article/us-pfizer-tax-insight-idUSKCN0T51ZS20151116,
20151117 11:40AM UTC,INSIGHT-How Pfizer has shifted U.S. profits overseas for years,http://www.reuters.com/article/pfizer-tax-idUSL8N1381SF20151116,
20151117 10:02AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw165959a+100+BSW20151116,
20151117 8:55AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG1g1wJ1+1c2+ONE20151116,
20151118 9:56AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw176240a+100+BSW20151117,
20151118 9:11AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG9h5Ysf+1c4+ONE20151117,
20151118 2:00AM UTC,RPT-INSIGHT-How Pfizer has shifted U.S. profits overseas for years,http://www.reuters.com/article/pfizer-tax-idUSL8N13B49U20151117,
20151119 11:45PM UTC,Pfizer discussing Allergan offer at $370-$380 per share: source,http://www.reuters.com/article/us-pfizer-m-a-allergan-idUSKCN0T801R20151119,
20151119 8:39PM UTC,UPDATE 3-Pfizer-Allergan talks accelerate amid new inversion clamp-down,http://www.reuters.com/article/usa-tax-inversions-idUSL1N13D2XA20151119,
20151119 7:34PM UTC,Pfizer discussing Allergan offer at $370-$380 per share-source,http://www.reuters.com/article/pfizer-ma-allergan-idUSL1N13E01020151119,
20151119 9:31AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG5499MQ+1c3+ONE20151118,
20151119 9:14AM UTC,REG-Wellington Management Form 8.3 - Pfizer Inc.,http://www.reuters.com/article/wellington-management-idUSnBw185965a+100+BSW20151118,
20151119 8:00AM UTC,Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORIÂ® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC),http://www.reuters.com/article/pfizer-idUSnBw185758a+100+BSW20151118,
20151119 7:08AM UTC,BRIEF-Merck KGAA and Pfizer receive FDA breakthrough status for Avelumab,http://www.reuters.com/article/idUSFWN13D02720151118,
20151119 7:00AM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma",http://www.reuters.com/article/pfizer-idUSnBw185702a+100+BSW20151118,
20151121 2:24PM UTC,"Exclusive: Pfizer, Allergan CEOs agree on combined company roles - sources",http://www.reuters.com/article/us-allergan-m-a-pfizer-ceo-idUSKCN0T92M120151120,
20151121 9:27AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUGFJcRD+fb+ONE20151120,
20151121 4:56AM UTC,U.S. funds optimistic about Allergan piled in before Pfizer bid,http://www.reuters.com/article/us-allergan-pfizer-investors-idUSKCN0T82RV20151120,
20151121 4:56AM UTC,Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources,http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0T827P20151120,
20151123 10:24PM UTC,UPDATE 4-Pfizer set to buy Allergan for more than $150 bln-sources,http://www.reuters.com/article/allergan-ma-pfizer-idUSL1N13H0K520151123,
20151123 9:51PM UTC,Pfizer-Allergan to throw down tax-reform gauntlet,http://www.reuters.com/article/idUS102183597220151123,
20151123 6:55PM UTC,Pfizer set to buy Allergan for more than $150 billion,http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKBN0TB0UT20151122,
20151123 6:54PM UTC,UPDATE 3-Pfizer set to buy Allergan for more than $150 bln-sources,http://www.reuters.com/article/allergan-ma-pfizer-idUSL1N13H0K520151122,
20151123 2:00PM UTC,Pfizer and Allergan to approve merger agreement on Sunday-sources,http://www.reuters.com/article/allergan-ma-pfizer-idUSL1N13H0JN20151122,
20151124 8:45PM UTC,UPDATE 3-U.S. politicians slam tax-avoiding Pfizer-Allergan deal,http://www.reuters.com/article/allergan-ma-pfizer-whitehouse-idUSL1N13I1QM20151124,
20151124 7:17PM UTC,Wall Street falls after strong week; Pfizer and Allergan drag,http://www.reuters.com/article/us-markets-stocks-idUSKBN0TC15Q20151124,
20151124 6:53PM UTC,Pfizer to buy Allergan in $160 billion deal,http://www.reuters.com/article/allergan-ma-pfizer-idUSL1N13I2OI20151123,
20151124 6:49PM UTC,Pfizer to buy Allergan in $160 billion deal,http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKBN0TB0UT20151123,
20151124 6:49PM UTC,Pfizer to buy Allergan in $160 billion deal,http://www.reuters.com/article/allergan-m-a-pfizer-idUSKBN0TC05F20151123,
20151124 6:46PM UTC,UPDATE 5-Pfizer to buy Allergan in $160 billion deal,http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N13I2Z320151123,
20151124 6:18PM UTC,Politicians slam tax-avoiding Pfizer-Allergan mega-deal,http://www.reuters.com/article/us-allergan-m-a-pfizer-whitehouse-idUSKBN0TC24820151123,
20151124 6:17PM UTC,Republican Trump calls Pfizer deal to move tax base overseas 'disgusting',http://www.reuters.com/article/us-allergan-m-a-pfizer-trump-idUSKBN0TC2KC20151123,
20151124 6:02PM UTC,U.S. Republican Trump calls Pfizer deal to move tax base overseas 'disgusting',http://www.reuters.com/article/allergan-ma-pfizer-trump-idUSL1N13I2KI20151123,
20151124 5:42PM UTC,Fitch Places Pfizer's L-T Ratings on Negative Watch Following Allergan Merger Announcement,http://www.reuters.com/article/ny-fitch-ratings-pfizer-idUSnBw236338a+100+BSW20151123,
20151124 5:31PM UTC,UPDATE 2-Politicians slam tax-avoiding Pfizer-Allergan mega-deal,http://www.reuters.com/article/allergan-ma-pfizer-whitehouse-idUSL1N13I1QM20151123,
20151124 5:22PM UTC,Fitch Places Allergan's Ratings on Positive Watch Following Pfizer Merger Announcement,http://www.reuters.com/article/ny-fitch-ratings-allerga-idUSnBw236325a+100+BSW20151123,
20151124 4:45PM UTC,Wall Street falls after strong week; Pfizer and Allergan drag,http://www.reuters.com/article/us-markets-stocks-idUSKBN0TC15Q20151123,
20151124 4:42PM UTC,US STOCKS-Wall St falls after strong week; Pfizer and Allergan drag,http://www.reuters.com/article/usa-stocks-idUSL1N13I2C420151123,
20151124 3:41PM UTC,"US STOCKS-Wall Street falls after strong week, Pfizer and Allergan drag",http://www.reuters.com/article/usa-stocks-idUSL1N13I1Z320151123,
20151124 2:49PM UTC,Pfizer-Allergan to take healthcare M&A; deals to above $600 billion in 2015,http://www.reuters.com/article/us-allergan-m-a-deals-idUSKBN0TC0JP20151123,
20151124 2:42PM UTC,UPDATE 1-Pfizer-Allergan to take healthcare M&A; deals to above $600 bln in 2015,http://www.reuters.com/article/allergan-ma-deals-idUSL8N13I4GH20151123,
20151124 2:04PM UTC,"Clinton bashes Pfizer-Allergan deal, to propose anti-inversion steps",http://www.reuters.com/article/allergan-m-a-pfizer-clinton-idUSKBN0TC24K20151123,
20151124 1:58PM UTC,"TIMELINE-Saunders gets key job as Pfizer, Allergan combine",http://www.reuters.com/article/allergan-ma-pfizer-saunders-idUSL3N13I3OW20151123,
20151124 1:20PM UTC,"Clinton bashes Pfizer-Allergan deal, to propose anti-inversion steps",http://www.reuters.com/article/us-allergan-m-a-pfizer-clinton-idUSKBN0TC20Q20151123,
20151124 1:18PM UTC,"Clinton bashes Pfizer-Allergan deal, to propose anti-inversion steps",http://www.reuters.com/article/allergan-ma-pfizer-clinton-idUSL1N13I1LD20151123,
20151124 12:10PM UTC,Pfizer/Allergan mega-merger pushes M&A; levels to all-time high,http://www.reuters.com/article/ma-record-data-idUSL1N13I1GA20151123,
20151124 12:05PM UTC,Pfizer/Allergan mega-merger pushes M&A; levels to all-time high,http://www.reuters.com/article/us-m-a-record-data-idUSKBN0TC1V420151123,
20151124 12:03PM UTC,Pfizer/Allergan mega-merger pushes M&A; levels to all-time high,http://www.reuters.com/article/ma-record-data-idUSL8N13I3WL20151123,
20151124 11:59AM UTC,Democratic candidate Sanders condemns Pfizer-Allergan deal as 'disaster',http://www.reuters.com/article/us-allergan-m-a-pfizer-sanders-idUSKBN0TC1UO20151123,
20151124 11:56AM UTC,Democratic candidate Sanders condemns Pfizer-Allergan deal as 'disaster',http://www.reuters.com/article/allergan-ma-pfizer-sanders-idUSL1N13I1E620151123,
20151124 10:38AM UTC,Pfizer barely washes face in $160 bln Allergan deal,http://www.reuters.com/article/idUS19665678420151123,
20151124 10:00AM UTC,REG-Form 8.3 - Pfizer Inc,http://www.reuters.com/article/idUSnHUG5HT2X8+1da+ONE20151123,
20151124 9:50AM UTC,Pfizer-Allergan to throw down tax-reform gauntlet,http://www.reuters.com/article/idUS288270627320151123,
20151124 9:49AM UTC,"BRIEF-Pfizer ceo says deal would give company unemcumbered access to the full value of (pfizer) balance sheet""""",http://www.reuters.com/article/idUSL1N13I0WQ20151123,
20151124 9:43AM UTC,Pfizer barely washes face in $160 bln Allergan deal,http://www.reuters.com/article/idUS343047132520151123,
20151124 7:28AM UTC,BRIEF-Pfizer shares fall 1.8 percent to $31.60 in premarket trading,http://www.reuters.com/article/idUSL1N13I0MV20151123,
20151124 7:11AM UTC,Pfizer to buy Allergan in $160 bln deal to create No. 1 drugmaker,http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N13I2L020151123,
20151124 7:03AM UTC,Pfizer and Allergan to Combine,http://www.reuters.com/article/pfizer-idUSnBw235580a+100+BSW20151123,
20151124 3:22AM UTC,Pfizer-Allergan to take healthcare M&A; deals to above $600 bln in 2015,http://www.reuters.com/article/allergan-ma-deals-idUSL8N13I03520151123,
20151124 12:26PM UTC,Breakingviews: Pfizer-Allergan's D.C. snub,http://www.reuters.com/news/video/videoStory?storyID=113749532,
20151124 10:44AM UTC,Taxes fuel Pfizer-Allergan merger,http://www.reuters.com/news/video/videoStory?storyID=113746904,
20151124 8:11AM UTC,Pfizer to buy Allergan in $160 bln deal,http://www.reuters.com/news/video/videoStory?storyID=113743308,
20151125 3:51PM UTC,"Saunders gets key job as Pfizer, Allergan combine (Nov. 23)",http://www.reuters.com/article/us-allergan-m-a-pfizer-saunders-idUSKBN0TC24020151124,
20151125 3:51PM UTC,Pfizer to buy Allergan in $160 billion deal,http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKBN0TB0UT20151124,
20151125 3:14PM UTC,Morgan Lewis Serves as Lead U.S. Antitrust Counsel to Pfizer in Blockbuster Combination with Allergan,http://www.reuters.com/article/idUSnGNX4fH6ZL+1cb+GNW20151124,
20151125 1:10PM UTC,"CORRECTED-TIMELINE-Saunders gets key job as Pfizer, Allergan combine (Nov. 23)",http://www.reuters.com/article/allergan-ma-pfizer-saunders-idUSL3N13I3OW20151124,
20151125 11:57AM UTC,Delay in Pfizer split is material adverse event,http://www.reuters.com/article/idUS281714936120151124,
20151125 10:17AM UTC,Pfizer-Allergan gets no support from scaredy arbs,http://www.reuters.com/article/idUS361553849420151124,
20151125 5:16AM UTC,Politicians slam tax-avoiding Pfizer-Allergan deal,http://www.reuters.com/article/us-allergan-m-a-pfizer-whitehouse-idUSKBN0TC24820151124,
20151125 12:25PM UTC,Breakingviews: Pfizer's sluggish dismemberment,http://www.reuters.com/news/video/videoStory?storyID=113779421,
20151126 12:43PM UTC,Pfizerâ€™s war chest stealthily rebuilt by Allergan,http://www.reuters.com/article/idUS25296548920151125,
20151126 8:34AM UTC,Pfizer's Lyrica shows no relief from post-traumatic nerve pain,http://www.reuters.com/article/us-pfizer-study-idUSKBN0TE1MN20151125,
20151126 8:29AM UTC,Pfizer's Lyrica shows no relief from post-traumatic nerve pain,http://www.reuters.com/article/pfizer-study-idUSL3N13K3X820151125,
20151126 8:00AM UTC,Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICAÂ® (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain,http://www.reuters.com/article/pfizer-idUSnBw255311a+100+BSW20151125,
20151126 4:00AM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products",http://www.reuters.com/article/pfizer-idUSnBw255077a+100+BSW20151125,
20151126 2:00AM UTC,Pfizer Receives European Approval to Expand Use of XALKORIÂ® (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer,http://www.reuters.com/article/pfizer-idUSnBw246345a+100+BSW20151125,
20151127 5:46PM UTC,Two-decade Pfizer mission pays off for Guggenheim's deal king,http://www.reuters.com/article/us-pfizer-guggenheim-idUSKBN0TF2AY20151126,
20151127 1:57PM UTC,Two-decade Pfizer mission pays off for Guggenheim's deal king,http://www.reuters.com/article/pfizer-guggenheim-idUSL8N13L2CM20151126,
20151128 2:00AM UTC,RPT-Two-decade Pfizer mission pays off for Guggenheim's deal king,http://www.reuters.com/article/pfizer-guggenheim-idUSL8N13L4FC20151127,
20151201 5:11AM UTC,Sosei Subsidiary Heptares Enters Strategic Drug Discovery Collaboration with Pfizer Inc. Focused on GPCR Targets Across Multiple Therapeutic Areas<4565.T>,http://www.reuters.com/article/sosei-group-corporation-idUSnBw305429a+100+BSW20151130,
20151202 10:00AM UTC,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,http://www.reuters.com/article/pfizer-idUSnBw015218a+100+BSW20151201,
20151202 9:13AM UTC,Kalorama: Allergan Merger Brings Pfizer Back into Dermatology,http://www.reuters.com/article/kalorama-mergerreport-idUSnPn7k3k40+80+PRN20151201,
20151204 5:30PM UTC,Cellectis Announces Conference Call to Discuss UCART19 Development Collaboration with Pfizer and Servier,http://www.reuters.com/article/cellectis-idUSnBw036352a+100+BSW20151203,
20151204 3:57PM UTC,Pfizer blocks key plaintiffs' expert in Zoloft MDL,http://www.reuters.com/article/products-zoloft-expert-idUSL1N13S2VY20151203,
20151209 11:01AM UTC,Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORIÂ® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer,http://www.reuters.com/article/pfizer-idUSnBw086222a+100+BSW20151208,
20151209 8:00AM UTC,Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015,http://www.reuters.com/article/pfizer-idUSnBw085838a+100+BSW20151208,
20151210 4:01PM UTC,Spark Therapeutics Announces $15 Million Milestone Payment From Pfizer for Progress in Hemophilia B Gene Therapy Program,http://www.reuters.com/article/idUSnGNXb52XwB+1c5+GNW20151209,
20151210 11:00AM UTC,"Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers",http://www.reuters.com/article/pfizer-idUSnBw095944a+100+BSW20151209,
20151211 8:00AM UTC,"Pfizer Announces FDA Acceptance of IBRANCEÂ® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer",http://www.reuters.com/article/pfizer-idUSnBw105592a+100+BSW20151210,
20151212 11:59AM UTC,CORRECTING and REPLACING Alliance for Clinical Trials in Oncology and Pfizer Receive the CEO Roundtable on Cancerâ€™s Dr. Charles A. Sanders Life Sciences Awards,http://www.reuters.com/article/cqn-nc-ceo-roundtable-idUSnBw115395a+100+BSW20151211,
20151215 4:30PM UTC,Pfizer Declares First-Quarter 2016 Dividend,http://www.reuters.com/article/pfizer-idUSnBw146311a+100+BSW20151214,
20151215 4:16PM UTC,Pfizer suit over Advil marketing gets green light,http://www.reuters.com/article/health-pfizer-idUSL1N14323C20151214,
20151215 10:30AM UTC,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,http://www.reuters.com/article/pfizer-idUSnBw145793a+100+BSW20151214,
20151219 4:00AM UTC,"Research and Markets: Supplement Market in the Us 2016-2020 - with Amway, GNC, Herbalife, NBTY, Otsuka and Pfizer Dominating the Market",http://www.reuters.com/article/research-and-markets-idUSnBw185167a+100+BSW20151218,
20151223 8:06PM UTC,Pfizer defeats NYU claim for cancer drug royalties,http://www.reuters.com/article/pfizer-nyu-idUSL1N14C02120151223,
20160109 10:33PM UTC,Pfizer hikes U.S. prices for over 100 drugs on January 1,http://www.reuters.com/article/us-pfizer-prices-idUSKBN0UM2FU20160109,
20160109 10:32PM UTC,UPDATE 1-Pfizer hikes U.S. prices for over 100 drugs on January 1,http://www.reuters.com/article/pfizer-prices-idUSL1N14T03X20160109,
20160109 5:02PM UTC,Pfizer hikes U.S. prices for over 100 drugs on January 1,http://www.reuters.com/article/us-pfizer-prices-idUSKBN0UM2FU20160108,
20160109 5:00PM UTC,Pfizer hikes U.S. prices for over 100 drugs on January 1,http://www.reuters.com/article/pfizer-prices-idUSL1N14S1OD20160108,
20160113 6:58PM UTC,"Pfizer, Allergan say combined drug pipeline 'underappreciated'",http://www.reuters.com/article/us-usa-healthcare-allergan-pfizer-idUSKCN0UQ2SM20160112,
20160113 6:56PM UTC,"Pfizer, Allergan say combined drug pipeline 'underappreciated'",http://www.reuters.com/article/usa-healthcare-allergan-pfizer-idUSL2N14W2PI20160112,
20160113 2:13PM UTC,BRIEF-Allergan research chief says Pfizer immuno-oncology pipeline underappreciated,http://www.reuters.com/article/idUSL2N14W1VR20160112,
20160114 10:24PM UTC,Pfizer weighing sale of Hospira's pump business: Bloomberg,http://www.reuters.com/article/us-hospira-m-a-pfizer-idUSKCN0US09J20160114,
20160114 10:20PM UTC,Pfizer weighing sale of Hospira's pump business -Bloomberg,http://www.reuters.com/article/hospira-ma-pfizer-idUSL3N14Y08720160114,
20160114 5:59PM UTC,Court upholds patents on Pfizer cancer drug Sutent,http://www.reuters.com/article/health-cancer-idUSL2N14X2V420160113,
20160114 5:46PM UTC,Pfizer says its CAR T cancer therapy could outshine rivals,http://www.reuters.com/article/us-pfizer-cancer-idUSKCN0UR2Z320160113,
20160114 5:44PM UTC,Pfizer says its CAR T cancer therapy could outshine rivals,http://www.reuters.com/article/pfizer-cancer-idUSL2N14X2WQ20160113,
20160123 6:30PM UTC,Pfizer loses cancer drug patent term fight at Federal Circuit,http://www.reuters.com/article/ip-pfizer-patent-idUSL2N1562HU,
20160129 4:23PM UTC,BRIEF-Pfizer says its biosimilar wins Norwegian infliximab biosimilar tender,http://www.reuters.com/article/idUSL8N15C5QK,
20160203 1:50PM UTC,Pfizer 2016 forecast disappoints,http://www.reuters.com/article/us-pfizer-results-idUSKCN0VB18C,
20160203 1:48PM UTC,UPDATE 4-Pfizer 2016 forecast disappoints,http://www.reuters.com/article/pfizer-results-idUSL3N15H3YY,
20160203 11:40AM UTC,BRIEF-Pfizer says see no legal roadblocks to Allergan merger,http://www.reuters.com/article/idUSL2N15H1HK,
20160203 6:52AM UTC,Pfizer revenue rises as pneumonia vaccine sales jump,http://www.reuters.com/article/pfizer-results-idUSL3N15H3YB,
20160204 8:54AM UTC,"Pfizer, J&J;, Merck evaluating technologies for Zika vaccine",http://www.reuters.com/article/us-health-zika-big-pharma-idUSKCN0VC1EB,
20160204 7:27AM UTC,"Pfizer, J&J;, Merck evaluating technologies for Zika vaccine",http://www.reuters.com/article/health-zika-big-pharma-idUSL3N15I45M,
20160213 1:05AM UTC,BRIEF-Novartis says Sandoz buys Pfizer's biosimilar infliximab in EEA,http://www.reuters.com/article/idUSFWN15Q05D,
20160217 8:06AM UTC,Pfizer unit to pay $784.6 mln in Medicaid rebate settlement,http://www.reuters.com/article/us-pfizer-settlement-idUSKCN0VP1G5,
20160217 8:01AM UTC,Pfizer unit to pay $784.6 mln in Medicaid rebate settlement,http://www.reuters.com/article/pfizer-settlement-idUSL2N15V0KT,
20160217 7:47AM UTC,UPDATE 1-Pfizer unit to pay $784.6 mln in Medicaid rebate settlement,http://www.reuters.com/article/pfizer-settlement-idUSL3N15V44H,
20160217 7:11AM UTC,CORRECTED-Pfizer unit to pay $784.6 mln in Medicaid rebate settlement,http://www.reuters.com/article/pfizer-settlement-idUSL3N15V41A,
20160312 12:41PM UTC,FDA approves Pfizer's lung cancer drug for expanded use,http://www.reuters.com/article/us-pfizer-fda-idUSKCN0WD25U,
20160312 12:40PM UTC,FDA approves Pfizer's lung cancer drug for expanded use,http://www.reuters.com/article/pfizer-fda-idUSL4N16J4SD,
20160312 8:15AM UTC,Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India,http://www.reuters.com/article/us-msf-pfizer-india-idUSKCN0WD1I5,
20160312 8:14AM UTC,Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India,http://www.reuters.com/article/msf-pfizer-india-idUSL4N16J279,
20160315 12:46PM UTC,Indian court grants Pfizer temporary relief on cough syrup ban,http://www.reuters.com/article/india-pfizer-medicine-idUSL2N16M0VW,
20160315 12:32PM UTC,Indian court grants Pfizer temporary relief on cough syrup ban,http://www.reuters.com/article/us-india-pfizer-medicine-idUSKCN0WG09H,
20160315 12:23PM UTC,UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup ban,http://www.reuters.com/article/india-pfizer-medicine-idUSL3N16M4DJ,
20160315 10:52AM UTC,CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrup,http://www.reuters.com/article/india-pfizer-medicine-idUSL3N16M1SX,
20160315 7:35AM UTC,Indian court stays government ban on Pfizer's Corex cough syrup - TV,http://www.reuters.com/article/india-pfizer-court-idUSI8N15H03K,
20160315 7:33AM UTC,Indian court stays government ban on Pfizer's Corex cough syrup - TV,http://www.reuters.com/article/india-pfizer-court-idUSD8N15U028,
20160315 12:23AM UTC,Pfizer stops selling popular Corex cough syrup in India after ban,http://www.reuters.com/article/india-pfizer-medicine-idUSL3N16M1R9,
20160319 1:03PM UTC,Pfizer's Xeljanz meets goals in ulcerative colitis trials,http://www.reuters.com/article/us-pfizer-colitis-idUSKCN0WK27V,
20160319 12:56PM UTC,Pfizer's Xeljanz meets goals in ulcerative colitis trials,http://www.reuters.com/article/pfizer-colitis-idUSL2N16Q159,
20160329 7:27AM UTC,Appeals court upholds verdict for Pfizer in diet drug case,http://www.reuters.com/article/health-pondimin-idUSL2N1700B2,
20160331 1:00PM UTC,"Pfizer, Allergan get request for additional information from FTC",http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0WW233,
20160331 12:58PM UTC,"Pfizer, Allergan get request for additional information from FTC",http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N1724J9,
20160401 5:45PM UTC,Pfizer says press release on drug pricing fake,http://www.reuters.com/article/us-pfizer-pressrelease-idUSKCN0WX2UN,
20160401 5:38PM UTC,Pfizer says press release on drug pricing fake,http://www.reuters.com/article/pfizer-pressrelease-idUSL3N1735DI,
20160405 11:06PM UTC,REFILE-UPDATE 3-New U.S. inversion rules threaten Pfizer-Allergan deal,http://www.reuters.com/article/usa-tax-inversions-idUSL2N1771OI,
20160405 7:17PM UTC,BRIEF-Pfizer and Allergan say conducting a review of U.S. Department of Treasury's actions,http://www.reuters.com/article/idUSFWN1770R9,
20160405 7:11PM UTC,Pfizer says won't speculate on impact of U.S. Treasury's inversion move,http://www.reuters.com/article/us-usa-tax-inversions-pfizer-idUSKCN0X12H2,
20160406 10:09PM UTC,"UPDATE 1-Pfizer, Allergan to mutually terminate merger on Wednesday morning- Source",http://www.reuters.com/article/allergan-ma-pfizer-idUSL2N17902W,
20160406 9:29PM UTC,"Pfizer, Allergan to mutually terminate merger on Wednesday morning - CNBC",http://www.reuters.com/article/allergan-ma-pfizer-idUSL2N17902H,
20160406 9:15PM UTC,"BRIEF-Pfizer and Allergan will mutually terminate their merger tomorrow morning - CNBC, citing sources",http://www.reuters.com/article/idUSFWN1780R3,
20160406 8:12PM UTC,Pfizer's Allergan deal teeters on new U.S. inversion curbs,http://www.reuters.com/article/allergan-ma-pfizer-idUSL2N1780QC,
20160406 5:42PM UTC,Exclusive: Pfizer leaning toward abandoning deal with Allergan - source,http://www.reuters.com/article/us-allergan-m-a-pfizer-deliberations-idUSKCN0X22B3,
20160406 4:46PM UTC,FDA approves Pfizer's biosimilar for inflammatory diseases,http://www.reuters.com/article/pfizer-fda-idUSL3N178467,
20160406 2:45PM UTC,U.S. Treasury rules put Pfizer-Allergan deal in question,http://www.reuters.com/article/allergan-ma-pfizer-idUSL2N1781FF,
20160406 9:35AM UTC,Allergan shares fall as investors bet on Pfizer deal collapse,http://www.reuters.com/article/allergan-ma-pfizer-idUSL2N1780LM,
20160406 4:55AM UTC,New U.S. inversion rules threaten Pfizer-Allergan deal,http://www.reuters.com/article/us-usa-tax-inversions-idUSKCN0X1299,
20160406 3:16PM UTC,Allergan - Pfizer deal in doubt,http://www.reuters.com/news/video/videoStory?storyID=117564865,
20160406 8:54AM UTC,New threat to Pfizer-Allergan deal,http://www.reuters.com/news/video/videoStory?storyID=117549881,
20160407 7:47PM UTC,Tax rules that killed Allergan-Pfizer deal may be hard to challenge,http://www.reuters.com/article/us-usa-tax-inversions-legal-idUSKCN0X31WY,
20160407 7:47PM UTC,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change",http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0X3188,
20160407 5:26PM UTC,UPDATE 1-Biotech shares rally as Pfizer-Allergan deal collapses,http://www.reuters.com/article/allergan-ma-pfizer-biotech-idUSL2N179248,
20160407 3:58PM UTC,BRIEF-Moody's affirms Pfizer's A1/Prime-1 ratings,http://www.reuters.com/article/idUSFWN1790QW,
20160407 3:54PM UTC,UPDATE 2-Tax rules that killed Allergan-Pfizer deal may be hard to challenge,http://www.reuters.com/article/usa-tax-inversions-legal-idUSL2N17911P,
20160407 2:17PM UTC,"UPDATE 3-Pfizer, Allergan scrap $160 bln deal after U.S. tax rule change",http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N17936X,
20160407 1:48PM UTC,Abandoned Pfizer deal leaves all sides tainted,http://www.reuters.com/article/idUS3660467020160406,
20160407 12:21PM UTC,Biotech shares rally as Pfizer-Allergan deal collapses,http://www.reuters.com/article/allergan-ma-pfizer-biotech-idUSL2N179110,
20160407 12:00PM UTC,Britain's FTSE lifted by pharma firms after Pfizer deal falls apart,http://www.reuters.com/article/britain-stocks-idUSL5N17947K,
20160407 11:06AM UTC,"Democratic White House hopefuls cheer end of Pfizer, Allergan deal",http://www.reuters.com/article/us-allergan-m-a-pfizer-election-idUSKCN0X31V0,
20160407 11:00AM UTC,"Democratic White House hopefuls cheer end of Pfizer, Allergan deal",http://www.reuters.com/article/allergan-ma-pfizer-election-idUSL2N1790WF,
20160407 10:56AM UTC,Pfizer beats hundreds of lawsuits alleging Zoloft birth defects,http://www.reuters.com/article/pfizer-lawsuit-zoloft-idUSL2N1790YJ,
20160407 10:42AM UTC,"BRIEF-Hillary Clinton says glad to hear Pfizer is calling off the merger""- Tweet""",http://www.reuters.com/article/idUSL5N1793YN,
20160407 10:07AM UTC,Pfizer beats hundreds of lawsuits alleging Zoloft birth defects,http://www.reuters.com/article/us-pfizer-lawsuit-zoloft-idUSKCN0X31PU,
20160407 10:00AM UTC,Pfizer beats hundreds of lawsuits alleging Zoloft birth defects,http://www.reuters.com/article/pfizer-lawsuit-zoloft-idUSL2N1790Q1,
20160407 9:16AM UTC,BRIEF-Allergan CEO Saunders on CNBC- appears that treasury targeted Allergan-Pfizer deal,http://www.reuters.com/article/idUSFWN1790J1,
20160407 7:34AM UTC,Britain's FTSE lifted by pharma companies as Pfizer deal falls apart,http://www.reuters.com/article/britain-stocks-idUSL5N1792FF,
20160407 7:00AM UTC,BRIEF-Allergan reiterates termination of Pfizer transaction,http://www.reuters.com/article/idUSASC08JYI,
20160407 6:50AM UTC,"Pfizer and Allergan scrap $160 bln inversion"" deal""",http://www.reuters.com/article/allergan-ma-pfizer-idUSL3N1792VQ,
20160407 4:44AM UTC,Britain's FTSE lifted by pharma firms after Pfizer deal falls apart,http://www.reuters.com/article/britain-stocks-idUSL5N1791JF,
20160407 12:18AM UTC,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal,http://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0X21NV,
20160407 12:15AM UTC,REFILE-UPDATE 7-Obama's inversion curbs kill Pfizer's $160 bln Allergan deal,http://www.reuters.com/article/allergan-ma-pfizer-idUSL2N1780NZ,
20160407 12:29PM UTC,Breakingviews: The Pfizer blame game,http://www.reuters.com/news/video/videoStory?storyID=117590513,
20160407 7:27AM UTC,Pfizer and Allergan scrap $160 bln deal,http://www.reuters.com/news/video/videoStory?storyID=117581141,
20160408 9:34PM UTC,Investors stick with Pfizer CEO after Allergan deal scrapped,http://www.reuters.com/article/us-allergan-m-a-pfizer-read-idUSKCN0X42VD,
20160409 6:02PM UTC,"BRIEF-S&P; - Pfizer Ratings affirmed, off watch on terminated acquisition plan outlook stable",http://www.reuters.com/article/idUSFWN17B0RJ,
20160413 1:47PM UTC,"Pfizer must face revived Celebrex, Bextra safety lawsuit",http://www.reuters.com/article/pfizer-lawsuit-idUSL2N17F113,
20160413 1:32PM UTC,"Pfizer must face revived Celebrex, Bextra safety lawsuit",http://www.reuters.com/article/us-pfizer-lawsuit-idUSKCN0X91SF,
20160413 1:29PM UTC,"UPDATE 3-Pfizer must face revived Celebrex, Bextra safety lawsuit",http://www.reuters.com/article/pfizer-lawsuit-idUSL2N17F0WM,
20160413 10:51AM UTC,"Lawsuit vs Pfizer over Celebrex, Bextra safety is revived",http://www.reuters.com/article/pfizer-lawsuit-idUSL2N17F0UA,
20160420 8:28AM UTC,BRIEF-Pfizer reports confimatory data on approved cancer drug Ibrance,http://www.reuters.com/article/idUSASD08E1T,
20160428 12:07PM UTC,Pfizer to pay $784.6 million to resolve Wyeth false claims lawsuit,http://www.reuters.com/article/us-pfizer-falseclaims-wyeth-idUSKCN0XO1TU,
20160428 12:05PM UTC,UPDATE 2-Pfizer to pay $784.6 million to resolve Wyeth false claims lawsuit,http://www.reuters.com/article/pfizer-falseclaims-wyeth-idUSL2N17U16G,
20160428 12:00PM UTC,Pfizer to pay $784.6 million to resolve Wyeth false claims lawsuit,http://www.reuters.com/article/pfizer-falseclaims-wyeth-idUSL2N17U1E2,
20160428 10:49AM UTC,Pfizer to pay $784.6 million to resolve Wyeth false claims lawsuit,http://www.reuters.com/article/pfizer-falseclaims-wyeth-idUSL2N17U129,
20160429 12:20PM UTC,BRIEF-Pfizer Inc declares $0.30 second-quarter 2016 dividend,http://www.reuters.com/article/idUSFWN17V1H5,
20160430 2:04AM UTC,BRIEF-Sobi extends manufacturing agreements with Pfizer,http://www.reuters.com/article/idUSFWN17W09C,
20160504 6:05PM UTC,Pfizer approaches Medivation about potential takeover -sources,http://www.reuters.com/article/medivation-ma-pfizer-idUSL2N18020Y,
20160504 5:05PM UTC,Pfizer CEO still interested in deals after losing Allergan,http://www.reuters.com/article/us-pfizer-results-deals-idUSKCN0XU27N,
20160504 11:30AM UTC,BRIEF-Pfizer says does not expect to seek tax-inversion deals in near term,http://www.reuters.com/article/idUSL2N1800P4,
20160504 10:42AM UTC,New drugs fuel strong Pfizer results; company raises 2016 forecasts,http://www.reuters.com/article/us-pfizer-results-idUSKCN0XU0YQ,
20160504 7:11AM UTC,BRIEF-Pfizer Inc reports Q1 adjusted earnings per share $0.67,http://www.reuters.com/article/idUSASC08M4C,
20160505 1:51AM UTC,Exclusive: Pfizer approaches Medivation about potential takeover - sources ,http://www.reuters.com/article/us-medivation-m-a-pfizer-exclusive-idUSKCN0XU2C6,
20160506 12:17PM UTC,Pfizer mulls actually having an M&A; strategy,http://www.reuters.com/article/idUS392373665920160505,
20160511 8:29AM UTC,BRIEF-Pfizer Canada says Health Canada has given conditional approval of IBRANCE TM,http://www.reuters.com/article/idUSFWN1870VA,
20160511 7:46AM UTC,BRIEF-First dosing of Pfizer DART candidate in phase 1 study triggers milestone payment to MacroGenics,http://www.reuters.com/article/idUSASC08ODR,
20160513 9:20AM UTC,BRIEF-Pfizer reports 8 pct passive stake in Wave Life Sciences,http://www.reuters.com/article/idUSFWN1890LN,
20160514 7:07PM UTC,Baupost took $461 mln Allergan stake before Pfizer deal collapsed,http://www.reuters.com/article/investments-funds-baupost-idUSL2N18A28M,
20160514 5:46PM UTC,UPDATE 1-Pfizer blocks its drugs from use in lethal injections,http://www.reuters.com/article/pfizer-deathpenalty-idUSL2N18A21Y,
20160514 4:17PM UTC,Pfizer blocks its drugs from use in lethal injections -NY Times,http://www.reuters.com/article/pfizer-deathpenalty-idUSL2N18A1UW,
20160514 6:45AM UTC,BRIEF-Pfizer presents results from two Phase 3 trumenba studies,http://www.reuters.com/article/idUSFWN18A0KV,
20160515 3:19AM UTC,Pfizer blocks its drugs from use in lethal injections,http://www.reuters.com/article/us-pfizer-deathpenalty-idUSKCN0Y42GF,
20160515 1:57AM UTC,Pfizer blocks drug use for executions,http://www.reuters.com/news/video/videoStory?storyID=118691243,
20160517 5:01PM UTC,BRIEF-Wave Life Sciences says cash resources with $40 mln in payments from Pfizer will fund expenses into 2019,http://www.reuters.com/article/idUSASC08PXV,
20160517 4:59PM UTC,"Cox: Pfizer death-row move serves investors, too",http://www.reuters.com/article/idUS87262044120160516,
20160517 2:18PM UTC,Pfizerâ€™s $5.2 bln Anacor bid dodges bigger issue,http://www.reuters.com/article/idUS290314243520160516,
20160517 1:34PM UTC,UPDATE 5-Pfizer to buy Anacor in $5.2 bln deal for access to eczema gel,http://www.reuters.com/article/anacor-pharma-ma-pfizer-idUSL3N18D3Y8,
20160517 1:09PM UTC,BRIEF-Moody's affirms Pfizer's A1/P-1 ratings,http://www.reuters.com/article/idUSFWN18D0V3,
20160517 7:25AM UTC,BRIEF-Anacor-Pfizer merger agreement includes $180.8 mln termination fee - SEC filing,http://www.reuters.com/article/idUSFWN18D0F7,
20160517 6:57AM UTC,BRIEF-Pfizer to buy Anacor in $5.2 bln deal,http://www.reuters.com/article/idUSASC08PPM,
20160517 6:54AM UTC,Pfizer to buy Anacor Pharma in $5.2 bln deal,http://www.reuters.com/article/anacor-pharma-ma-pfizer-idUSL3N18D3XD,
20160517 11:17AM UTC,Pfizer buying Anacor for $5.2 bln.,http://www.reuters.com/news/video/videoStory?storyID=118736432,
20160518 4:34PM UTC,Pfizer ban on lethal drug sales complicates executions in 20 states ,http://www.reuters.com/article/us-pfizer-deathpenalty-idUSKCN0Y82E3,
20160518 3:20PM UTC,Pfizer ban on lethal drug sales complicates executions in 20 U.S. states,http://www.reuters.com/article/pfizer-deathpenalty-idUSL2N18E0VY,
20160518 4:38AM UTC,Pfizer's Anacor deal showcases new wave of eczema therapies ,http://www.reuters.com/article/us-health-eczema-analysis-idUSKCN0Y80CX,
20160518 1:52AM UTC,Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel,http://www.reuters.com/article/us-anacor-pharma-m-a-pfizer-analysis-idUSKCN0Y7143,
20160519 6:25PM UTC,"German Merck, Pfizer immunotherapy shows promise in rare skin cancer",http://www.reuters.com/article/us-health-cancer-merck-idUSKCN0Y92X1,
20160519 5:04PM UTC,Pfizer cancer drug shows promise in combo with Merck's Keytruda,http://www.reuters.com/article/us-health-cancer-pfizer-immunotherapy-idUSKCN0Y92W2,
20160519 5:03PM UTC,Pfizer's Ibrance delays breast cancer progression: study,http://www.reuters.com/article/us-health-cancer-pfizer-ibrance-idUSKCN0Y92VZ,
20160519 5:00PM UTC,"German Merck, Pfizer immunotherapy shows promise in rare skin cancer",http://www.reuters.com/article/health-cancer-merck-idUSL2N18F1ZY,
20160519 5:00PM UTC,Pfizer cancer drug shows promise in combo with Merck's Keytruda,http://www.reuters.com/article/health-cancer-pfizer-immunotherapy-idUSL2N18F0Z4,
20160519 5:00PM UTC,Pfizer's Ibrance delays breast cancer progression -study,http://www.reuters.com/article/health-cancer-pfizer-ibrance-idUSL2N18E1JA,
20160519 7:00AM UTC,2nd Circuit rejects doctor's whistleblower case over Pfizer's Lipitor,http://www.reuters.com/article/health-pfizer-idUSL2N18F0AZ,
20160519 5:01AM UTC,Novartis breast cancer drug set to take on Pfizer's Ibrance,http://www.reuters.com/article/us-novartis-cancer-idUSKCN0Y90Y8,
20160519 4:51AM UTC,Novartis breast cancer drug set to take on Pfizer's Ibrance,http://www.reuters.com/article/novartis-cancer-idUSL5N18F1O6,
20160520 1:33PM UTC,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the Sale of Anacor Pharmaceuticals, Inc. to Pfizer Inc. for $99.25 Per Share",http://www.reuters.com/article/ny-levi-korsinky-llp-idUSnBw196423a+100+BSW20160519,
20160520 6:45AM UTC,"BRIEF-Spark Therapeutics, Pfizer announce data from initial subjects in hemophilia B trial",http://www.reuters.com/article/idUSFWN18G0AG,
20160520 5:02AM UTC,U.N.'s rights chief urges firms to follow Pfizer's lead on death penalty,http://www.reuters.com/article/us-pfizer-deathpenalty-un-idUSKCN0YA0YJ,
20160520 4:55AM UTC,U.N.'s rights chief urges firms to follow Pfizer's lead on death penalty,http://www.reuters.com/article/pfizer-deathpenalty-un-idUSL5N18G250,
20160521 8:10AM UTC,BRIEF-Pfizer says EMA acceptance for Trumenba marketing authorization application review,http://www.reuters.com/article/idUSFWN18H08E,
20160524 7:13AM UTC,Europe lifts warning on Pfizer smoking cessation drug,http://www.reuters.com/article/us-pfizer-europe-smoking-idUSKCN0YE1CZ,
20160524 7:00AM UTC,Europe lifts warning on Pfizer smoking cessation drug,http://www.reuters.com/article/pfizer-europe-smoking-idUSL5N18K1JP,
20160209 10:27AM UTC,Pfizer unveils management line up for combined company,http://www.reuters.com/article/us-allergan-m-a-pfizer-restructuring-idUSKCN0VH1E7,
20160209 10:26AM UTC,UPDATE 1-Pfizer unveils management line up for combined company,http://www.reuters.com/article/allergan-ma-pfizer-restructuring-idUSL3N15N2ZA,
20160209 9:56AM UTC,Pfizer to create operating unit after Allergan deal closes,http://www.reuters.com/article/allergan-ma-pfizer-restructuring-idUSL3N15N2XR,
20160421 10:08AM UTC,BRIEF-Pfizer Canada says partnered with Rexall in new service called OneStopMeds,http://www.reuters.com/article/idUSFWN17N0Q5,
20160527 5:31PM UTC,Anacor received rival bid before Pfizer deal - filing,http://www.reuters.com/article/anacor-pharma-ma-idUSL2N18N1T4,
20160527 5:29PM UTC,Anacor received rival bid before Pfizer deal: filing,http://www.reuters.com/article/us-anacor-pharma-m-a-idUSKCN0YH2G6,
20160527 5:27PM UTC,UPDATE 1-Anacor received rival bid before Pfizer deal - filing,http://www.reuters.com/article/anacor-pharma-ma-idUSL3N18N4WX,
20160527 3:36PM UTC,Anacor reveals receiving rival bid before Pfizer deal - filing,http://www.reuters.com/article/anacor-pharma-ma-idUSL3N18N4R6,
20160702 5:35PM UTC,BRIEF-Bind Therapeutics files motion for sale of assets after accepting stalking horse bid from Pfizer,http://www.reuters.com/article/idUSL8N19N4YR,
20160720 8:35AM UTC,BRIEF-Pfizer gets WHO prequalification for multi-dose vial presentation of Prevenar 13,http://www.reuters.com/article/idUSFWN1A50JI,
20160825 11:42AM UTC,Pfizer to buy antibiotics business from AstraZeneca,http://www.reuters.com/article/us-astrazeneca-m-a-pfizer-idUSKCN10Z0HG,
20160825 3:44AM UTC,UPDATE 1-Pfizer to buy antibiotics business from AstraZeneca,http://www.reuters.com/article/astrazeneca-ma-pfizer-idUSL8N1B510M,
20160825 2:15AM UTC,AstraZeneca to sell antibiotics business to Pfizer,http://www.reuters.com/article/astrazeneca-ma-pfizer-idUSASM0005LQ,
20160825 10:39AM UTC,Pfizer buys antibiotics business,http://www.reuters.com/news/video/videoStory?storyID=121571429,
20161018 6:02PM UTC,Pfizer to start shipping biosimilar version of J&J;'s Remicade in November,http://www.reuters.com/article/us-pfizer-biosimilar-idUSKBN12H2FZ,
20161018 6:01PM UTC,UPDATE 2-Pfizer to start shipping biosimilar version of J&J;'s Remicade in November,http://www.reuters.com/article/pfizer-biosimilar-idUSL1N1CN1O0,
20161018 4:49PM UTC,Pfizer set to start shipping Remicade biosimilar next month,http://www.reuters.com/article/pfizer-biosimilar-idUSL1N1CN1N0,
20161018 4:14PM UTC,BRIEF-Pfizer says company to begin shipping Inflectra to wholesalers in late November,http://www.reuters.com/article/idUSASC09BFI,
20161105 8:46AM UTC,BRIEF-Fuelcell energy announces completion of 5.6 megawatt power plant installation for Pfizer,http://www.reuters.com/article/idUSASC09GDI,
20161105 7:34AM UTC,BRIEF-Pfizer Ltd Sept-qtr profit up about 52 pct,http://www.reuters.com/article/idUSFWN1D50S4,
20161123 8:07AM UTC,"BRIEF-QuintilesIMS forms new Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to generate real world insights on usage of anti-cancer therapies across Europe",http://www.reuters.com/article/idUSFWN1DN0L3,
20160601 7:31PM UTC,BRIEF-Pfizer prices $5.0 billion debt offering,http://www.reuters.com/article/idUSL8N18S6AM,
20160601 9:16AM UTC,BRIEF-Biorap Technologies enters into an agreement with Pfizer,http://www.reuters.com/article/idUSFWN18S0MF,
20160604 6:19PM UTC,Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips,http://www.reuters.com/article/usa-insidertrading-idUSL1N18V0ZB,
20160604 6:03PM UTC,Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips,http://www.reuters.com/article/usa-insidertrading-idUSL1N18V1JA,
20160604 5:58PM UTC,Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips,http://www.reuters.com/article/us-usa-insidertrading-idUSKCN0YP22B,
20160604 5:52PM UTC,UPDATE 4-Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips,http://www.reuters.com/article/usa-insidertrading-idUSL1N18V0WX,
20160604 10:35AM UTC,Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips,http://www.reuters.com/article/usa-insidertrading-idUSL1N18V0V7,
20160607 6:41PM UTC,Pfizer's opioid painkiller can be manipulated for abuse -FDA,http://www.reuters.com/article/pfizer-fda-idUSL1N18Y179,
20160607 6:24PM UTC,Pfizer's opioid painkiller can be manipulated for abuse: FDA,http://www.reuters.com/article/us-pfizer-fda-idUSKCN0YS1P9,
20160607 6:23PM UTC,UPDATE 3-Pfizer's opioid painkiller can be manipulated for abuse -FDA,http://www.reuters.com/article/pfizer-fda-idUSL4N18Y3SZ,
20160607 5:39PM UTC,BRIEF-Pfizer says takes 7.1 pct passive stake in Merus NV,http://www.reuters.com/article/idUSFWN18Y0KE,
20160607 12:03PM UTC,"Fresenius, Smiths in two-way race for Pfizer infusion pumps: sources",http://www.reuters.com/article/us-pfizerpumps-m-a-fresenius-smiths-idUSKCN0YS1Q7,
20160607 12:00PM UTC,"UPDATE 1-Fresenius, Smiths in two-way race for Pfizer infusion pumps - sources",http://www.reuters.com/article/pfizerpumps-ma-fresenius-smiths-idUSL8N18Y3UC,
20160607 11:40AM UTC,"CORRECTED-BRIEF-Merck KGaA, Pfizer present positive mid-stage data on merkel cell carcinoma drug at ASCO",http://www.reuters.com/article/idUSFWN18Y0H6,
20160607 11:28AM UTC,"Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources",http://www.reuters.com/article/pfizerpumps-ma-fresenius-smiths-idUSL8N18Y3TW,
20160607 11:17AM UTC,Pfizer's opioid painkiller can be manipulated for abuse - FDA,http://www.reuters.com/article/pfizer-fda-idUSL4N18Y33N,
20160607 8:14AM UTC,"BRIEF-Pfizer says encouraging"" new data from Phase 1/2 study of Lorlatinib""",http://www.reuters.com/article/idUSFWN18Y0GR,
20160608 7:18AM UTC,BRIEF-Pfizer announces positive top-line results from second Phase 3 oral Xeljanz trial,http://www.reuters.com/article/idUSASC08SXI,
20160609 7:21PM UTC,BRIEF-Pfizer says FDA advisory committees' recommend ALO-02 extended-release capsules for approval,http://www.reuters.com/article/idUSASC08TCB,
20160609 6:24PM UTC,FDA panel backs approval of Pfizer's opioid painkiller,http://www.reuters.com/article/us-pfizer-opioids-fda-idUSKCN0YU2J4,
20160609 6:20PM UTC,UPDATE 2-U.S. FDA panel backs approval of Pfizer's opioid painkiller,http://www.reuters.com/article/pfizer-opioids-fda-idUSL1N19020L,
20160609 4:03PM UTC,U.S. FDA panel backs approval of Pfizer's opioid painkiller,http://www.reuters.com/article/pfizer-opioids-fda-idUSL1N1901UV,
20160609 7:32AM UTC,"BRIEF-Pfizer presents more data on rheumatoid arthritis drug, Xeljanz",http://www.reuters.com/article/idUSFWN18Z0OU,
20160610 12:59AM UTC,BRIEF-DKSH and Pfizer expand collaboration in Thailand,http://www.reuters.com/article/idUSL8N1910B9,
20160611 6:29AM UTC,BRIEF-ICON signed new three-year agreement with Pfizer Inc.,http://www.reuters.com/article/idUSFWN1910UG,
20160611 6:12AM UTC,BRIEF-Icon announces service agreement with Pfizer,http://www.reuters.com/article/idUSASC08TKN,
20160615 2:53PM UTC,Shire buys bowel drug rights from Pfizer,http://www.reuters.com/article/us-pfizer-ibd-shire-idUSKCN0Z01C3,
20160615 8:09AM UTC,UPDATE 1-Shire buys bowel drug rights from Pfizer,http://www.reuters.com/article/pfizer-ibd-shire-idUSL4N1963KA,
20160615 7:25AM UTC,Drugmaker Shire buys bowel drug rights from Pfizer,http://www.reuters.com/article/pfizer-ibd-shire-idUSL4N1963I5,
20160615 7:06AM UTC,BRIEF-Shire to license investigational gastric drug from Pfizer,http://www.reuters.com/article/idUSFWN1950R0,
20160621 8:47AM UTC,BRIEF-Oracle announces Pfizer's selection of Oracle cloud for clinical data management,http://www.reuters.com/article/idUSASC08UNY,
20160624 4:03PM UTC,BRIEF-Pfizer declares Q3 2016 $0.30 dividend,http://www.reuters.com/article/idUSFWN19F0IZ,
20160625 11:10AM UTC,BRIEF-Pfizer completes acquisition of Anacor,http://www.reuters.com/article/idUSFWN19G08P,
20160629 9:24AM UTC,BRIEF-Pfizer says 2 additional late stage studies of cholesterol drug met goals,http://www.reuters.com/article/idUSFWN19K02F,
20160629 12:50AM UTC,"Pfizer to invest $350 million in China biotech hub, first in Asia",http://www.reuters.com/article/us-pfizer-china-idUSKCN0ZE0A8,
20160629 12:47AM UTC,"Pfizer to invest $350 mln in China biotech hub, first in Asia",http://www.reuters.com/article/pfizer-china-idUSL4N19K1RJ,
20160707 7:28PM UTC,BRIEF-Pfizer's Leukemia drug Bosulif has won backing of UK's national institute for health and care excellence- Bloomberg,http://www.reuters.com/article/idUSFWN19S0OT,
20160707 4:41PM UTC,"Pfizer, Germany's Merck begin large ovarian cancer trial",http://www.reuters.com/article/us-cancer-ovarian-pfizer-idUSKCN0ZM2DV,
20160707 4:37PM UTC,"Pfizer, Germany's Merck begin large ovarian cancer trial",http://www.reuters.com/article/cancer-ovarian-pfizer-idUSL1N19S1YN,
20160708 6:38PM UTC,Court approves bankrupt Bind's sale plan following Pfizer offer,http://www.reuters.com/article/bankruptcy-bind-idUSL1N19T2IQ,
20160708 11:56AM UTC,REFILE-BRIEF-Pfizer and Germany's Merck KGaA initiate phase III trial,http://www.reuters.com/article/idUSFWN19S06Y,
20160709 8:41AM UTC,BRIEF-Pfizer announces positive top-line results from phase 3 S-TRAC trial,http://www.reuters.com/article/idUSFWN19T0U3,
20160713 4:58PM UTC,FDA expands use of Pfizer's best-selling pneumonia vaccine,http://www.reuters.com/article/us-pfizer-fda-idUSKCN0ZS2O4,
20160713 4:52PM UTC,FDA expands use of Pfizer's best-selling pneumonia vaccine,http://www.reuters.com/article/pfizer-fda-idUSL4N19Y4VN,
20160713 4:18PM UTC,BRIEF-Pfizer receives FDA approval for Prevnar 13,http://www.reuters.com/article/idUSFWN19Y0N8,
20160714 8:18AM UTC,BRIEF-Pfizer publishes results from two Pivotal phase 3 studies of crisaborole topical ointment,http://www.reuters.com/article/idUSFWN19Z0MC,
20160726 8:55AM UTC,BRIEF-Spark Therapeutics and Pfizer announce data from first cohort in Hemophilia B Phase 1/2 trial,http://www.reuters.com/article/idUSASC08Y13,
20160726 7:23AM UTC,BRIEF-Bind Therapeutics says two bidders join Pfizer's stalking horse bid,http://www.reuters.com/article/idUSFWN1AB0AF,
20160727 5:29PM UTC,BRIEF-Bind Therapeutics determines Pfizer's $40 mln bid highest,http://www.reuters.com/article/idUSFWN1AC17B,
20160727 9:43AM UTC,"Exclusive: Teva, Mylan eye Pfizer's Brazil venture, sources say",http://www.reuters.com/article/us-pfizer-divestment-brazil-idUSKCN1061RA,
20160729 4:37PM UTC,BRIEF-Bind Therapeutics says it entered into an asset purchase agreement with Pfizer,http://www.reuters.com/article/idUSFWN1AE1MM,
20160729 4:12PM UTC,BRIEF-Pfizer announces positive top-line results from Phase 3 Maintenance Trial of Oral XELJANZ,http://www.reuters.com/article/idUSFWN1AE1LP,
20160729 10:39AM UTC,BRIEF-Pfizer and Western Oncolytics announce immuno-oncology research collaboration,http://www.reuters.com/article/idUSFWN1AE19D,
20160730 9:40AM UTC,"BRIEF-Sanofi, Pfizer, Gilead & Celgene interested in Medivation - CNBC citing sources",http://www.reuters.com/article/idUSFWN1AF0WB,
20160802 10:02AM UTC,Pfizer acquires Bamboo Therapeutics to beef up gene therapy arsenal,http://www.reuters.com/article/us-bamboo-m-a-pfizer-idUSKCN10C2H7,
20160802 10:00AM UTC,Pfizer acquires Bamboo Therapeutics to beef up gene therapy arsenal,http://www.reuters.com/article/bamboo-ma-pfizer-idUSL3N1AI3XN,
20160803 12:36PM UTC,"Pfizer beats estimates, but branded drugs disappoint",http://www.reuters.com/article/us-pfizer-results-idUSKCN10D103,
20160803 12:34PM UTC,"UPDATE 5-Pfizer beats estimates, but branded drugs disappoint",http://www.reuters.com/article/pfizer-results-idUSL3N1AJ3JG,
20160803 11:49AM UTC,"Pfizer in $486 million settlement of Celebrex, Bextra litigation",http://www.reuters.com/article/us-pfizer-lawsuit-idUSKCN10D1D8,
20160803 11:19AM UTC,BRIEF-Pfizer says to decide by year end on potential split of company,http://www.reuters.com/article/idUSL1N1AJ0RC,
20160803 11:08AM UTC,"Pfizer in $486 mln settlement of Celebrex, Bextra litigation",http://www.reuters.com/article/pfizer-lawsuit-idUSL1N1AJ0W8,
20160803 11:05AM UTC,"UPDATE 2-Pfizer in $486 mln settlement of Celebrex, Bextra litigation",http://www.reuters.com/article/pfizer-lawsuit-idUSL1N1AJ0ME,
20160803 10:07AM UTC,US STOCKS-Wall St opens lower; Pfizer weighs on Dow,http://www.reuters.com/article/usa-stocks-idUSL3N1AJ42M,
20160803 9:15AM UTC,"Pfizer reaches $486 mln settlement of Celebrex, Bextra litigation",http://www.reuters.com/article/pfizer-lawsuit-idUSL1N1AJ0K7,
20160803 7:12AM UTC,BRIEF-Pfizer Q2 adjusted EPS $0.64,http://www.reuters.com/article/idUSASC08ZVT,
20160803 6:55AM UTC,Pfizer revenue rises 11 percent,http://www.reuters.com/article/pfizer-results-idUSL3N1AJ3IX,
20160803 10:54AM UTC,Cancer drug boosts Pfizer's sales,http://www.reuters.com/news/video/videoStory?storyID=120952862,
20160806 10:43AM UTC,"AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes",http://www.reuters.com/article/us-astrazeneca-cancer-idUSKCN10G1L6,
20160812 6:16PM UTC,BRIEF-Pfizer says as of July 3 offsetting foreign currency exposures was $31.5 bln,http://www.reuters.com/article/idUSFWN1AS0TI,
20160813 4:35PM UTC,"BRIEF-Appaloosa LP dissolves share stake in Pfizer, United Rentals - SEC FILING",http://www.reuters.com/article/idUSFWN1AT0VA,
20160816 5:51PM UTC,BRIEF-Paulson & Co cuts stake in Pfizer,http://www.reuters.com/article/idUSFWN1AW0NP,
20160816 11:53AM UTC,"BRIEF-Jana Partners dissolves sole share stake in Pfizer, NXP Semiconductors",http://www.reuters.com/article/idUSFWN1AW0DP,
20160817 3:16PM UTC,Circuit rejects Apotex challenge to Pfizer antibiotic patent,http://www.reuters.com/article/health-tigecycline-idUSL1N1AX1RP,
20160820 6:29PM UTC,BRIEF-FDA approves Pfizer's TROXYCA ER extended-release capsules CII for pain management,http://www.reuters.com/article/idUSFWN1B00TD,
20160822 7:15PM UTC,UPDATE 1-Pfizer nears deal to acquire Medivation for close to $14 bln -sources,http://www.reuters.com/article/medivation-ma-pfizer-idUSL1N1B20OJ,
20160822 6:09PM UTC,Pfizer nears $14 billion deal for Medivation-source,http://www.reuters.com/article/medivation-ma-pfizer-idUSL1N1B20NK,
20160823 6:39PM UTC,Pfizer boosts cancer drug roster with $14 billion Medivation deal,http://www.reuters.com/article/us-medivation-m-a-pfizer-idUSKCN10W0YG,
20160823 5:01PM UTC,UPDATE 5-Pfizer boosts cancer drug roster with $14 bln Medivation deal,http://www.reuters.com/article/medivation-ma-pfizer-idUSL3N1B33CO,
20160823 4:30PM UTC,Pfizer's Medivation buy seen prescribing more biotech M&A;,http://www.reuters.com/article/us-biotechnology-m-a-idUSKCN10X241,
20160823 4:27PM UTC,Pfizer's Medivation buy seen prescribing more biotech M&A;,http://www.reuters.com/article/biotechnology-ma-idUSL1N1B30ZB,
20160823 2:14PM UTC,Pfizer bets $14 bln it knows better than market,http://www.reuters.com/article/idUS360482090620160822,
20160823 9:47AM UTC,BRIEF-Pfizer says Medivation deal will not affect split-up decision,http://www.reuters.com/article/idUSL1N1B30FF,
20160823 8:30AM UTC,"BRIEF-Medivation to pay fee of $510 mln, upon Pfizer deal termination",http://www.reuters.com/article/idUSFWN1B306V,
20160823 6:55AM UTC,BRIEF-Pfizer to acquire Medivation for about $14 bln,http://www.reuters.com/article/idUSASC093QZ,
20160823 6:54AM UTC,Pfizer to buy Medivation in $14 bln deal,http://www.reuters.com/article/medivation-ma-pfizer-idUSL3N1B33C7,
20160823 10:29AM UTC,Pfizer to buy Medivation for $14 billion,http://www.reuters.com/news/video/videoStory?storyID=121501067,
20160901 7:36AM UTC,BRIEF-Pfizer says European Commission has approved Xalkori the treatment of adults with lung cancer,http://www.reuters.com/article/idUSFWN1BC08D,
20160908 9:29AM UTC,BRIEF-Pfizer appoints Chief Scientific Officer for Neuroscience Research,http://www.reuters.com/article/idUSASC095K1,
20160909 3:04PM UTC,Pfizer CEO says Clinton plan to curb drug prices would hurt consumers,http://www.reuters.com/article/us-pfizer-ceo-clinton-idUSKCN11E2N7,
20160909 3:01PM UTC,UPDATE 1-Pfizer CEO says Clinton plan to curb drug prices would hurt consumers,http://www.reuters.com/article/pfizer-ceo-clinton-idUSL1N1BK1JB,
20160909 2:18PM UTC,Pfizer CEO says Clinton plan to curb drug prices would hurt consumers,http://www.reuters.com/article/pfizer-ceo-clinton-idUSL1N1BK1FY,
20160909 9:25AM UTC,"BRIEF-Antolrx announces series a equity funding from Pfizer, JDRF and Orion Equity Partners",http://www.reuters.com/article/idUSASC095RT,
20160910 11:33AM UTC,Clinton spokeswoman defends drug plan after Pfizer comments,http://www.reuters.com/article/us-usa-election-clinton-pfizer-idUSKCN11F266,
20160910 11:28AM UTC,Clinton spokeswoman defends drug plan after Pfizer comments,http://www.reuters.com/article/usa-election-clinton-pfizer-idUSL1N1BL0XH,
20160910 7:22AM UTC,BRIEF-Medivation and Pfizer file premerger notification,http://www.reuters.com/article/idUSFWN1BL0E5,
20160913 2:04PM UTC,FDA staff flags concerns about Pfizer's quit-smoking drug study,http://www.reuters.com/article/us-pfizer-chantix-fda-idUSKCN11I1GI,
20160913 1:43PM UTC,RPT-UPDATE 3-FDA staff flags concerns about Pfizer's quit-smoking drug study,http://www.reuters.com/article/pfizer-chantix-fda-idUSL3N1BO46H,
20160913 1:37PM UTC,UPDATE 3-FDA staff flags concerns about Pfizer's quit-smoking drug study,http://www.reuters.com/article/pfizer-chantix-fda-idUSL3N1BO3RE,
20160913 9:22AM UTC,"BRIEF-FDA staff say neuropsychiatric risk with Pfizer's quit-smoking drug varies in studies, trial design has limitations",http://www.reuters.com/article/idUSFWN1BO09T,
20160913 9:10AM UTC,FDA staff flags concerns about Pfizer's quit-smoking drug study,http://www.reuters.com/article/pfizer-chantix-fda-idUSL3N1BO3PK,
20160915 7:35PM UTC,FDA panel recommends dropping serious warning on Pfizer's Chantix,http://www.reuters.com/article/us-pfizer-chantix-fda-idUSKCN11K2S7,
20160915 7:34PM UTC,FDA panel recommends dropping serious warning on Pfizer's Chantix,http://www.reuters.com/article/pfizer-chantix-fda-idUSL2N1BQ26Y,
20160915 7:32PM UTC,UPDATE 1-FDA panel recommends dropping serious warning on Pfizer's Chantix,http://www.reuters.com/article/pfizer-chantix-fda-idUSL3N1BQ4MH,
20160915 5:32PM UTC,FDA panel recommends dropping serious warning on Pfizer's Chantix,http://www.reuters.com/article/pfizer-chantix-fda-idUSL3N1BQ4LI,
20160915 4:58PM UTC,BRIEF-U.S. FDA panel votes in favor of removing boxed warning on Pfizer's quit-smoking drug Chantix,http://www.reuters.com/article/idUSFWN1BQ0CW,
20160916 9:42AM UTC,BRIEF-Oncoimmune announces option and license agreement with Pfizer Inc,http://www.reuters.com/article/idUSL8N1BR3HX,
20160916 8:58AM UTC,"BRIEF-Merck, Pfizer say investigational Ertugliflozin met primary endpoint",http://www.reuters.com/article/idUSFWN1BR05I,
20160917 5:32PM UTC,BRIEF-Pfizer reports positive top-line results from reflections B537-02 study for PF-06438179,http://www.reuters.com/article/idUSFWN1BS0E8,
20160917 9:15AM UTC,EMA panel recommends nod for Pfizer's breast cancer drug,http://www.reuters.com/article/us-pfizer-study-cancer-idUSKCN11M18O,
20160917 9:10AM UTC,UPDATE 1-EMA panel recommends nod for Pfizer's breast cancer drug,http://www.reuters.com/article/pfizer-study-cancer-idUSL3N1BS1ZK,
20160917 8:16AM UTC,EMA advisory panel recommends nod for Pfizer's breast cancer drug,http://www.reuters.com/article/pfizer-study-cancer-idUSL3N1BS1YC,
20160921 7:00AM UTC,"Regeneron, Teva take aim at Lilly/Pfizer pain drug",http://www.reuters.com/article/regeneron-teva-pain-idUSL2N1BV1OY,
20160923 12:06PM UTC,BRIEF-Pfizer declares 30-cent fourth-quarter 2016 dividend,http://www.reuters.com/article/idUSFWN1BY0IR,
20160924 8:44AM UTC,BRIEF-Pfizer announces expiration of Hart-Scott-Rodino waiting period for acquisition of medivation,http://www.reuters.com/article/idUSFWN1BZ0GY,
20160927 2:51PM UTC,UPDATE 4-Pfizer decides against split-up; more deals seen likely,http://www.reuters.com/article/pfizer-split-idUSL3N1C23FJ,
20160927 1:44PM UTC,"CORRECTED-US STOCKS-Pfizer, banks lead Wall St lower; presidential debate eyed",http://www.reuters.com/article/usa-stocks-idUSL3N1C248B,
20160927 1:13PM UTC,"BRIEF-Moody's changes outlook on Pfizer's to stable from negative, affirms ratings",http://www.reuters.com/article/idUSFWN1C20FU,
20160927 1:09PM UTC,Pfizerâ€™s pricey non-split may only defer problem,http://www.reuters.com/article/idUS258481381520160926,
20160927 12:52PM UTC,Pfizer abandons plan to split into two companies,http://www.reuters.com/article/pfizer-split-idUSL2N1C20LR,
20160927 11:20AM UTC,US STOCKS-Wall St drops as Pfizer falls; presidential debate eyed,http://www.reuters.com/article/usa-stocks-idUSL3N1C23ZH,
20160927 10:05AM UTC,"US STOCKS-Wall St drops as Pfizer falls, Deutsche Bank drags financials",http://www.reuters.com/article/usa-stocks-idUSL3N1C23TH,
20160927 7:02AM UTC,Pfizer says not to split into two,http://www.reuters.com/article/pfizer-split-idUSL3N1C23CZ,
20160927 6:59AM UTC,BRIEF-Pfizer says it will not pursue splitting into two separate publicly traded companies,http://www.reuters.com/article/idUSFWN1C20B5,
20160927 6:32AM UTC,BRIEF-Pfizer Ltd completes sale of 4 products to Piramal Enterprises,http://www.reuters.com/article/idUSFWN1C206R,
20160927 11:09AM UTC,Pfizer won't split,http://www.reuters.com/news/video/videoStory?storyID=122531547,
20160928 12:48PM UTC,Pfizer decides against split-up; more deals seen likely,http://www.reuters.com/article/us-pfizer-split-idUSKCN11W13W,
20160928 10:55AM UTC,BRIEF-Fitch says Pfizer's scrapped split decision will not affect ratings,http://www.reuters.com/article/idUSFWN1C30AL,
20160928 11:43AM UTC,Breakingviews: Pfizer's non-split,http://www.reuters.com/news/video/videoStory?storyID=122567092,
20160929 8:59AM UTC,BRIEF-Pfizer completes acquisition of Medivation,http://www.reuters.com/article/idUSASC099IU,
20160929 6:22AM UTC,BRIEF-Pfizer to showcase progress of broad-based oncology portfolio at ESMO 2016 Congress,http://www.reuters.com/article/idUSASC099GZ,
20161005 5:42PM UTC,BRIEF-Theravance Biopharma's unit enters into fourth amendment with Pfizer,http://www.reuters.com/article/idUSFWN1CA0LZ,
20161007 5:12PM UTC,Pfizer to seek more modern headquarters in Manhattan,http://www.reuters.com/article/us-pfizer-headquarters-idUSKCN1261UO,
20161007 5:11PM UTC,UPDATE 3-Pfizer to seek more modern headquarters in Manhattan,http://www.reuters.com/article/pfizer-headquarters-idUSL2N1CC16G,
20161007 4:48PM UTC,"Pfizer to sell infusion business to ICU Medical, take stake",http://www.reuters.com/article/us-pfizer-divestiture-icu-medical-idUSKCN12616X,
20161007 3:56PM UTC,"UPDATE 4-Pfizer to sell infusion business to ICU Medical, take stake",http://www.reuters.com/article/pfizer-divestiture-icu-medical-idUSL3N1CC2BZ,
20161007 12:03PM UTC,Pfizer says to seek more modern Manhattan headquarters,http://www.reuters.com/article/pfizer-headquarters-idUSL2N1CC156,
20161007 11:09AM UTC,"BRIEF-Pfizer to sell NYC HQ by end of 2017 - CNBC, citing DJ",http://www.reuters.com/article/idUSFWN1CC0MK,
20161007 8:02AM UTC,ICU Medical to buy Pfizer's infusion therapy business for $1 bln,http://www.reuters.com/article/pfizer-divestiture-icu-medical-idUSL3N1CC2BH,
20161007 7:59AM UTC,"BRIEF-ICU Medical to buy Hospira Infusion Systems business from Pfizer for $1 bln in cash, stock",http://www.reuters.com/article/idUSASC09ADU,
20161009 5:13AM UTC,Novartis challenges Pfizer with strong breast cancer drug data,http://www.reuters.com/article/us-health-cancer-novartis-idUSKCN128084,
20161009 5:04AM UTC,UPDATE 1-Novartis challenges Pfizer with strong breast cancer drug data,http://www.reuters.com/article/health-cancer-novartis-idUSL5N1CE063,
20161009 2:15AM UTC,Novartis challenges Pfizer with strong breast cancer drug data,http://www.reuters.com/article/health-cancer-novartis-idUSL5N1CA4FI,
20161011 3:57AM UTC,Exelixis and Pfizer drugs compete in kidney cancer trial,http://www.reuters.com/article/us-health-cancer-exelixis-idUSKCN12A0G2,
20161011 3:32AM UTC,UPDATE 1-Exelixis and Pfizer drugs compete in kidney cancer trial,http://www.reuters.com/article/health-cancer-exelixis-idUSL8N1CG0WW,
20161011 2:20AM UTC,BRIEF-Pfizer announces results from Phase 3 S-TRAC clinical trial,http://www.reuters.com/article/idUSASC09AL6,
20161011 2:15AM UTC,Exelixis and Pfizer drugs face off in kidney cancer,http://www.reuters.com/article/health-cancer-exelixis-idUSL5N1CE0LG,
20161012 12:09PM UTC,"BRIEF-Transgene announces collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the combination of TG4001 with Avelumab",http://www.reuters.com/article/idUSASC09ATC,
20161014 5:52PM UTC,BRIEF-Icu Medical says termination rights in connection of Hospira deal include payment of $75 mln from Pfizer,http://www.reuters.com/article/idUSFWN1CJ0X6,
20161014 9:10AM UTC,Pfizer loses appeal in UK patent case over use of Lyrica drug for pain,http://www.reuters.com/article/us-pfizer-britain-lyrica-idUSKCN12D1R4,
20161014 8:20AM UTC,Pfizer loses appeal in UK patent case over use of Lyrica drug for pain,http://www.reuters.com/article/pfizer-britain-lyrica-idUSL1N1CJ0G7,
20161014 7:30AM UTC,UPDATE 1-Pfizer loses appeal in UK patent case over use of Lyrica drug for pain,http://www.reuters.com/article/pfizer-britain-lyrica-idUSL8N1CJ37U,
20161014 7:06AM UTC,Pfizer loses appeal in UK patent case over use of Lyrica drug for pain,http://www.reuters.com/article/pfizer-britain-lyrica-idUSL8N1CJ31D,
20161019 1:36PM UTC,J&J; shares lose ground on fears of Pfizer's answer to Remicade,http://www.reuters.com/article/us-johnson-johnson-results-idUSKCN12I15K,
20161019 1:35PM UTC,UPDATE 4-J&J; shares lose ground on fears of Pfizer's answer to Remicade,http://www.reuters.com/article/johnsonjohnson-results-idUSL1N1CO19S,
20161020 6:35PM UTC,BRIEF-CDC's ACIP votes to recommend new dosing schedule for vaccination with Pfizer's trumenba,http://www.reuters.com/article/idUSFWN1CP0WK,
20161020 8:12AM UTC,BRIEF-Pfizer awarded grant to evaluate vaccine for newborns,http://www.reuters.com/article/idUSFWN1CP0G0,
20161021 8:29AM UTC,BRIEF-Debiopharm reports clinical collaboration with Merck KGaA and Pfizer,http://www.reuters.com/article/idUSASC09C2M,
20161022 10:08AM UTC,"Advent, Bain gain edge in bid for Pfizer's Brazil venture -sources",http://www.reuters.com/article/pfizer-divestiture-brazil-idUSL1N1CQ22J,
20161102 4:28PM UTC,"Pfizer cholesterol drug fizzles, hitting shares",http://www.reuters.com/article/us-pfizer-results-idUSKBN12W3S8,
20161102 4:21PM UTC,"UPDATE 4-Pfizer cholesterol drug fizzles, hitting shares",http://www.reuters.com/article/pfizer-results-idUSL4N1D23WX,
20161102 11:27AM UTC,BRIEF-Pfizer says cholesterol drug lost potency at 52 wks,http://www.reuters.com/article/idUSL1N1D20WL,
20161102 8:02AM UTC,BRIEF-Pfizer Q3 worldwide Ibrance revenue $550 mln vs.$230 mln last year,http://www.reuters.com/article/idUSFWN1D20FT,
20161102 7:51AM UTC,BRIEF-Pfizer Q3 adjusted EPS $0.61,http://www.reuters.com/article/idUSASC09EMF,
20161102 7:47AM UTC,"BRIEF-Pfizer discontinues global development of Bococizumab, its investigational pcsk9 inhibitor",http://www.reuters.com/article/idUSASC09ELS,
20161102 7:00AM UTC,Pfizer quarterly profit falls 38 pct,http://www.reuters.com/article/pfizer-results-idUSL4N1D23W4,
20161102 4:20AM UTC,"Novartis breast cancer drug gets FDA fast track, takes on Pfizer",http://www.reuters.com/article/us-novartis-lee-idUSKBN12W31T,
20161102 4:19AM UTC,"UPDATE 1-Novartis breast cancer drug gets FDA fast track, takes on Pfizer",http://www.reuters.com/article/novartis-lee-idUSL8N1D2108,
20161102 10:52AM UTC,Pfizer's profit plummets,http://www.reuters.com/news/video/videoStory?storyID=123592929,
20161103 7:12AM UTC,BRIEF-Pfizer's says Prevenar 13 receives approval for use in in China,http://www.reuters.com/article/idUSASC09F42,
20161103 4:53AM UTC,China approves Pfizer vaccine Prevenar,http://www.reuters.com/article/us-pfizer-china-vaccine-idUSKBN12X0UW,
20161103 3:11AM UTC,UPDATE 1-China approves Pfizer vaccine Prevenar,http://www.reuters.com/article/pfizer-china-vaccine-idUSL4N1D32EB,
20161103 2:22AM UTC,Pfizer vaccine Prevenar gains approval in China,http://www.reuters.com/article/pfizer-china-vaccine-idUSB9N1A9016,
20161104 9:26AM UTC,BRIEF-Spark Therapeutics and Pfizer report updated data from hemophilia b phase 1/2 trial,http://www.reuters.com/article/idUSASC09FX2,
20161108 7:04AM UTC,BRIEF-Pfizer to present additional research for XELJANZ in rheumatologic diseases,http://www.reuters.com/article/idUSASC09GJQ,
20161109 12:09PM UTC,"Pfizer says closing two British sites, not Brexit-related",http://www.reuters.com/article/pfizer-britain-closure-idUSL8N1D96QM,
20161110 7:03PM UTC,"Novartis, Pfizer cut prices to win UK approval for cancer drugs",http://www.reuters.com/article/us-health-cancer-britain-idUSKBN13500N,
20161110 7:01PM UTC,"Novartis, Pfizer cut prices to win UK approval for cancer drugs",http://www.reuters.com/article/health-cancer-britain-idUSL8N1DA5OO,
20161110 6:46PM UTC,Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources,http://www.reuters.com/article/us-pfizer-m-a-exclusive-idUSKBN1343R5,
20161111 8:21AM UTC,BRIEF-Bristol-Myers Squibb and Pfizer to deliver 12 new Eliquis (apixaban) presentations at American Heart Association (AHA) scientific sessions 2016,http://www.reuters.com/article/idUSASC09HVU,
20161111 3:08AM UTC,Pfizer wins EU's approval for Ibrance as Novartis readies rival drug,http://www.reuters.com/article/us-pfizer-ibrance-idUSKBN1350Q9,
20161111 3:05AM UTC,Pfizer wins EU's approval for Ibrance as Novartis readies rival drug,http://www.reuters.com/article/pfizer-ibrance-idUSL8N1DB2L0,
20161112 2:08PM UTC,UPDATE 1-Pfizer offers cut-price pneumonia shot for humanitarian crises,http://www.reuters.com/article/pfizer-vaccines-emergencies-idUSL8N1DC5PW,
20161112 6:19AM UTC,Pfizer offers cut-price pneumonia shot for humanitarian crises,http://www.reuters.com/article/us-pfizer-vaccines-emergencies-idUSKBN13612H,
20161112 6:17AM UTC,Pfizer offers cut-price pneumonia shot for humanitarian crises,http://www.reuters.com/article/pfizer-vaccines-emergencies-idUSL8N1DC2XB,
20161112 6:05AM UTC,BRIEF-Pfizer announces major expansion of humanitarian assistance program,http://www.reuters.com/article/idUSASC09I8N,
20161114 5:13PM UTC,Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen: study,http://www.reuters.com/article/us-heart-pfizer-celebrex-idUSKBN1380VA,
20161114 4:45PM UTC,Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen -study,http://www.reuters.com/article/heart-pfizer-celebrex-idUSL1N1DB2V2,
20161115 7:37PM UTC,BRIEF-Pfizer prices $6 billion debt offering,http://www.reuters.com/article/idUSASC09IW1,
20161115 5:35PM UTC,"BRIEF-Paulson & Co cuts share stake in Pfizer, raises share stake in Facebook",http://www.reuters.com/article/idUSFWN1DF1L3,
20161115 8:56AM UTC,BRIEF-Pfizer says announces tender offer,http://www.reuters.com/article/idUSASC09IK7,
20161115 8:09AM UTC,BRIEF-Pfizer to collaborate with National Cancer Institute,http://www.reuters.com/article/idUSASC09IHU,
20161116 3:39PM UTC,Fitch Rates Pfizer's Notes Offering 'A+(exp)'; Outlook Stable,http://www.reuters.com/article/idUSFit980210,
20161116 8:08AM UTC,BRIEF-Pfizer announces results from phase 3 Opal clinical development program investigating Xeljanz,http://www.reuters.com/article/idUSASC09J0A,
20161119 7:42PM UTC,Pfizer sues Texas health agency for releasing confidential information,http://www.reuters.com/article/health-pfizer-idUSL1N1DK01M,
20161119 2:59PM UTC,"BRIEF-Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019",http://www.reuters.com/article/idUSASC09JS3,
20161122 10:34AM UTC,BRIEF-Pfizer says Pfizer Global Supply President to retire,http://www.reuters.com/article/idUSASC09JY1,
20161130 8:09AM UTC,"German Merck, Pfizer get FDA priority review for cancer drug",http://www.reuters.com/article/us-merck-kgaa-priorityreview-idUSKBN13O1KL,
20161130 8:06AM UTC,"German Merck, Pfizer get FDA priority review for cancer drug",http://www.reuters.com/article/merck-kgaa-priorityreview-idUSF9N1D405H,
20161201 9:36AM UTC,Pfizer's Herceptin biosimilar succeeds in key breast cancer study,http://www.reuters.com/article/us-pfizer-study-idUSKBN13P1R9,
20161201 9:33AM UTC,UPDATE 1-Pfizer's Herceptin biosimilar succeeds in key breast cancer study,http://www.reuters.com/article/pfizer-study-idUSL4N1DV43U,
20161201 8:58AM UTC,Pfizer's Herceptin biosimilar succeeds in key breast cancer study,http://www.reuters.com/article/pfizer-study-idUSL4N1DV426,
20161201 8:35AM UTC,BRIEF-Pfizer announces positive top-line results from the pivotal comparative reflections B3271002 study for PF-05280014,http://www.reuters.com/article/idUSFWN1DV0FQ,
20161202 8:20AM UTC,BRIEF-Pfizer's pain drug Lyrica meets goal in late-stage pediatric epilepsy study,http://www.reuters.com/article/idUSASC09LEE,
20161202 8:18AM UTC,"BRIEF-Pfizer Inc, IBM announced a collaboration that will utilize IBM watson for drug discovery",http://www.reuters.com/article/idUSASC09LEQ,
20161206 10:19AM UTC,Pfizer blood cancer drug tops standard therapy for untreated patients,http://www.reuters.com/article/us-pfizer-study-bosulif-idUSKBN13U1OZ,
20161206 8:43AM UTC,Pfizer's blood cancer drug Bosulif effective in untreated patients,http://www.reuters.com/article/pfizer-study-bosulif-idUSL4N1E042B,
20161206 8:13AM UTC,"BRIEF-Pfizer, Avillion announce positive top-line results for Phase 3 BFORE study of BOSULIF",http://www.reuters.com/article/idUSASC09LTD,
20161208 7:09PM UTC,BRIEF-Medadvisor signs Pfizer for patient engagement program,http://www.reuters.com/article/idUSASN0004H3,
20161208 9:22AM UTC,Britain fines Pfizer record $107 million for huge drug price hike,http://www.reuters.com/article/us-pfizer-britain-fine-idUSKBN13W0VT,
20161208 9:19AM UTC,UPDATE 3-Britain fines Pfizer record $107 mln for huge drug price hike,http://www.reuters.com/article/pfizer-britain-fine-idUSL5N1E215F,
20161208 2:27AM UTC,BRIEF-Pfizer to appeal all aspects of decision by UK's CMA,http://www.reuters.com/article/idUSL5N1E213Q,
20161208 2:19AM UTC,Britain fines Pfizer record $107 mln for huge drug price hike,http://www.reuters.com/article/pfizer-britain-fine-idUSL5N1E2123,
20161208 2:18AM UTC,"BRIEF-UK's CMA fines Pfizer, Flynn Pharma for epilepsy drug price hike",http://www.reuters.com/article/idUSFWN1E10UJ,
20161209 11:22AM UTC,Pfizer gets record UK fine for drug price hike,http://www.reuters.com/news/video/videoStory?storyID=124675013,
20161210 11:49AM UTC,BRIEF-Akili and Pfizer present positive data from digital biomarker study,http://www.reuters.com/article/idUSASC09MRU,
20161214 1:17PM UTC,BRIEF-Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies,http://www.reuters.com/article/idUSASC09N8G,
20161215 5:23PM UTC,Pfizer's Xtandi fails in progression trial vs. J&J;'s Zytiga,http://www.reuters.com/article/us-pfizer-cancer-idUSKBN1432XQ,
20161215 5:22PM UTC,Pfizer's Xtandi fails in progression trial vs J&J;'s Zytiga,http://www.reuters.com/article/pfizer-cancer-idUSL1N1E9287,
20161215 5:10PM UTC,FDA approves Pfizer ointment for chronic itchy skin condition,http://www.reuters.com/article/us-pfizer-fda-eczema-idUSKBN1432GT,
20161215 5:07PM UTC,UPDATE 2-FDA approves Pfizer ointment for chronic itchy skin condition,http://www.reuters.com/article/pfizer-fda-eczema-idUSL4N1E94N7,
20161215 4:53PM UTC,BRIEF-Pfizer says Phase 4 PLATO study did not meet its primary endpoint,http://www.reuters.com/article/idUSASC09NJ4,
20161215 1:25PM UTC,FDA approves Pfizer's eczema ointment,http://www.reuters.com/article/pfizer-fda-eczema-idUSL4N1E94MV,
20161215 2:04AM UTC,BRIEF- Inteliwise signs deal with Pfizer Inc,http://www.reuters.com/article/idUSL5N1E90UZ,
20161217 2:46PM UTC,BRIEF-Pfizer says FDA drops black box warning on anti-smoking drug Chantix,http://www.reuters.com/article/idUSASC09NYJ,
20161217 2:31PM UTC,FDA drops black box warning on Pfizer's anti-smoking drug,http://www.reuters.com/article/pfizer-fda-idUSL1N1EB18B,
20161217 2:30PM UTC,FDA drops black box warning on Pfizer's anti-smoking drug,http://www.reuters.com/article/us-pfizer-fda-idUSKBN1452JJ,
20161217 2:26PM UTC,FDA drops black box warning on Pfizer's anti-smoking drug,http://www.reuters.com/article/pfizer-fda-idUSL4N1EB4PO,
20161217 7:39AM UTC,BRIEF-EMA recommends approval of Pfizer's lifmior drug,http://www.reuters.com/article/idUSFWN1EB0ER,
20161220 8:26AM UTC,BRIEF-Portola Pharmaceuticals enters loan agreement with Bristol-Myers Squibb and Pfizer,http://www.reuters.com/article/idUSASC09O2Z,
20161220 8:13AM UTC,"BRIEF-Catalyst Biosciences secures all rights to manufacturing process for Marzeptacog Alfa from Wyeth LLC, a wholly-owned subsidiary of Pfizer",http://www.reuters.com/article/idUSFWN1EE0B1,
20161220 7:22AM UTC,BRIEF-Pfizer receives approval in the european union for nimenrix in infants six weeks of age and older,http://www.reuters.com/article/idUSASC09O1Z,
20161221 7:27AM UTC,BRIEF-Draper to build preclinical microphysiological systems with Pfizer to help predict clinical outcomes,http://www.reuters.com/article/idUSASC09OAR,
20161222 2:09AM UTC,"BRIEF-BioInvent enters research collaboration, issues new shares to Pfizer",http://www.reuters.com/article/idUSFWN1EG00P,
20161224 3:22AM UTC,BRIEF-Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca,http://www.reuters.com/article/idUSASC09OVB,
20161224 2:10AM UTC,BRIEF-AstraZeneca completes sale of antibiotics business to Pfizer,http://www.reuters.com/article/idUSFWN1EH0QO,
20161231 12:15PM UTC,Growth hormone deficiency drug from OPKO and Pfizer fails study,http://www.reuters.com/article/us-opko-health-trial-idUSKBN14J1AX,
20161231 12:14PM UTC,UPDATE 2-Growth hormone deficiency drug from OPKO and Pfizer fails study,http://www.reuters.com/article/opko-health-trial-idUSL4N1EP36F,
20161231 8:51AM UTC,Growth hormone deficiency drug from OPKO and Pfizer fails study,http://www.reuters.com/article/opko-health-trial-idUSL4N1EP35W,
20170105 3:47PM UTC,Pfizer escapes Lipitor MDL as diabetes link fails,http://www.reuters.com/article/products-lipitor-idUSL1N1EU1I0,
20170105 8:09AM UTC,BRIEF-Absorption Systems announces a technology licensing agreement with Pfizer,http://www.reuters.com/article/idUSFWN1EU0JM,
20170106 8:50AM UTC,BRIEF-Pfizer announces positive top-line results from study for potential Humira biosimilar,http://www.reuters.com/article/idUSFWN1EV0HR,
20170119 7:49AM UTC,BRIEF-Pfizer enters into delegation of authority with Astrazeneca Pharma India,http://www.reuters.com/article/idUSFWN1F80F7,
20170128 7:44AM UTC,BRIEF-Pfizer receives positive CHMP opinion in Europe for Xeljanz,http://www.reuters.com/article/idUSFWN1FH0IN,
20170131 5:40AM UTC,BRIEF-Pfizer Ltd Dec-qtr profit up about 4 pct,http://www.reuters.com/article/idUSFWN1FK09C,
20170201 3:03PM UTC,Pfizer CEO says no need to alter its drug pricing practices,http://www.reuters.com/article/us-pfizer-results-idUSKBN15F1B9,
20170201 3:01PM UTC,UPDATE 4-Pfizer CEO says no need to alter its drug pricing practices,http://www.reuters.com/article/pfizer-results-idUSL4N1FL255,
20170201 11:42AM UTC,BRIEF-Pfizer sees 2017 Prevnar sales flat to slightly down,http://www.reuters.com/article/idUSL1N1FL0YF,
20170201 7:17AM UTC,BRIEF-Pfizer Inc reports Q4 reported diluted EPS of $0.13,http://www.reuters.com/article/idUSL5N1FL3MO,
20170201 7:16AM UTC,BRIEF-Pfizer's Q4 Lyrica IH revenue was $1.06 bln vs $955 mln yr ago,http://www.reuters.com/article/idUSFWN1FL0FC,
20170201 6:57AM UTC,Pfizer quarterly revenue slips 3 percent,http://www.reuters.com/article/pfizer-results-idUSL4N1FL24S,
20170203 7:09PM UTC,UK agency says Pfizer breast cancer drug too expensive,http://www.reuters.com/article/us-pfizer-britain-cancer-idUSKBN15I00B,
20170203 7:01PM UTC,UK agency says Pfizer breast cancer drug too expensive,http://www.reuters.com/article/pfizer-britain-cancer-idUSL5N1FN6NI,
20170203 1:03PM UTC,Pfizer hires JPMorgan to weigh sale of some drugs: Bloomberg,http://www.reuters.com/article/us-pfizer-divestiture-idUSKBN15H2CX,
20170203 12:59PM UTC,Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg,http://www.reuters.com/article/pfizer-divestiture-idUSL4N1FN3S7,
20170203 12:27PM UTC,"BRIEF-Pfizer said to hire JPMorgan to weigh $2 bln portfolio sale - Bloomberg, citing sources",http://www.reuters.com/article/idUSFWN1FN10Q,
20170204 9:05AM UTC,BRIEF-Pfizer commences $5 billion accelerated share repurchase,http://www.reuters.com/article/idUSASB0AYGS,
20170207 8:09AM UTC,BRIEF-ICU Medical completes the acquisition of Hospira Infusion Systems from Pfizer,http://www.reuters.com/article/idUSFWN1FR0KC,
20170214 4:41PM UTC,BRIEF-Pfizer Inc reports  16.4 pct stake in ICU Medical,http://www.reuters.com/article/idUSFWN1FY10H,
20170215 6:23PM UTC,BRIEF-Paulson & Co ups share stake in Pfizer,http://www.reuters.com/article/idUSFWN1FZ1EF,
20170217 8:12AM UTC,BRIEF-Pfizer announces top-line results from oral strategy trial of Xeljanz compared to Humira,http://www.reuters.com/article/idUSL8N1G14VI,
20170218 1:21PM UTC,BRIEF-Pfizer says new data in Crohn's disease patients shows similar efficacy and safety profiles for Inflectra and Remicade A,http://www.reuters.com/article/brief-pfizer-says-new-data-in-crohns-dis-idUSFWN1G20YC,
20170222 8:28AM UTC,BRIEF-Pfizer says U.S. FDA accepts regulatory submission for inotuzumab ozogamicin,http://www.reuters.com/article/brief-pfizer-says-us-fda-accepts-regulat-idUSASB0B189,
20170224 5:49PM UTC,BRIEF-Pfizer says monitoring potential impact related to any changes to ACA,http://www.reuters.com/article/brief-pfizer-says-monitoring-potential-i-idUSFWN1G818Y,
20170224 4:51PM UTC,BRIEF-Ronald Blaylock elected to Pfizer's board of directors,http://www.reuters.com/article/brief-ronald-blaylock-elected-to-pfizers-idUSASB0B22I,
20170225 9:52PM UTC,Pfizer subpoenaed in U.S. over patient assistance plans,http://www.reuters.com/article/us-pfizer-subpoena-idUSKBN1632M3,
20170225 9:50PM UTC,UPDATE 1-Pfizer subpoenaed in U.S. over patient assistance plans,http://www.reuters.com/article/pfizer-subpoena-idUSL1N1GA02J,
20170225 6:41PM UTC,Pfizer subpoenaed in U.S. over patient assistance plans,http://www.reuters.com/article/pfizer-subpoena-idUSL1N1G922Z,
20170225 1:12PM UTC,BRIEF-Pfizer announces pricing of $1.07 bln debt offering,http://www.reuters.com/article/brief-pfizer-announces-pricing-of-107-bl-idUSASB0B2A7,
20170228 7:45AM UTC,Pfizer subpoenaed in U.S. over patient assistance plans,http://www.reuters.com/article/pfizer-subpoena-idUSL2N1GC0EG,
20170301 3:29PM UTC,UPDATE 1-FDA warns Pfizer over contaminated drugs at Kansas plant,http://www.reuters.com/article/pfizer-fda-idUSL2N1GD1FC,
20170301 3:04PM UTC,FDA warns Pfizer over contaminated drugs at Kansas plant,http://www.reuters.com/article/us-pfizer-fda-idUSKBN1672G2,
20170301 2:43PM UTC,FDA warns Pfizer over contaminated drugs at Kansas plant,http://www.reuters.com/article/pfizer-fda-idUSL2N1GD18S,
20170301 7:42AM UTC,"Merck KGaA, Pfizer get priority review for bladder cancer drug",http://www.reuters.com/article/us-merck-pharmaceuticals-pfizer-idUSKBN1671F6,
20170301 7:38AM UTC,"Merck KGaA, Pfizer get priority review for bladder cancer drug",http://www.reuters.com/article/merck-pharmaceuticals-pfizer-idUSFWN1GD0J5,
20170301 7:17AM UTC,BRIEF-Pfizer says FDA accepts Biologics License Application for Avelumab for priority review,http://www.reuters.com/article/brief-pfizer-says-fda-accepts-biologics-idUSASB0B2OP,
20170302 4:46PM UTC,"BRIEF-Spark Therapeutics, Pfizer say SPK-9001 granted access to priority medicines program",http://www.reuters.com/article/brief-spark-therapeutics-pfizer-say-spk-idUSFWN1GE18D,
20170302 11:17AM UTC,Fitch Rates Pfizer's Euro Notes Offering 'A+'; Outlook Stable,http://www.reuters.com/article/fitch-rates-pfizers-euro-notes-offering-idUSFit991437,
20170310 2:04AM UTC,"BRIEF-Servier, Pfizer announce FDA clearance of IND application for UCART19",http://www.reuters.com/article/brief-servier-pfizer-announce-fda-cleara-idUSASB0B4KJ,
20170223 2:59AM UTC,BRIEF-Pfizer to cancel listing in the United Kingdom,http://www.reuters.com/article/brief-pfizer-to-cancel-listing-in-the-un-idUSFWN1G708E,
20170223 1:05AM UTC,BRIEF-Pfizer said SIX swiss exchange approved delisting of its shares,http://www.reuters.com/article/brief-pfizer-said-six-swiss-exchange-app-idUSFWN1G614W,
20170331 5:55PM UTC,Pfizer takes fight over Missouri court's reach to 8th Circuit,http://www.reuters.com/article/products-pfizer-idUSL2N1H729M,
20170314 6:00PM UTC,Novartis wins FDA approval for breast cancer drug aiming for Pfizer's Ibrance,http://www.reuters.com/article/novartis-approval-idUSASN0005Y0,
20170315 5:02PM UTC,Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance,http://www.reuters.com/article/novartis-approval-idUSL2N1GR1I6,
20170315 10:18AM UTC,Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance,http://www.reuters.com/article/us-novartis-approval-idUSKBN16L1RG,
20170315 10:13AM UTC,UPDATE 1-Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance,http://www.reuters.com/article/novartis-approval-idUSL5N1GR48O,
20170315 6:18AM UTC,"BRIEF-Pfizer launches zavicefta in UK, Germany",http://www.reuters.com/article/brief-pfizer-launches-zavicefta-in-uk-ge-idUSFWN1GR06N,
20170316 9:05PM UTC,BRIEF-Pfizer announces approval by China FDA of XELJANZ,http://www.reuters.com/article/brief-pfizer-announces-approval-by-china-idUSASB0B5RR,
20170316 5:21PM UTC,NY jury convicts ex-law firm partner of insider trading on Pfizer-King deal,http://www.reuters.com/article/us-usa-insidertrading-pfizer-idUSKBN16M31Y,
20170316 5:07PM UTC,NY jury convicts ex-law firm partner of insider trading on Pfizer-King deal,http://www.reuters.com/article/usa-insidertrading-pfizer-idUSL2N1GQ0UH,
20170317 4:47PM UTC,NY jury convicts ex-law firm partner of insider trading on Pfizer-King deal,http://www.reuters.com/article/usa-insidertrading-pfizer-idUSL2N1GT1WR,
20170317 2:36PM UTC,BRIEF-Pfizer says CEO Ian Read total 2016 compensation was $17.3 mln,http://www.reuters.com/article/brief-pfizer-says-ceo-ian-read-total-idUSFWN1GT0O3,
20170323 3:50PM UTC,Exclusive: Advent pulls bid for Pfizer's Brazil venture - sources,http://www.reuters.com/article/us-pfizer-divestiture-brazil-idUSKBN16T2UM,
20170324 3:11PM UTC,"FDA approves Pfizer, German Merck immunotherapy for skin cancer",http://www.reuters.com/article/us-pfizer-merck-fda-idUSKBN16U2PG,
20170324 3:10PM UTC,"FDA approves Pfizer, German Merck immunotherapy for skin cancer",http://www.reuters.com/article/pfizer-merck-fda-idUSL2N1H01KV,
20170325 7:42AM UTC,"BRIEF-Pfizer Ltd says news on USFDA observations for Hospira Vizag unit does not relate to Pfizer, India",http://www.reuters.com/article/brief-pfizer-ltd-says-news-on-usfda-obse-idUSFWN1H109Y,
20170329 9:26PM UTC,BRIEF-Suda enters feasibility agreement with Pfizer,http://www.reuters.com/article/brief-suda-enters-feasibility-agreement-idUSFWN1H50S1,
20170408 5:38PM UTC,Bristol-Myers Squibb and Pfizer sue to block generic Eliquis,http://www.reuters.com/article/bristol-myers-squibb-and-pfizer-sue-to-b/bristol-myers-squibb-and-pfizer-sue-to-block-generic-eliquis-idUSL1N1HF1WL,
20170411 2:00AM UTC,Roche's Alecensa notches trial win against Pfizer's Xalkori,http://www.reuters.com/article/us-roche-pfizer/roches-alecensa-notches-trial-win-against-pfizers-xalkori-idUSKBN17C0FG,
20170411 1:38AM UTC,Roche's Alecensa notches trial win against Pfizer's Xalkori,http://www.reuters.com/article/roche-pfizer/roches-alecensa-notches-trial-win-against-pfizers-xalkori-idUSFWN1HH021,
20170419 3:21AM UTC,"BRIEF-Hitgen, Pfizer enter research collaboration and license agreement to build and screen novel DNA-encoded libraries",http://www.reuters.com/article/brief-hitgen-pfizer-enter-research-colla/brief-hitgen-pfizer-enter-research-collaboration-and-license-agreement-to-build-and-screen-novel-dna-encoded-libraries-idUSFWN1HQ024,
20170420 9:13PM UTC,UPDATE 3-Pfizer subpoenaed in U.S. intravenous saline solution probe,http://www.reuters.com/article/pfizer-antitrust/update-3-pfizer-subpoenaed-in-u-s-intravenous-saline-solution-probe-idUSL1N1HR0S7,
20170420 4:05PM UTC,Pfizer receives subpoenas in U.S. intravenous saline solution probe,http://www.reuters.com/article/pfizer-antitrust/pfizer-receives-subpoenas-in-u-s-intravenous-saline-solution-probe-idUSL1N1HR1NG,
20170420 3:10PM UTC,Pfizer subpoenaed in U.S. intravenous saline solution probe,http://www.reuters.com/article/us-pfizer-antitrust/pfizer-subpoenaed-in-u-s-intravenous-saline-solution-probe-idUSKBN17L1XT,
20170420 10:57AM UTC,Pfizer receives subpoenas in U.S. intravenous saline solution probe,http://www.reuters.com/article/pfizer-antitrust/pfizer-receives-subpoenas-in-u-s-intravenous-saline-solution-probe-idUSL1N1HR0QE,
20170426 8:31AM UTC,"BRIEF-Aquinnah receives $10 mln investment from Pfizer, Abbvie",http://www.reuters.com/article/brief-aquinnah-receives-10-mln-investmen/brief-aquinnah-receives-10-mln-investment-from-pfizer-abbvie-idUSFWN1HX0MI,
20170428 3:10PM UTC,BRIEF-Pfizer Inc declared a 32-cent Q2 2017 dividend on co's common stock,http://www.reuters.com/article/brief-pfizer-inc-declared-a-32-cent-q2-2/brief-pfizer-inc-declared-a-32-cent-q2-2017-dividend-on-cos-common-stock-idUSFWN1HZ1G1,
20170428 9:12AM UTC,BRIEF-InSphero announces agreement with Pfizer to develop novel assays for predicting drug-induced liver injury,http://www.reuters.com/article/brief-insphero-announces-agreement-with/brief-insphero-announces-agreement-with-pfizer-to-develop-novel-assays-for-predicting-drug-induced-liver-injury-idUSFWN1HZ11Q,
20170428 8:17AM UTC,BRIEF-Pfizerâ€™s ALK/ROS1 inhibitor granted breakthrough therapy designation from FDA,http://www.reuters.com/article/brief-pfizers-alk-ros1-inhibitor-granted/brief-pfizers-alk-ros1-inhibitor-granted-breakthrough-therapy-designation-from-fda-idUSASA09KVK,
20170503 4:15PM UTC,"Prescription for growth at Pfizer? Analysts say, deals",http://www.reuters.com/article/pfizer-results/prescription-for-growth-at-pfizer-analysts-say-deals-idUSL1N1I41QM,
20170503 12:58PM UTC,Prescription for growth at Pfizer? Analysts say deals,http://www.reuters.com/article/us-pfizer-results/prescription-for-growth-at-pfizer-analysts-say-deals-idUSKBN17Y14L,
20170503 12:52PM UTC,UPDATE 4-Prescription for growth at Pfizer? Analysts say deals,http://www.reuters.com/article/pfizer-results/update-4-prescription-for-growth-at-pfizer-analysts-say-deals-idUSL4N1I430D,
20170503 7:10AM UTC,BRIEF-Pfizer Q1 adjusted earnings per share $0.69,http://www.reuters.com/article/brief-pfizer-q1-adjusted-earnings-per-sh/brief-pfizer-q1-adjusted-earnings-per-share-0-69-idUSASA09LY3,
20170503 6:55AM UTC,Pfizer's quarterly profit rises 2.7 pct,http://www.reuters.com/article/pfizer-results/pfizers-quarterly-profit-rises-2-7-pct-idUSL4N1I42W1,
20170504 5:18PM UTC,New York appeals court revives NYU royalty case against Pfizer,http://www.reuters.com/article/health-pfizer/new-york-appeals-court-revives-nyu-royalty-case-against-pfizer-idUSL1N1I528Z,
20170504 9:09AM UTC,BRIEF-Pfizer announces U.S. FDA filing acceptance of supplemental new drug application for Xeljanz,http://www.reuters.com/article/brief-pfizer-announces-us-fda-filing-acc/brief-pfizer-announces-u-s-fda-filing-acceptance-of-supplemental-new-drug-application-for-xeljanz-idUSASA09MHH,
20170509 12:37PM UTC,"BRIEF-Pfizer says multi-year extension of collaboration with Bill & Melinda Gates Foundation, Children's Investment Fund Foundation",http://www.reuters.com/article/brief-pfizer-says-multi-year-extension-o/brief-pfizer-says-multi-year-extension-of-collaboration-with-bill-melinda-gates-foundation-childrens-investment-fund-foundation-idUSFWN1IA0OP,
20170510 5:34PM UTC,"Bristol-Myers, Pfizer beat amended Eliquis case over bleeding risks",http://www.reuters.com/article/products-eliquis/bristol-myers-pfizer-beat-amended-eliquis-case-over-bleeding-risks-idUSL1N1IB1YM,
20170510 5:16PM UTC,Pfizer immuno-oncology drug wins U.S. approval for bladder cancer,http://www.reuters.com/article/us-pfizer-approval/pfizer-immuno-oncology-drug-wins-u-s-approval-for-bladder-cancer-idUSKBN18522F,
20170510 5:12PM UTC,UPDATE 1-Pfizer immuno-oncology drug wins U.S. approval for bladder cancer,http://www.reuters.com/article/pfizer-approval/update-1-pfizer-immuno-oncology-drug-wins-u-s-approval-for-bladder-cancer-idUSL1N1IB1Q8,
20170510 3:58PM UTC,Pfizer immuno-oncology drug wins U.S. approval for bladder cancer,http://www.reuters.com/article/pfizer-approval/pfizer-immuno-oncology-drug-wins-u-s-approval-for-bladder-cancer-idUSL1N1IB1KX,
20170510 12:47PM UTC,Pfizer immuno-oncology drug wins U.S. approval for bladder cancer,http://www.reuters.com/article/pfizer-approval/pfizer-immuno-oncology-drug-wins-u-s-approval-for-bladder-cancer-idUSL1N1IB11J,
20170511 5:41PM UTC,"Pfizer strikes deal with Sangamo, broadening hemophilia pipeline",http://www.reuters.com/article/us-sangamo-pfizer-deal/pfizer-strikes-deal-with-sangamo-broadening-hemophilia-pipeline-idUSKBN1862Y0,
20170511 5:36PM UTC,"Pfizer strikes deal with Sangamo, broadening hemophilia pipeline",http://www.reuters.com/article/sangamo-pfizer-deal/pfizer-strikes-deal-with-sangamo-broadening-hemophilia-pipeline-idUSL1N1IC27E,
20170511 4:18PM UTC,BRIEF-Sangamo Therapeutics and Pfizer announce collaboration for Hemophilia A gene therapy,http://www.reuters.com/article/brief-sangamo-therapeutics-and-pfizer-an/brief-sangamo-therapeutics-and-pfizer-announce-collaboration-for-hemophilia-a-gene-therapy-idUSFWN1IC178,
20170512 4:43PM UTC,"BRIEF-Pfizer says in connection with Hospira acquisition, expects to incur costs of about $1 bln for up to 3-yr period post-acquisition",http://www.reuters.com/article/brief-pfizer-says-in-connection-with-hos/brief-pfizer-says-in-connection-with-hospira-acquisition-expects-to-incur-costs-of-about-1-bln-for-up-to-3-yr-period-post-acquisition-idUSFWN1ID18P,
20170518 5:09PM UTC,Pfizer drug from Medivation deal shows promise in breast cancer: study,http://www.reuters.com/article/us-health-cancer-pfizer/pfizer-drug-from-medivation-deal-shows-promise-in-breast-cancer-study-idUSKCN18D2Q2,
20170518 5:00PM UTC,Pfizer drug from Medivation deal shows promise in breast cancer -study,http://www.reuters.com/article/health-cancer-pfizer/pfizer-drug-from-medivation-deal-shows-promise-in-breast-cancer-study-idUSL2N1IH1SU,
20170525 5:35PM UTC,Pfizer must face Lipitor injury lawsuits in California state court - judge,http://www.reuters.com/article/products-lipitor/pfizer-must-face-lipitor-injury-lawsuits-in-california-state-court-judge-idUSL1N1IQ28X,
20170525 7:03AM UTC,BRIEF-Pfizer recommends shareholders reject below-market mini-tender offer by TRC Capital,http://www.reuters.com/article/brief-pfizer-recommends-shareholders-rej/brief-pfizer-recommends-shareholders-reject-below-market-mini-tender-offer-by-trc-capital-idUSFWN1IQ0F4,
20170526 1:27PM UTC,BRIEF-FDA committee recommends approval of Pfizer's epoetin alfa biosimilar,http://www.reuters.com/article/brief-fda-committee-recommends-approval/brief-fda-committee-recommends-approval-of-pfizers-epoetin-alfa-biosimilar-idUSASA09RG1,
20170531 10:13AM UTC,BRIEF-EU approves Pfizerâ€™s Trumenba to help prevent meningococcal group B disease in adolescents and adults,http://www.reuters.com/article/brief-eu-approves-pfizers-trumenba-to-he/brief-eu-approves-pfizers-trumenba-to-help-prevent-meningococcal-group-b-disease-in-adolescents-and-adults-idUSFWN1IW0PI,
20170601 8:36AM UTC,BRIEF-Pfizer announces acceptance of regulatory submissions by U.S. FDA and European Medicines Agency for Sutent,http://www.reuters.com/article/brief-pfizer-announces-acceptance-of-reg/brief-pfizer-announces-acceptance-of-regulatory-submissions-by-u-s-fda-and-european-medicines-agency-for-sutent-idUSASA09S28,
20170601 6:38AM UTC,"BRIEF-India's Pfizer Ltd signs deal to buy Neksium brand from AstraZeneca AB, Sweden",http://www.reuters.com/article/brief-indias-pfizer-ltd-signs-deal-to-bu/brief-indias-pfizer-ltd-signs-deal-to-buy-neksium-brand-from-astrazeneca-ab-sweden-idUSFWN1IX0B2,
20170603 2:55PM UTC,REFILE-Pfizer hikes U.S. prices of 91 drugs by average 20 pct in 2017-FT,http://www.reuters.com/article/pfizer-pricing/refile-pfizer-hikes-u-s-prices-of-91-drugs-by-average-20-pct-in-2017-ft-idUSL3N1IZ4J2,
20170603 2:55PM UTC,Pfizer hikes U.S. prices of 91 drugs by average 20 percent in 2017: Financial Times,http://www.reuters.com/article/us-pfizer-pricing/pfizer-hikes-u-s-prices-of-91-drugs-by-average-20-percent-in-2017-financial-times-idUSKBN18T2QF,
20170603 2:43PM UTC,"BRIEF-Pfizer says for coâ€™s U.S. biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4 pct in the U.S.",http://www.reuters.com/article/brief-pfizer-says-for-cos-us-biopharma-b/brief-pfizer-says-for-cos-u-s-biopharma-business-as-of-the-first-quarter-the-weighted-average-net-selling-price-increase-ytd-is-4-pct-in-the-u-s-idUSFWN1IZ0G5,
20170603 2:40PM UTC,Pfizer defeats appeals linking Zoloft to birth defects,http://www.reuters.com/article/us-pfizer-lawsuit-zoloft/pfizer-defeats-appeals-linking-zoloft-to-birth-defects-idUSKBN18T1VZ,
20170603 2:38PM UTC,UPDATE 3-Pfizer defeats appeals linking Zoloft to birth defects,http://www.reuters.com/article/pfizer-lawsuit-zoloft/update-3-pfizer-defeats-appeals-linking-zoloft-to-birth-defects-idUSL1N1IZ0LD,
20170603 12:51PM UTC,Pfizer defeats appeals linking Zoloft to birth defects,http://www.reuters.com/article/pfizer-lawsuit-zoloft/pfizer-defeats-appeals-linking-zoloft-to-birth-defects-idUSL1N1IZ0LL,
20170603 9:10AM UTC,Pfizer defeats appeals over Zoloft birth defects,http://www.reuters.com/article/pfizer-lawsuit-zoloft/pfizer-defeats-appeals-over-zoloft-birth-defects-idUSL1N1IZ0KG,
20170603 8:57AM UTC,BRIEF-Pfizer defeats appeal over Zoloft,http://www.reuters.com/article/pfizer-ruling/brief-pfizer-defeats-appeal-over-zoloft-idUSL1N1IZ0IC,
20170606 4:53PM UTC,Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial,http://www.reuters.com/article/health-cancer-roche-pfizer/roches-alecensa-bests-pfizers-xalkori-in-lung-cancer-trial-idUSL1N1J21QT,
20170606 7:46AM UTC,Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial,http://www.reuters.com/article/us-health-cancer-roche-pfizer/roches-alecensa-bests-pfizers-xalkori-in-lung-cancer-trial-idUSKBN18W1HH,
20170606 7:37AM UTC,Pfizer drug delays lung cancer growth longer than Astra's Iressa: study,http://www.reuters.com/article/us-health-cancer-pfizer/pfizer-drug-delays-lung-cancer-growth-longer-than-astras-iressa-study-idUSKBN18W1HD,
20170606 7:30AM UTC,Pfizer drug delays lung cancer growth longer than Astra's Iressa-study,http://www.reuters.com/article/health-cancer-pfizer/pfizer-drug-delays-lung-cancer-growth-longer-than-astras-iressa-study-idUSL1N1IZ13A,
20170606 7:30AM UTC,Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial,http://www.reuters.com/article/health-cancer-roche-pfizer/roches-alecensa-bests-pfizers-xalkori-in-lung-cancer-trial-idUSL1N1IY1TF,
20170607 8:11AM UTC,BRIEF-Pfizer receives FDA fast track designation for Tafamidis for transthyretin cardiomyopathy,http://www.reuters.com/article/brief-pfizer-receives-fda-fast-track-des/brief-pfizer-receives-fda-fast-track-designation-for-tafamidis-for-transthyretin-cardiomyopathy-idUSASA09STU,
20170610 8:17AM UTC,"BRIEF-Astellas, Pfizer announce amendment to clinical research protocol for phase 3 prosper trial of enzalutamide",http://www.reuters.com/article/brief-astellas-pfizer-announce-amendment/brief-astellas-pfizer-announce-amendment-to-clinical-research-protocol-for-phase-3-prosper-trial-of-enzalutamide-idUSFWN1J60BK,
20170614 12:27PM UTC,"UPDATE 2-Pfizer, Roche and Aspen face South African probe into cancer drug prices",http://www.reuters.com/article/safrica-pharmaceuticals/update-2-pfizer-roche-and-aspen-face-south-african-probe-into-cancer-drug-prices-idUSL8N1JA35D,
20170614 8:32AM UTC,BRIEF-Pfizer and Lilly receive FDA fast track designation for Tanezumab,http://www.reuters.com/article/brief-pfizer-and-lilly-receive-fda-fast/brief-pfizer-and-lilly-receive-fda-fast-track-designation-for-tanezumab-idUSASA09TML,
20170615 1:31PM UTC,BRIEF-Basilea announces license agreement with Pfizer for antifungal Cresemba,http://www.reuters.com/article/brief-basilea-announces-license-agreemen/brief-basilea-announces-license-agreement-with-pfizer-for-antifungal-cresemba-idUSFWN1JB0OY,
20170615 1:27PM UTC,"BRIEF-Pfizer to have exclusive rights to distribute, commercialize CRESEMBA in Europe",http://www.reuters.com/article/brief-pfizer-to-have-exclusive-rights-to/brief-pfizer-to-have-exclusive-rights-to-distribute-commercialize-cresemba-in-europe-idUSASM000BW4,
20170615 10:02AM UTC,"Pfizer, Roche and Aspen face South African probe into cancer drug prices",http://www.reuters.com/article/us-safrica-pharmaceuticals/pfizer-roche-and-aspen-face-south-african-probe-into-cancer-drug-prices-idUSKBN1941HG,
20170615 10:02AM UTC,Pfizer denies over-charging for cancer drugs in South Africa,http://www.reuters.com/article/us-safrica-pharmaceuticals-reaction/pfizer-denies-over-charging-for-cancer-drugs-in-south-africa-idUSKBN195216,
20170615 9:59AM UTC,Pfizer denies over-charging for cancer drugs in South Africa,http://www.reuters.com/article/safrica-pharmaceuticals/pfizer-denies-over-charging-for-cancer-drugs-in-south-africa-idUSL8N1JB48S,
20170616 6:32PM UTC,BRIEF-U.S. FDA updates on Pfizer drug shortages,http://www.reuters.com/article/brief-us-fda-updates-on-pfizer-drug-shor/brief-u-s-fda-updates-on-pfizer-drug-shortages-idUSFWN1JC0NZ,
20170620 8:21AM UTC,BRIEF-Pfizer begins Phase 1 clinical trial to evaluate investigational Group B streptococcus vaccine,http://www.reuters.com/article/brief-pfizer-begins-phase-1-clinical-tri/brief-pfizer-begins-phase-1-clinical-trial-to-evaluate-investigational-group-b-streptococcus-vaccine-idUSASA09U8F,
20170621 8:54AM UTC,BRIEF-Effector Therapeutics to collaborate with Pfizer and Merck to evaluate immuno-oncology combination in microsatellite stable colorectal cancer,http://www.reuters.com/article/brief-effector-therapeutics-to-collabora/brief-effector-therapeutics-to-collaborate-with-pfizer-and-merck-to-evaluate-immuno-oncology-combination-in-microsatellite-stable-colorectal-cancer-idUSFWN1JH0FQ,
20170622 8:12AM UTC,"BRIEF-Pfizer receives Health Canada approval for Ibrance in hr+, her2- metastatic breast cancer",http://www.reuters.com/article/brief-pfizer-receives-health-canada-appr/brief-pfizer-receives-health-canada-approval-for-ibrance-in-hr-her2-metastatic-breast-cancer-idUSFWN1JI0IG,
20170623 4:17PM UTC,BRIEF-Pfizer sets quarterly dividend of $0.32 per share,http://www.reuters.com/article/brief-pfizer-sets-quarterly-dividend-of/brief-pfizer-sets-quarterly-dividend-of-0-32-per-share-idUSFWN1JJ0LS,
20170628 9:21AM UTC,"BRIEF-Pfizer expects to hire an additional 80 employees over coming years to support research at new research and development facility in Chesterfield, Missouri",http://www.reuters.com/article/brief-pfizer-expects-to-hire-an-addition/brief-pfizer-expects-to-hire-an-additional-80-employees-over-coming-years-to-support-research-at-new-research-and-development-facility-in-chesterfield-missouri-idUSFWN1JO09P,
20170701 7:52AM UTC,BRIEF-Pfizer says Besponsa approved in the EU for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia,http://www.reuters.com/article/brief-pfizer-says-besponsa-approved-in-t/brief-pfizer-says-besponsa-approved-in-the-eu-for-adult-patients-with-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukemia-idUSFWN1JR0H6,
20170705 1:51PM UTC,"Pfizer receives token payment to exit Brazil venture, sources say",http://www.reuters.com/article/us-pfizer-divestiture-brazil/pfizer-receives-token-payment-to-exit-brazil-venture-sources-say-idUSKBN19P293,
20170705 1:44PM UTC,"Pfizer receives token payment to exit Brazil venture, sources say",http://www.reuters.com/article/pfizer-divestiture-brazil/pfizer-receives-token-payment-to-exit-brazil-venture-sources-say-idUSL1N1JV0EG,
20170712 4:42PM UTC,BRIEF-FDA Advisory Committee votes in favor of Pfizer's Mylotarg for acute myeloid leukemia,http://www.reuters.com/article/brief-fda-advisory-committee-votes-in-fa/brief-fda-advisory-committee-votes-in-favor-of-pfizers-mylotarg-for-acute-myeloid-leukemia-idUSFWN1K20MG,
20170714 4:29PM UTC,BRIEF-Mersana Therapeutics says Pfizer reports 9.8 percent passive stake in Mersana as of July 3 - SEC Filing,http://www.reuters.com/article/brief-mersana-therapeutics-says-pfizer-r/brief-mersana-therapeutics-says-pfizer-reports-9-8-percent-passive-stake-in-mersana-as-of-july-3-sec-filing-idUSFWN1K40GM,
20170714 8:25AM UTC,BRIEF-Pfizer says FDA accepted supplemental NDA for ulcerative colitis treatment,http://www.reuters.com/article/brief-pfizer-says-fda-accepted-supplemen/brief-pfizer-says-fda-accepted-supplemental-nda-for-ulcerative-colitis-treatment-idUSASA09WYB,
20170721 1:23AM UTC,BRIEF-Basilea completes license agreement with Pfizer for Cresemba,http://www.reuters.com/article/brief-basilea-completes-license-agreemen/brief-basilea-completes-license-agreement-with-pfizer-for-cresemba-idUSFWN1KA0XB,
20170722 7:38AM UTC,BRIEF-Merck KGaA and Pfizer: CHMP recommends approval of avelumab,http://www.reuters.com/article/brief-merck-kgaa-and-pfizer-chmp-recomme/brief-merck-kgaa-and-pfizer-chmp-recommends-approval-of-avelumab-idUSFWN1KC0AK,
20170722 7:36AM UTC,"Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval",http://www.reuters.com/article/us-pfizer-merck-cancer/pfizer-merck-kgaa-skin-cancer-drug-gets-ema-nod-for-approval-idUSKBN1A61C9,
20170722 7:34AM UTC,"Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval",http://www.reuters.com/article/pfizer-merck-cancer/pfizer-merck-kgaa-skin-cancer-drug-gets-ema-nod-for-approval-idUSL3N1KC3E0,
20170725 8:38AM UTC,BRIEF-Pfizer announces positive top-line results,http://www.reuters.com/article/brief-pfizer-announces-positive-top-line/brief-pfizer-announces-positive-top-line-results-idUSFWN1KF0DR,
20170726 6:00PM UTC,Adviser charged with insider trading on Pfizer-King deal pleads guilty,http://www.reuters.com/article/usa-insidertrading-pfizer/adviser-charged-with-insider-trading-on-pfizer-king-deal-pleads-guilty-idUSL1N1KG256,
20170726 5:54PM UTC,Adviser charged with insider trading on Pfizer-King deal pleads guilty,http://www.reuters.com/article/us-usa-insidertrading-pfizer/adviser-charged-with-insider-trading-on-pfizer-king-deal-pleads-guilty-idUSKBN1AA2RN,
20170726 5:36PM UTC,Adviser charged with insider trading on Pfizer-King deal pleads guilty,http://www.reuters.com/article/usa-insidertrading-pfizer/adviser-charged-with-insider-trading-on-pfizer-king-deal-pleads-guilty-idUSL1N1KG21S,
20170729 4:34PM UTC,"Federal judge tosses most Eliquis cases vs. Bristol-Myers, Pfizer",http://www.reuters.com/article/products-eliquis/federal-judge-tosses-most-eliquis-cases-vs-bristol-myers-pfizer-idUSL1N1KJ1TO,
20170802 1:36PM UTC,Pfizer delays major M&A; as it awaits U.S. tax reform clarity,http://www.reuters.com/article/us-pfizer-results/pfizer-delays-major-ma-as-it-awaits-u-s-tax-reform-clarity-idUSKBN1AH3ZJ,
20170802 1:35PM UTC,UPDATE 4-Pfizer delays major M&A; as it awaits U.S. tax reform clarity,http://www.reuters.com/article/pfizer-results/update-4-pfizer-delays-major-ma-as-it-awaits-u-s-tax-reform-clarity-idUSL4N1KN41O,
20170802 9:10AM UTC,BRIEF-Pfizer reports Q2 worldwide Ibrance revenue $853 mln vs $514 mln,http://www.reuters.com/article/brief-pfizer-reports-q2-worldwide-ibranc/brief-pfizer-reports-q2-worldwide-ibrance-revenue-853-mln-vs-514-mln-idUSFWN1KN0EC,
20170802 7:05AM UTC,BRIEF-Pfizer Q2 earnings per share $0.51,http://www.reuters.com/article/brief-pfizer-q2-earnings-per-share-051/brief-pfizer-q2-earnings-per-share-0-51-idUSL5N1KN39I,
20170802 6:55AM UTC,Pfizer quarterly revenue slips 2 percent,http://www.reuters.com/article/pfizer-results/pfizer-quarterly-revenue-slips-2-percent-idUSL4N1KN412,
20170802 10:36AM UTC,Pfizer's revenue falls again,http://www.reuters.com/news/video/videoStory?storyID=131261553,
20170803 5:54AM UTC,CORRECTED-BRIEF-Pfizer reports second-quarter results (Aug 1),http://www.reuters.com/article/idUSASB0BC15,
20170809 8:22AM UTC,BRIEF-Avara Pharmaceutical buys Pfizer's Italy sterile facility,http://www.reuters.com/article/brief-avara-pharmaceutical-buys-pfizers/brief-avara-pharmaceutical-buys-pfizers-italy-sterile-facility-idUSASB0BE2W,
20170811 4:47PM UTC,BRIEF-Pfizer Inc - U.S. DOJ's antitrust division is investigating co's greenstone generics business -  SEC Filingâ€â€‹,http://www.reuters.com/article/brief-pfizer-inc-us-dojs-antitrust-divis/brief-pfizer-inc-u-s-dojs-antitrust-division-is-investigating-cos-greenstone-generics-business-sec-filing-idUSFWN1KW1AU,
20170815 6:15PM UTC,"BRIEF-Soros Fund Management dissolves share stake in Tesla, Pfizer, ConocoPhillips",http://www.reuters.com/article/brief-soros-fund-management-dissolves-sh/brief-soros-fund-management-dissolves-share-stake-in-tesla-pfizer-conocophillips-idUSFWN1L00YS,
20170815 5:12PM UTC,"BRIEF-Paulson & Co dissolves share stake in Pfizer, ups in ValeantÂ â€â€‹",http://www.reuters.com/article/brief-paulson-co-dissolves-share-stake-i/brief-paulson-co-dissolves-share-stake-in-pfizer-ups-in-valeant-idUSFWN1L00WL,
20170815 4:41PM UTC,"BRIEF-Appaloosa dissolves share stake in Snap Inc, Pfizer Inc",http://www.reuters.com/article/brief-appaloosa-dissolves-share-stake-in/brief-appaloosa-dissolves-share-stake-in-snap-inc-pfizer-inc-idUSFWN1L00VP,
20170818 4:22PM UTC,BRIEF-Pfizer receives FDA approval for BESPONSA (inotuzumab ozogamicin),http://www.reuters.com/article/brief-pfizer-receives-fda-approval-for-b/brief-pfizer-receives-fda-approval-for-besponsa-idUSASB0BGCB,
20170818 4:17PM UTC,"BRIEF-Pfizer says based on typical duration of treatment, total cost of Besponsa is $168,300",http://www.reuters.com/article/brief-pfizer-says-based-on-typical-durat/brief-pfizer-says-based-on-typical-duration-of-treatment-total-cost-of-besponsa-is-168300-idUSFWN1L30ON,
20170818 3:59PM UTC,FDA approves Pfizer's drug for rare blood cancer,http://www.reuters.com/article/us-pfizer-fda-leukemia/fda-approves-pfizers-drug-for-rare-blood-cancer-idUSKCN1AX2A0,
20170818 3:59PM UTC,UPDATE 2-FDA approves Pfizer's drug for rare blood cancer,http://www.reuters.com/article/pfizer-fda-leukemia/update-2-fda-approves-pfizers-drug-for-rare-blood-cancer-idUSL4N1L34QA,
20170818 1:48PM UTC,FDA approves Pfizer's drug for rare blood cancer,http://www.reuters.com/article/pfizer-fda-leukemia/fda-approves-pfizers-drug-for-rare-blood-cancer-idUSL4N1L34PQ,
20170818 1:40PM UTC,BRIEF-U.S. FDA approves Pfizer's leukemia drug Besponsa â€â€‹,http://www.reuters.com/article/brief-us-fda-approves-pfizers-leukemia-d/brief-u-s-fda-approves-pfizers-leukemia-drug-besponsa-idUSFWN1L30OI,
20170823 9:48AM UTC,India grants Pfizer patent on pneumonia vaccine in blow to aid group,http://www.reuters.com/article/us-pfizer-india-vaccine/india-grants-pfizer-patent-on-pneumonia-vaccine-in-blow-to-aid-group-idUSKCN1B218S,
20170823 7:33AM UTC,India grants Pfizer patent on pneumonia vaccine in blow to aid group,http://www.reuters.com/article/pfizer-india-vaccine/india-grants-pfizer-patent-on-pneumonia-vaccine-in-blow-to-aid-group-idUSL4N1L830X,
20170824 2:21AM UTC,REFILE-UPDATE 1-India grants Pfizer patent on pneumonia vaccine in blow to aid group,http://www.reuters.com/article/pfizer-india-vaccine/refile-update-1-india-grants-pfizer-patent-on-pneumonia-vaccine-in-blow-to-aid-group-idUSL4N1L845T,
20170826 11:50AM UTC,BRIEF-Pfizer and Sangamo updates on early stage trial on its blood disorder therapy,http://www.reuters.com/article/brief-pfizer-and-sangamo-updates-on-earl/brief-pfizer-and-sangamo-updates-on-early-stage-trial-on-its-blood-disorder-therapy-idUSASB0BH5B,
20170830 7:16AM UTC,BRIEF-Pfizer says U.S. FDA and EMA accept regulatory submissions for bosuliffor,http://www.reuters.com/article/brief-pfizer-says-us-fda-and-ema-accept/brief-pfizer-says-u-s-fda-and-ema-accept-regulatory-submissions-for-bosuliffor-idUSASM000EB7,
20170902 3:25PM UTC,FDA approves Pfizer's leukemia drug,http://www.reuters.com/article/us-pfizer-fda/fda-approves-pfizers-leukemia-drug-idUSKCN1BC5B7,
20170902 3:21PM UTC,UPDATE 2-FDA approves Pfizer's leukemia drug,http://www.reuters.com/article/pfizer-fda/update-2-fda-approves-pfizers-leukemia-drug-idUSL2N1LI1MA,
20170902 3:01PM UTC,CORRECTED-UPDATE 1-FDA approves Pfizer's leukemia drug,http://www.reuters.com/article/pfizer-fda/corrected-update-1-fda-approves-pfizers-leukemia-drug-idUSL4N1LI4B9,
20170902 11:54AM UTC,FDA approves Pfizer's leukemia drug,http://www.reuters.com/article/us-pfizer-fda/fda-approves-pfizers-leukemia-drug-idUSKCN1BC5BF,
20170902 11:39AM UTC,BRIEF-Pfizer receives FDA approval for MYLOTARG (gemtuzumab ozogamicin),http://www.reuters.com/article/brief-pfizer-receives-fda-approval-for-m/brief-pfizer-receives-fda-approval-for-mylotarg-idUSASB0BHWH,
20170902 11:33AM UTC,FDA approves Pfizer's leukemia drug,http://www.reuters.com/article/pfizer-fda/fda-approves-pfizers-leukemia-drug-idUSL4N1LI4AW,
20170902 11:19AM UTC,BRIEF-U.S. FDA approves Pfizer's Mylotarg for treatment of acute myeloid leukemia,http://www.reuters.com/article/brief-us-fda-approves-pfizers-mylotarg-f/brief-u-s-fda-approves-pfizers-mylotarg-for-treatment-of-acute-myeloid-leukemia-idUSFWN1LI0JG,
20170911 4:23AM UTC,"Lilly takes on Pfizer, Novartis with new breast cancer drug data",http://www.reuters.com/article/us-health-cancer-lilly/lilly-takes-on-pfizer-novartis-with-new-breast-cancer-drug-data-idUSKCN1BK0WS,
20170911 4:19AM UTC,"UPDATE 1-Lilly takes on Pfizer, Novartis with new breast cancer drug data",http://www.reuters.com/article/health-cancer-lilly/update-1-lilly-takes-on-pfizer-novartis-with-new-breast-cancer-drug-data-idUSL2N1LR07O,
20170912 7:32AM UTC,BRIEF-Pfizer says â€results indicated a improvement in OS for patients,http://www.reuters.com/article/brief-pfizer-says-results-indicated-a-im/brief-pfizer-says-results-indicated-a-improvement-in-os-for-patients-idUSFWN1LS0DQ,
20170915 11:29AM UTC,"Pfizer, Astellas prostate cancer drug promising in late-stage trial",http://www.reuters.com/article/us-pfizer-trials/pfizer-astellas-prostate-cancer-drug-promising-in-late-stage-trial-idUSKCN1BP146,
20170915 11:29AM UTC,"UPDATE 3-Pfizer, Astellas prostate cancer drug promising in late-stage trial",http://www.reuters.com/article/pfizer-trials/update-3-pfizer-astellas-prostate-cancer-drug-promising-in-late-stage-trial-idUSL4N1LV4RO,
20170915 9:51AM UTC,"CORRECTED-UPDATE 2-Pfizer, Astellas prostate cancer drug succeeds key trial",http://www.reuters.com/article/pfizer-trials/corrected-update-2-pfizer-astellas-prostate-cancer-drug-succeeds-key-trial-idUSL4N1LV3P0,
20170915 6:16AM UTC,"Pfizer, Astellas prostate cancer drug clears late-stage trial",http://www.reuters.com/article/us-pfizer-trials/pfizer-astellas-prostate-cancer-drug-clears-late-stage-trial-idUSKCN1BP142,
20170915 5:54AM UTC,"CORRECTED-Pfizer, Astellas prostate cancer drug clears late-stage trial",http://www.reuters.com/article/pfizer-trials/corrected-pfizer-astellas-prostate-cancer-drug-clears-late-stage-trial-idUSL4N1LV3OB,
20170915 5:17AM UTC,BRIEF-Astellas Pharma and Pfizer say positive top-line results from phase 3 prosper trial of XTANDI (enzalutamide),http://www.reuters.com/article/brief-astellas-pharma-and-pfizer-say-pos/brief-astellas-pharma-and-pfizer-say-positive-top-line-results-from-phase-3-prosper-trial-of-xtandi-idUSL4N1LV3LU,
20170915 5:10AM UTC,"BRIEF-Pfizer, Astellas report positive top-line results from phase 3 PROSPER trial of XTANDI",http://www.reuters.com/article/brief-pfizer-astellas-report-positive-to/brief-pfizer-astellas-report-positive-top-line-results-from-phase-3-prosper-trial-of-xtandi-idUSASB0BJFO,
20170920 1:22PM UTC,BRIEF-Pfizer announces outcome of FDA advisory committee meeting for Sutent,http://www.reuters.com/article/brief-pfizer-announces-outcome-of-fda-ad/brief-pfizer-announces-outcome-of-fda-advisory-committee-meeting-for-sutent-idUSFWN1M00J4,
20170921 3:24PM UTC,Pfizer files suit against J&J; over Remicade contracts,http://www.reuters.com/article/us-pfizer-trial-johnson-johnson/pfizer-files-suit-against-jj-over-remicade-contracts-idUSKCN1BV1S8,
20170921 3:22PM UTC,UPDATE 3-Pfizer files suit against J&J; over Remicade contracts,http://www.reuters.com/article/pfizer-trial-johnsonjohnson/update-3-pfizer-files-suit-against-jj-over-remicade-contracts-idUSL4N1M14A1,
20170921 11:01AM UTC,Pfizer files suit against J&J; over Remicade contracts,http://www.reuters.com/article/legal-us-pfizer-trial-johnson-johnson/pfizer-files-suit-against-jj-over-remicade-contracts-idUSKCN1BV1ZL,
20170921 9:43AM UTC,Pfizer sues Johnson & Johnson over Remicade biosimilar,http://www.reuters.com/article/pfizer-trial-johnsonjohnson/pfizer-sues-johnson-johnson-over-remicade-biosimilar-idUSL4N1M1475,
20170921 9:39AM UTC,BRIEF-â€Pfizer files lawsuit against Johnson & Johnsonâ€‹,http://www.reuters.com/article/brief-pfizer-files-lawsuit-against-johns/brief-pfizer-files-lawsuit-against-johnson-johnson-idUSFWN1M10M9,
20170922 3:21AM UTC,"Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod",http://www.reuters.com/article/us-merck-bavencio/merck-kgaa-pfizers-cancer-drug-bavencio-gets-eu-nod-idUSKCN1BW0V3,
20170922 3:19AM UTC,"Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod",http://www.reuters.com/article/merck-bavencio/merck-kgaa-pfizers-cancer-drug-bavencio-gets-eu-nod-idUSL5N1M213A,
20170928 8:32AM UTC,BRIEF-Pfizer declares 32-cent fourth-quarter 2017 dividend,http://www.reuters.com/article/brief-pfizer-declares-32-cent-fourth-qua/brief-pfizer-declares-32-cent-fourth-quarter-2017-dividend-idUSFWN1M80I1,
20170929 7:38PM UTC,Pfizer sues Sun Pharmaceuticals to block generic Bosulif,http://www.reuters.com/article/ip-bosulif/pfizer-sues-sun-pharmaceuticals-to-block-generic-bosulif-idUSL2N1M92GX,
20171011 2:02PM UTC,Breakingviews - Pfizer and Glaxo may find romance over the counter,http://www.reuters.com/article/us-pfizer-divestiture-breakingviews/breakingviews-pfizer-and-glaxo-may-find-romance-over-the-counter-idUSKBN1CF2JQ,
20171011 1:04PM UTC,Pfizer weighs $15 billion sale of consumer healthcare business,http://www.reuters.com/article/us-pfizer-divestiture/pfizer-weighs-15-billion-sale-of-consumer-healthcare-business-idUSKBN1CF19M,
20171011 1:01PM UTC,UPDATE 4-Pfizer weighs $15 bln sale of consumer healthcare business,http://www.reuters.com/article/pfizer-divestiture/update-4-pfizer-weighs-15-bln-sale-of-consumer-healthcare-business-idUSL4N1ML3RG,
20171011 6:58AM UTC,Pfizer mulling sale of consumer healthcare business,http://www.reuters.com/article/pfizer-divestiture/pfizer-mulling-sale-of-consumer-healthcare-business-idUSL4N1ML3QI,
20171011 6:49AM UTC,BRIEF-Pfizer reviewing strategic alternatives for Consumer Healthcare business,http://www.reuters.com/article/brief-pfizer-reviewing-strategic-alterna/brief-pfizer-reviewing-strategic-alternatives-for-consumer-healthcare-business-idUSASB0BMGY,
20171012 3:19AM UTC,BRIEF-Nestle has no comment on Pfizer's consumer healthcare business,http://www.reuters.com/article/brief-nestle-has-no-comment-on-pfizers-c/brief-nestle-has-no-comment-on-pfizers-consumer-healthcare-business-idUSZ8N1LU00I,
20171013 8:14AM UTC,BRIEF-FDA approves Pfizer's LyricaÂ® CR extended-release tablets CV,http://www.reuters.com/article/brief-fda-approves-pfizers-lyrica-cr-ext/brief-fda-approves-pfizers-lyrica-cr-extended-release-tablets-cv-idUSASB0BMUS,
20171017 7:30AM UTC,BRIEF-Pfizer presents results from Phase 2 study of investigational ALK-inhibitor lorlatinib,http://www.reuters.com/article/brief-pfizer-presents-results-from-phase/brief-pfizer-presents-results-from-phase-2-study-of-investigational-alk-inhibitor-lorlatinib-idUSFWN1MR0HL,
20171019 3:45PM UTC,BRIEF-Pfizer reports 5.4 pct passive stake in Rhythm Pharmaceuticals - â€â€‹SEC filing,http://www.reuters.com/article/brief-pfizer-reports-54-pct-passive-stak/brief-pfizer-reports-5-4-pct-passive-stake-in-rhythm-pharmaceuticals-sec-filing-idUSFWN1MT0SQ,
20171026 11:31AM UTC,"GSK may bid for Pfizer consumer unit, stoking dividend fears",http://www.reuters.com/article/us-gsk-results/gsk-may-bid-for-pfizer-consumer-unit-stoking-dividend-fears-idUSKBN1CU1HF,
20171026 11:27AM UTC,"UPDATE 3-GSK may bid for Pfizer consumer unit, stoking dividend fears",http://www.reuters.com/article/gsk-results/update-3-gsk-may-bid-for-pfizer-consumer-unit-stoking-dividend-fears-idUSL8N1N04CT,
20171026 7:47AM UTC,"BRIEF-GSK will look at Pfizer, Merck consumer assets if offered for sale",http://www.reuters.com/article/brief-gsk-will-look-at-pfizer-merck-cons/brief-gsk-will-look-at-pfizer-merck-consumer-assets-if-offered-for-sale-idUSL9N15G04B,
20171027 6:00AM UTC,Exclusive: Pfizer to launch consumer health sale in November - sources,http://www.reuters.com/article/us-pfizer-divestiture-exclusive/exclusive-pfizer-to-launch-consumer-health-sale-in-november-sources-idUSKBN1CU2RW,
20171101 2:06PM UTC,Pfizer expects broad interest for consumer health business,http://www.reuters.com/article/us-pfizer-results/pfizer-expects-broad-interest-for-consumer-health-business-idUSKBN1D01BD,
20171101 2:03PM UTC,UPDATE 4-Pfizer expects broad interest for consumer health business,http://www.reuters.com/article/pfizer-results/update-4-pfizer-expects-broad-interest-for-consumer-health-business-idUSL4N1N64LD,
20171101 11:27AM UTC,BRIEF-Pfizer sees broad interest for consumer health,http://www.reuters.com/article/brief-pfizer-sees-broad-interest-for-con/brief-pfizer-sees-broad-interest-for-consumer-health-idUSL2N1N6108,
20171101 7:09AM UTC,"BRIEF-Pfizer says qtrly worldwide total lyrica revenue $ 1,150 mln versus $1,049 ln",http://www.reuters.com/article/brief-pfizer-says-qtrly-worldwide-total/brief-pfizer-says-qtrly-worldwide-total-lyrica-revenue-1150-mln-versus-1049-ln-idUSFWN1N60N0,
20171101 7:03AM UTC,BRIEF-Pfizer reports Q3 earnings per share of $0.47,http://www.reuters.com/article/brief-pfizer-reports-q3-earnings-per-sha/brief-pfizer-reports-q3-earnings-per-share-of-0-47-idUSASB0BPT5,
20171101 6:55AM UTC,Pfizer's quarterly profit more than doubles,http://www.reuters.com/article/pfizer-results/pfizers-quarterly-profit-more-than-doubles-idUSL4N1N64K1,
20171101 10:26AM UTC,Pfizer raises profit outlook,http://www.reuters.com/news/video/videoStory?storyID=133974954,
